<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2026 Workiva-->
<!--r:d503d8ff-2f1c-4dbc-a412-c9393c830895,g:e88d7619-7e4b-4760-9a34-a239b32ebe12-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.innate-pharma.com/role/Cover" xlink:type="simple" xlink:href="inpha-20260630.xsd#Cover"/>
  <link:presentationLink xlink:role="http://www.innate-pharma.com/role/Cover" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_bc863c71-f10f-4224-a232-1044021a4730" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_2c011ea0-e1c9-4202-b8d0-2d1694fefd23" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_bc863c71-f10f-4224-a232-1044021a4730" xlink:to="loc_dei_DocumentType_2c011ea0-e1c9-4202-b8d0-2d1694fefd23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_bf0e10a3-065f-48ea-ad1c-13e6295ac48d" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_bc863c71-f10f-4224-a232-1044021a4730" xlink:to="loc_dei_EntityRegistrantName_bf0e10a3-065f-48ea-ad1c-13e6295ac48d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_90898d84-997a-40b5-9579-047533a35cbb" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_bc863c71-f10f-4224-a232-1044021a4730" xlink:to="loc_dei_AmendmentFlag_90898d84-997a-40b5-9579-047533a35cbb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_37fd300c-32b0-44d8-8610-bd8921395f8e" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_bc863c71-f10f-4224-a232-1044021a4730" xlink:to="loc_dei_DocumentPeriodEndDate_37fd300c-32b0-44d8-8610-bd8921395f8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_e6e0b1e5-8ac9-4905-884c-e87944079fdd" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalYearFocus"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_bc863c71-f10f-4224-a232-1044021a4730" xlink:to="loc_dei_DocumentFiscalYearFocus_e6e0b1e5-8ac9-4905-884c-e87944079fdd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_d06a310e-a30c-465a-88cf-52e0ed085ce4" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_bc863c71-f10f-4224-a232-1044021a4730" xlink:to="loc_dei_DocumentFiscalPeriodFocus_d06a310e-a30c-465a-88cf-52e0ed085ce4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_6506658f-8d49-411c-b833-dbf8526760a5" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_bc863c71-f10f-4224-a232-1044021a4730" xlink:to="loc_dei_EntityCentralIndexKey_6506658f-8d49-411c-b833-dbf8526760a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_2df19c39-1292-434d-8be4-d6cc001bee2e" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_bc863c71-f10f-4224-a232-1044021a4730" xlink:to="loc_dei_CurrentFiscalYearEndDate_2df19c39-1292-434d-8be4-d6cc001bee2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.innate-pharma.com/role/InterimCondensedConsolidatedStatementsofFinancialPosition" xlink:type="simple" xlink:href="inpha-20260630.xsd#InterimCondensedConsolidatedStatementsofFinancialPosition"/>
  <link:presentationLink xlink:role="http://www.innate-pharma.com/role/InterimCondensedConsolidatedStatementsofFinancialPosition" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_StatementOfFinancialPositionAbstract_d0905853-5e48-4738-be4d-0ded22e8f86d" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AssetsAbstract_50113bbb-7052-49d8-b090-b3c806af1f28" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfFinancialPositionAbstract_d0905853-5e48-4738-be4d-0ded22e8f86d" xlink:to="loc_ifrs-full_AssetsAbstract_50113bbb-7052-49d8-b090-b3c806af1f28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CurrentAssetsAbstract_496eb54c-3c6c-48f2-a503-25e7f358403f" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentAssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AssetsAbstract_50113bbb-7052-49d8-b090-b3c806af1f28" xlink:to="loc_ifrs-full_CurrentAssetsAbstract_496eb54c-3c6c-48f2-a503-25e7f358403f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CashAndCashEquivalents_dffb8e08-229f-4ea7-b6f7-84fe99d0a6b1" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CashAndCashEquivalents"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CurrentAssetsAbstract_496eb54c-3c6c-48f2-a503-25e7f358403f" xlink:to="loc_ifrs-full_CashAndCashEquivalents_dffb8e08-229f-4ea7-b6f7-84fe99d0a6b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CurrentFinancialAssets_baf984e9-4b3c-41f6-a819-3d95cbe083f5" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentFinancialAssets"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CurrentAssetsAbstract_496eb54c-3c6c-48f2-a503-25e7f358403f" xlink:to="loc_ifrs-full_CurrentFinancialAssets_baf984e9-4b3c-41f6-a819-3d95cbe083f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TradeAndOtherCurrentReceivables_94ee58c1-5f70-413f-9c25-9558eedba205" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TradeAndOtherCurrentReceivables"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CurrentAssetsAbstract_496eb54c-3c6c-48f2-a503-25e7f358403f" xlink:to="loc_ifrs-full_TradeAndOtherCurrentReceivables_94ee58c1-5f70-413f-9c25-9558eedba205" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CurrentAssets_346e59b2-67e3-419e-8220-2cfbd5e51f9f" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentAssets"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CurrentAssetsAbstract_496eb54c-3c6c-48f2-a503-25e7f358403f" xlink:to="loc_ifrs-full_CurrentAssets_346e59b2-67e3-419e-8220-2cfbd5e51f9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NoncurrentAssetsAbstract_6934313b-38c9-4dc6-96e3-c20a57789305" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NoncurrentAssetsAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AssetsAbstract_50113bbb-7052-49d8-b090-b3c806af1f28" xlink:to="loc_ifrs-full_NoncurrentAssetsAbstract_6934313b-38c9-4dc6-96e3-c20a57789305" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IntangibleAssetsOtherThanGoodwill_bfe6aae7-b009-40c6-a58b-04d572d455ef" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IntangibleAssetsOtherThanGoodwill"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_NoncurrentAssetsAbstract_6934313b-38c9-4dc6-96e3-c20a57789305" xlink:to="loc_ifrs-full_IntangibleAssetsOtherThanGoodwill_bfe6aae7-b009-40c6-a58b-04d572d455ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PropertyPlantAndEquipmentIncludingRightofuseAssets_10320c49-af6e-44fb-b76c-5ed79d70300f" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_PropertyPlantAndEquipmentIncludingRightofuseAssets"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_NoncurrentAssetsAbstract_6934313b-38c9-4dc6-96e3-c20a57789305" xlink:to="loc_ifrs-full_PropertyPlantAndEquipmentIncludingRightofuseAssets_10320c49-af6e-44fb-b76c-5ed79d70300f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NoncurrentFinancialAssets_bb4f33ae-a961-49ec-9069-015ab98a15ea" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NoncurrentFinancialAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_NoncurrentAssetsAbstract_6934313b-38c9-4dc6-96e3-c20a57789305" xlink:to="loc_ifrs-full_NoncurrentFinancialAssets_bb4f33ae-a961-49ec-9069-015ab98a15ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherNoncurrentNonfinancialAssets_26cb1a3a-23ea-4789-8bbe-85c9284de5dd" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherNoncurrentNonfinancialAssets"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_NoncurrentAssetsAbstract_6934313b-38c9-4dc6-96e3-c20a57789305" xlink:to="loc_ifrs-full_OtherNoncurrentNonfinancialAssets_26cb1a3a-23ea-4789-8bbe-85c9284de5dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NoncurrentReceivables_04f22f58-d279-4161-bdd1-4ed772707904" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NoncurrentReceivables"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_NoncurrentAssetsAbstract_6934313b-38c9-4dc6-96e3-c20a57789305" xlink:to="loc_ifrs-full_NoncurrentReceivables_04f22f58-d279-4161-bdd1-4ed772707904" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NoncurrentAssets_a40fbe4f-a7a0-4096-84ac-12fab2f2d548" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NoncurrentAssets"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_NoncurrentAssetsAbstract_6934313b-38c9-4dc6-96e3-c20a57789305" xlink:to="loc_ifrs-full_NoncurrentAssets_a40fbe4f-a7a0-4096-84ac-12fab2f2d548" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_Assets_8c739f13-e84f-4dbe-890b-f6bd404f72c9" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_Assets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AssetsAbstract_50113bbb-7052-49d8-b090-b3c806af1f28" xlink:to="loc_ifrs-full_Assets_8c739f13-e84f-4dbe-890b-f6bd404f72c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EquityAndLiabilitiesAbstract_397d9b33-a12d-4a5c-9286-b8f42efedf62" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_EquityAndLiabilitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfFinancialPositionAbstract_d0905853-5e48-4738-be4d-0ded22e8f86d" xlink:to="loc_ifrs-full_EquityAndLiabilitiesAbstract_397d9b33-a12d-4a5c-9286-b8f42efedf62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CurrentLiabilitiesAbstract_e9728423-0919-4d2f-8a9e-404cc8d41681" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentLiabilitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EquityAndLiabilitiesAbstract_397d9b33-a12d-4a5c-9286-b8f42efedf62" xlink:to="loc_ifrs-full_CurrentLiabilitiesAbstract_e9728423-0919-4d2f-8a9e-404cc8d41681" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TradeAndOtherCurrentPayables_50462d6b-c0ac-44a0-ba79-7866f89fb040" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TradeAndOtherCurrentPayables"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CurrentLiabilitiesAbstract_e9728423-0919-4d2f-8a9e-404cc8d41681" xlink:to="loc_ifrs-full_TradeAndOtherCurrentPayables_50462d6b-c0ac-44a0-ba79-7866f89fb040" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_CollaborationLiabilitiesCurrent_74b31b3a-e0cf-4103-8cc3-4a1f634e479b" xlink:href="inpha-20260630.xsd#inpha_CollaborationLiabilitiesCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CurrentLiabilitiesAbstract_e9728423-0919-4d2f-8a9e-404cc8d41681" xlink:to="loc_inpha_CollaborationLiabilitiesCurrent_74b31b3a-e0cf-4103-8cc3-4a1f634e479b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CurrentFinancialLiabilities_cc25640c-7dfd-4f27-9d76-1a7f42089ae9" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentFinancialLiabilities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CurrentLiabilitiesAbstract_e9728423-0919-4d2f-8a9e-404cc8d41681" xlink:to="loc_ifrs-full_CurrentFinancialLiabilities_cc25640c-7dfd-4f27-9d76-1a7f42089ae9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CurrentDeferredIncomeIncludingCurrentContractLiabilities_37bce1e3-80b9-4a4f-b419-b67bbbae6f33" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentDeferredIncomeIncludingCurrentContractLiabilities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CurrentLiabilitiesAbstract_e9728423-0919-4d2f-8a9e-404cc8d41681" xlink:to="loc_ifrs-full_CurrentDeferredIncomeIncludingCurrentContractLiabilities_37bce1e3-80b9-4a4f-b419-b67bbbae6f33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CurrentProvisions_daa4f125-1fe3-4c8a-a7dc-29dedbd0baff" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentProvisions"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CurrentLiabilitiesAbstract_e9728423-0919-4d2f-8a9e-404cc8d41681" xlink:to="loc_ifrs-full_CurrentProvisions_daa4f125-1fe3-4c8a-a7dc-29dedbd0baff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CurrentLiabilities_8e531bb8-545d-4136-abb6-13d5bd22eaa0" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentLiabilities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CurrentLiabilitiesAbstract_e9728423-0919-4d2f-8a9e-404cc8d41681" xlink:to="loc_ifrs-full_CurrentLiabilities_8e531bb8-545d-4136-abb6-13d5bd22eaa0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NoncurrentLiabilitiesAbstract_bb940e9c-0aed-4fc3-a669-ce8448024174" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NoncurrentLiabilitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EquityAndLiabilitiesAbstract_397d9b33-a12d-4a5c-9286-b8f42efedf62" xlink:to="loc_ifrs-full_NoncurrentLiabilitiesAbstract_bb940e9c-0aed-4fc3-a669-ce8448024174" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_CollaborationLiabilitiesNonCurrent_0eeffcea-9e77-4cdb-8e93-ecb47abb6719" xlink:href="inpha-20260630.xsd#inpha_CollaborationLiabilitiesNonCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_NoncurrentLiabilitiesAbstract_bb940e9c-0aed-4fc3-a669-ce8448024174" xlink:to="loc_inpha_CollaborationLiabilitiesNonCurrent_0eeffcea-9e77-4cdb-8e93-ecb47abb6719" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NoncurrentFinancialLiabilities_235193bc-71de-4fb6-9223-713e8963a47a" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NoncurrentFinancialLiabilities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_NoncurrentLiabilitiesAbstract_bb940e9c-0aed-4fc3-a669-ce8448024174" xlink:to="loc_ifrs-full_NoncurrentFinancialLiabilities_235193bc-71de-4fb6-9223-713e8963a47a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NoncurrentProvisionsForEmployeeBenefits_4758e580-3158-4f23-b054-3d9f1291d49c" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NoncurrentProvisionsForEmployeeBenefits"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_NoncurrentLiabilitiesAbstract_bb940e9c-0aed-4fc3-a669-ce8448024174" xlink:to="loc_ifrs-full_NoncurrentProvisionsForEmployeeBenefits_4758e580-3158-4f23-b054-3d9f1291d49c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NoncurrentDeferredIncomeIncludingNoncurrentContractLiabilities_d35306b1-8057-43f5-86c1-e3ff7f80d38c" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NoncurrentDeferredIncomeIncludingNoncurrentContractLiabilities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_NoncurrentLiabilitiesAbstract_bb940e9c-0aed-4fc3-a669-ce8448024174" xlink:to="loc_ifrs-full_NoncurrentDeferredIncomeIncludingNoncurrentContractLiabilities_d35306b1-8057-43f5-86c1-e3ff7f80d38c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NoncurrentProvisions_61657ec6-bcc2-4faf-85bd-23805729bf5a" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NoncurrentProvisions"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_NoncurrentLiabilitiesAbstract_bb940e9c-0aed-4fc3-a669-ce8448024174" xlink:to="loc_ifrs-full_NoncurrentProvisions_61657ec6-bcc2-4faf-85bd-23805729bf5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NoncurrentLiabilities_c2b44569-c014-4251-82df-a66dd45155ff" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NoncurrentLiabilities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_NoncurrentLiabilitiesAbstract_bb940e9c-0aed-4fc3-a669-ce8448024174" xlink:to="loc_ifrs-full_NoncurrentLiabilities_c2b44569-c014-4251-82df-a66dd45155ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EquityAbstract_5272b0a7-ca7e-477e-92e4-1bcac5861a31" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_EquityAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfFinancialPositionAbstract_d0905853-5e48-4738-be4d-0ded22e8f86d" xlink:to="loc_ifrs-full_EquityAbstract_5272b0a7-ca7e-477e-92e4-1bcac5861a31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IssuedCapital_c16a17dd-64bc-43b4-9909-00fa4bb0508c" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IssuedCapital"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EquityAbstract_5272b0a7-ca7e-477e-92e4-1bcac5861a31" xlink:to="loc_ifrs-full_IssuedCapital_c16a17dd-64bc-43b4-9909-00fa4bb0508c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SharePremium_f7d77ab4-34e3-4418-815a-8a7336f0ea7f" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_SharePremium"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EquityAbstract_5272b0a7-ca7e-477e-92e4-1bcac5861a31" xlink:to="loc_ifrs-full_SharePremium_f7d77ab4-34e3-4418-815a-8a7336f0ea7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RetainedEarningsExcludingProfitLossForReportingPeriod_4f550f3c-e8e1-40e1-8127-b6acb4bcd0c4" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RetainedEarningsExcludingProfitLossForReportingPeriod"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EquityAbstract_5272b0a7-ca7e-477e-92e4-1bcac5861a31" xlink:to="loc_ifrs-full_RetainedEarningsExcludingProfitLossForReportingPeriod_4f550f3c-e8e1-40e1-8127-b6acb4bcd0c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherReserves_c0dee9a6-b885-4701-94d7-7b7e97631686" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherReserves"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EquityAbstract_5272b0a7-ca7e-477e-92e4-1bcac5861a31" xlink:to="loc_ifrs-full_OtherReserves_c0dee9a6-b885-4701-94d7-7b7e97631686" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RetainedEarningsProfitLossForReportingPeriod_8b6cc21f-d5f3-4d44-b19c-69c846516829" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RetainedEarningsProfitLossForReportingPeriod"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EquityAbstract_5272b0a7-ca7e-477e-92e4-1bcac5861a31" xlink:to="loc_ifrs-full_RetainedEarningsProfitLossForReportingPeriod_8b6cc21f-d5f3-4d44-b19c-69c846516829" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_Equity_302fa456-f991-4130-9e32-75d69c5c3b5e" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_Equity"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EquityAbstract_5272b0a7-ca7e-477e-92e4-1bcac5861a31" xlink:to="loc_ifrs-full_Equity_302fa456-f991-4130-9e32-75d69c5c3b5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EquityAndLiabilities_9c98754e-b477-4e22-ab98-3a4d64ffd895" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_EquityAndLiabilities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfFinancialPositionAbstract_d0905853-5e48-4738-be4d-0ded22e8f86d" xlink:to="loc_ifrs-full_EquityAndLiabilities_9c98754e-b477-4e22-ab98-3a4d64ffd895" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.innate-pharma.com/role/InterimCondensedConsolidatedStatementsofIncomeLoss" xlink:type="simple" xlink:href="inpha-20260630.xsd#InterimCondensedConsolidatedStatementsofIncomeLoss"/>
  <link:presentationLink xlink:role="http://www.innate-pharma.com/role/InterimCondensedConsolidatedStatementsofIncomeLoss" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProfitLossAbstract_d3b37f6e-28ec-4993-817b-f20ac5e720cd" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProfitLossAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RevenueFromContractsWithCustomers_220655c3-1df0-4aa5-8ec1-d8b5b895e040" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RevenueFromContractsWithCustomers"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ProfitLossAbstract_d3b37f6e-28ec-4993-817b-f20ac5e720cd" xlink:to="loc_ifrs-full_RevenueFromContractsWithCustomers_220655c3-1df0-4aa5-8ec1-d8b5b895e040" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_GovernmentFinancingForResearchExpenditures_18a44ca6-8923-4a5c-a5b5-fa24b9d966ca" xlink:href="inpha-20260630.xsd#inpha_GovernmentFinancingForResearchExpenditures"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ProfitLossAbstract_d3b37f6e-28ec-4993-817b-f20ac5e720cd" xlink:to="loc_inpha_GovernmentFinancingForResearchExpenditures_18a44ca6-8923-4a5c-a5b5-fa24b9d966ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherIncome_019fb2db-24c2-7422-93c9-53e03f2cf162" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherIncome"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ProfitLossAbstract_d3b37f6e-28ec-4993-817b-f20ac5e720cd" xlink:to="loc_ifrs-full_OtherIncome_019fb2db-24c2-7422-93c9-53e03f2cf162" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_Revenue_d5ba702b-1efc-4906-ac1e-6e73cdf96c2b" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_Revenue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ProfitLossAbstract_d3b37f6e-28ec-4993-817b-f20ac5e720cd" xlink:to="loc_ifrs-full_Revenue_d5ba702b-1efc-4906-ac1e-6e73cdf96c2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ResearchAndDevelopmentExpense_e3f73ae1-ec18-4e3c-a722-823b9941c590" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ResearchAndDevelopmentExpense"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ProfitLossAbstract_d3b37f6e-28ec-4993-817b-f20ac5e720cd" xlink:to="loc_ifrs-full_ResearchAndDevelopmentExpense_e3f73ae1-ec18-4e3c-a722-823b9941c590" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GeneralAndAdministrativeExpense_a2b39db0-f7b6-4f3b-b714-d13886aef758" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_GeneralAndAdministrativeExpense"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ProfitLossAbstract_d3b37f6e-28ec-4993-817b-f20ac5e720cd" xlink:to="loc_ifrs-full_GeneralAndAdministrativeExpense_a2b39db0-f7b6-4f3b-b714-d13886aef758" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OperatingExpense_b129347d-0dca-4f2e-80a3-1870728ea374" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OperatingExpense"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ProfitLossAbstract_d3b37f6e-28ec-4993-817b-f20ac5e720cd" xlink:to="loc_ifrs-full_OperatingExpense_b129347d-0dca-4f2e-80a3-1870728ea374" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProfitLossFromOperatingActivities_8061196e-4a94-4d34-b781-2ef745b64b14" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProfitLossFromOperatingActivities"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ProfitLossAbstract_d3b37f6e-28ec-4993-817b-f20ac5e720cd" xlink:to="loc_ifrs-full_ProfitLossFromOperatingActivities_8061196e-4a94-4d34-b781-2ef745b64b14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FinanceIncome_d37719fb-c99b-452d-8907-22cf4c22bb08" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_FinanceIncome"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ProfitLossAbstract_d3b37f6e-28ec-4993-817b-f20ac5e720cd" xlink:to="loc_ifrs-full_FinanceIncome_d37719fb-c99b-452d-8907-22cf4c22bb08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FinanceCosts_d093e0e0-bfbc-436f-9065-4b7d1ca8987d" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_FinanceCosts"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ProfitLossAbstract_d3b37f6e-28ec-4993-817b-f20ac5e720cd" xlink:to="loc_ifrs-full_FinanceCosts_d093e0e0-bfbc-436f-9065-4b7d1ca8987d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FinanceIncomeCost_bb205854-954a-4e36-80c6-34e183b74108" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_FinanceIncomeCost"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ProfitLossAbstract_d3b37f6e-28ec-4993-817b-f20ac5e720cd" xlink:to="loc_ifrs-full_FinanceIncomeCost_bb205854-954a-4e36-80c6-34e183b74108" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProfitLossBeforeTax_9778efbb-6077-46d1-9026-3e1323826b48" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProfitLossBeforeTax"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ProfitLossAbstract_d3b37f6e-28ec-4993-817b-f20ac5e720cd" xlink:to="loc_ifrs-full_ProfitLossBeforeTax_9778efbb-6077-46d1-9026-3e1323826b48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncomeTaxExpenseContinuingOperations_1c774d20-2ef3-48b7-aa8e-7a4b17ae7c79" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IncomeTaxExpenseContinuingOperations"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ProfitLossAbstract_d3b37f6e-28ec-4993-817b-f20ac5e720cd" xlink:to="loc_ifrs-full_IncomeTaxExpenseContinuingOperations_1c774d20-2ef3-48b7-aa8e-7a4b17ae7c79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProfitLoss_dbe96b19-ef96-45f8-bb39-a0132fdcd48b" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProfitLoss"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ProfitLossAbstract_d3b37f6e-28ec-4993-817b-f20ac5e720cd" xlink:to="loc_ifrs-full_ProfitLoss_dbe96b19-ef96-45f8-bb39-a0132fdcd48b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EarningsPerShareAbstract_ac4910cf-fdbc-4fee-972e-400cee6aa208" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_EarningsPerShareAbstract"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ProfitLossAbstract_d3b37f6e-28ec-4993-817b-f20ac5e720cd" xlink:to="loc_ifrs-full_EarningsPerShareAbstract_ac4910cf-fdbc-4fee-972e-400cee6aa208" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_WeightedAverageShares_ce339c88-a38a-4669-83aa-ba6a802fb9f2" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_WeightedAverageShares"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EarningsPerShareAbstract_ac4910cf-fdbc-4fee-972e-400cee6aa208" xlink:to="loc_ifrs-full_WeightedAverageShares_ce339c88-a38a-4669-83aa-ba6a802fb9f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AdjustedWeightedAverageShares_7492c7eb-f679-4ee1-b21c-54cd54ce7038" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AdjustedWeightedAverageShares"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EarningsPerShareAbstract_ac4910cf-fdbc-4fee-972e-400cee6aa208" xlink:to="loc_ifrs-full_AdjustedWeightedAverageShares_7492c7eb-f679-4ee1-b21c-54cd54ce7038" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BasicEarningsLossPerShare_39c57db8-8f6c-4375-a2f5-df0acafe2270" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BasicEarningsLossPerShare"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EarningsPerShareAbstract_ac4910cf-fdbc-4fee-972e-400cee6aa208" xlink:to="loc_ifrs-full_BasicEarningsLossPerShare_39c57db8-8f6c-4375-a2f5-df0acafe2270" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DilutedEarningsLossPerShare_112b8c1a-9619-420f-a964-779464e9dddd" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DilutedEarningsLossPerShare"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EarningsPerShareAbstract_ac4910cf-fdbc-4fee-972e-400cee6aa208" xlink:to="loc_ifrs-full_DilutedEarningsLossPerShare_112b8c1a-9619-420f-a964-779464e9dddd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.innate-pharma.com/role/InterimCondensedConsolidatedStatementsofComprehensiveIncomeLoss" xlink:type="simple" xlink:href="inpha-20260630.xsd#InterimCondensedConsolidatedStatementsofComprehensiveIncomeLoss"/>
  <link:presentationLink xlink:role="http://www.innate-pharma.com/role/InterimCondensedConsolidatedStatementsofComprehensiveIncomeLoss" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_StatementOfComprehensiveIncomeAbstract_59c31d27-83bf-49e6-a6ff-572dcc85af5f" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_StatementOfComprehensiveIncomeAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProfitLoss_9a48bb97-866b-4bd0-a32a-55877bf9afbc" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProfitLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfComprehensiveIncomeAbstract_59c31d27-83bf-49e6-a6ff-572dcc85af5f" xlink:to="loc_ifrs-full_ProfitLoss_9a48bb97-866b-4bd0-a32a-55877bf9afbc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ComponentsOfOtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTaxAbstract_ada0062d-3437-4a14-9f9d-e0f8cb35a1b4" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ComponentsOfOtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTaxAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfComprehensiveIncomeAbstract_59c31d27-83bf-49e6-a6ff-572dcc85af5f" xlink:to="loc_ifrs-full_ComponentsOfOtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTaxAbstract_ada0062d-3437-4a14-9f9d-e0f8cb35a1b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans_7e43f24e-8ade-42be-9e95-086384b9e167" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ComponentsOfOtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTaxAbstract_ada0062d-3437-4a14-9f9d-e0f8cb35a1b4" xlink:to="loc_ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans_7e43f24e-8ade-42be-9e95-086384b9e167" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ComponentsOfOtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTaxAbstract_c1169362-9c84-48f7-8eec-4302556a5493" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ComponentsOfOtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTaxAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfComprehensiveIncomeAbstract_59c31d27-83bf-49e6-a6ff-572dcc85af5f" xlink:to="loc_ifrs-full_ComponentsOfOtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTaxAbstract_c1169362-9c84-48f7-8eec-4302556a5493" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation_119e54ce-b5d2-4da1-b507-a9b0b5621297" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ComponentsOfOtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTaxAbstract_c1169362-9c84-48f7-8eec-4302556a5493" xlink:to="loc_ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation_119e54ce-b5d2-4da1-b507-a9b0b5621297" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherComprehensiveIncome_4fa3bc15-9c53-4a11-9293-052b1c74a02a" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherComprehensiveIncome"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfComprehensiveIncomeAbstract_59c31d27-83bf-49e6-a6ff-572dcc85af5f" xlink:to="loc_ifrs-full_OtherComprehensiveIncome_4fa3bc15-9c53-4a11-9293-052b1c74a02a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ComprehensiveIncome_e06f4588-d099-48d9-a10d-ce813f1d1670" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ComprehensiveIncome"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfComprehensiveIncomeAbstract_59c31d27-83bf-49e6-a6ff-572dcc85af5f" xlink:to="loc_ifrs-full_ComprehensiveIncome_e06f4588-d099-48d9-a10d-ce813f1d1670" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.innate-pharma.com/role/InterimCondensedConsolidatedStatementsofCashFlows" xlink:type="simple" xlink:href="inpha-20260630.xsd#InterimCondensedConsolidatedStatementsofCashFlows"/>
  <link:presentationLink xlink:role="http://www.innate-pharma.com/role/InterimCondensedConsolidatedStatementsofCashFlows" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_StatementOfCashFlowsAbstract_22de8d6b-c42c-42fb-9177-fa48ef8f1703" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProfitLoss_a385f108-8f34-4fdd-945a-15a6a415456f" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProfitLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfCashFlowsAbstract_22de8d6b-c42c-42fb-9177-fa48ef8f1703" xlink:to="loc_ifrs-full_ProfitLoss_a385f108-8f34-4fdd-945a-15a6a415456f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AdjustmentsForDepreciationAndAmortisationExpense_d21ff2d3-b7a3-4419-a102-ed9a6ef9e419" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AdjustmentsForDepreciationAndAmortisationExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfCashFlowsAbstract_22de8d6b-c42c-42fb-9177-fa48ef8f1703" xlink:to="loc_ifrs-full_AdjustmentsForDepreciationAndAmortisationExpense_d21ff2d3-b7a3-4419-a102-ed9a6ef9e419" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities_0bf6a0cf-4696-4645-a1b2-66d7c3d64fa9" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfCashFlowsAbstract_22de8d6b-c42c-42fb-9177-fa48ef8f1703" xlink:to="loc_ifrs-full_AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities_0bf6a0cf-4696-4645-a1b2-66d7c3d64fa9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AdjustmentsForProvisions_ef71c7d8-3e25-4844-8de5-85d24b420dc4" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AdjustmentsForProvisions"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfCashFlowsAbstract_22de8d6b-c42c-42fb-9177-fa48ef8f1703" xlink:to="loc_ifrs-full_AdjustmentsForProvisions_ef71c7d8-3e25-4844-8de5-85d24b420dc4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AdjustmentsForSharebasedPayments_cec60313-4341-4c5b-8726-08c8ff29aaa7" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AdjustmentsForSharebasedPayments"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfCashFlowsAbstract_22de8d6b-c42c-42fb-9177-fa48ef8f1703" xlink:to="loc_ifrs-full_AdjustmentsForSharebasedPayments_cec60313-4341-4c5b-8726-08c8ff29aaa7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AdjustmentsForFairValueGainsLosses_b1080e9a-6bbb-4c98-84b7-4b4664b00238" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AdjustmentsForFairValueGainsLosses"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfCashFlowsAbstract_22de8d6b-c42c-42fb-9177-fa48ef8f1703" xlink:to="loc_ifrs-full_AdjustmentsForFairValueGainsLosses_b1080e9a-6bbb-4c98-84b7-4b4664b00238" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AdjustmentsForUnrealisedForeignExchangeLossesGains_561f55d3-fd15-4d5f-b32e-88c8d816c981" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AdjustmentsForUnrealisedForeignExchangeLossesGains"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfCashFlowsAbstract_22de8d6b-c42c-42fb-9177-fa48ef8f1703" xlink:to="loc_ifrs-full_AdjustmentsForUnrealisedForeignExchangeLossesGains_561f55d3-fd15-4d5f-b32e-88c8d816c981" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AdjustmentsForDecreaseIncreaseInAccruedIncomeIncludingContractAssets_5524814d-b35e-42e9-a2bf-56bc599ab7a5" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AdjustmentsForDecreaseIncreaseInAccruedIncomeIncludingContractAssets"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfCashFlowsAbstract_22de8d6b-c42c-42fb-9177-fa48ef8f1703" xlink:to="loc_ifrs-full_AdjustmentsForDecreaseIncreaseInAccruedIncomeIncludingContractAssets_5524814d-b35e-42e9-a2bf-56bc599ab7a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AdjustmentsForGainLossOnDisposalsPropertyPlantAndEquipment_724656f4-0349-4b73-bf4c-d5bb0c2bb2a7" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AdjustmentsForGainLossOnDisposalsPropertyPlantAndEquipment"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfCashFlowsAbstract_22de8d6b-c42c-42fb-9177-fa48ef8f1703" xlink:to="loc_ifrs-full_AdjustmentsForGainLossOnDisposalsPropertyPlantAndEquipment_724656f4-0349-4b73-bf4c-d5bb0c2bb2a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherAdjustmentsToReconcileProfitLoss_78597cbf-c062-4ac7-a2f4-b69632616b6b" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherAdjustmentsToReconcileProfitLoss"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfCashFlowsAbstract_22de8d6b-c42c-42fb-9177-fa48ef8f1703" xlink:to="loc_ifrs-full_OtherAdjustmentsToReconcileProfitLoss_78597cbf-c062-4ac7-a2f4-b69632616b6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital_2648f28f-4e43-4c2d-a34a-26665a3ceda4" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfCashFlowsAbstract_22de8d6b-c42c-42fb-9177-fa48ef8f1703" xlink:to="loc_ifrs-full_CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital_2648f28f-4e43-4c2d-a34a-26665a3ceda4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncreaseDecreaseInWorkingCapital_2c57f347-e4cb-49ce-ae47-c739194333bd" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IncreaseDecreaseInWorkingCapital"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfCashFlowsAbstract_22de8d6b-c42c-42fb-9177-fa48ef8f1703" xlink:to="loc_ifrs-full_IncreaseDecreaseInWorkingCapital_2c57f347-e4cb-49ce-ae47-c739194333bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CashFlowsFromUsedInOperatingActivities_5da0ab9a-fc4f-4d18-a635-1cd77be436f7" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CashFlowsFromUsedInOperatingActivities"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfCashFlowsAbstract_22de8d6b-c42c-42fb-9177-fa48ef8f1703" xlink:to="loc_ifrs-full_CashFlowsFromUsedInOperatingActivities_5da0ab9a-fc4f-4d18-a635-1cd77be436f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities_b37b5bf5-53f0-46bb-b1ae-97983627f9f4" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfCashFlowsAbstract_22de8d6b-c42c-42fb-9177-fa48ef8f1703" xlink:to="loc_ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities_b37b5bf5-53f0-46bb-b1ae-97983627f9f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities_019fb2dc-b7c8-7f63-9752-e055fd7a16fa" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfCashFlowsAbstract_22de8d6b-c42c-42fb-9177-fa48ef8f1703" xlink:to="loc_ifrs-full_ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities_019fb2dc-b7c8-7f63-9752-e055fd7a16fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProceedsFromOtherLongtermAssetsClassifiedAsInvestingActivities_019fb2dc-c313-7983-b87b-d18c534d3689" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProceedsFromOtherLongtermAssetsClassifiedAsInvestingActivities"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfCashFlowsAbstract_22de8d6b-c42c-42fb-9177-fa48ef8f1703" xlink:to="loc_ifrs-full_ProceedsFromOtherLongtermAssetsClassifiedAsInvestingActivities_019fb2dc-c313-7983-b87b-d18c534d3689" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PurchaseOfOtherLongtermAssetsClassifiedAsInvestingActivities_dcf80412-a8ba-439c-aebe-704953e8b02d" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_PurchaseOfOtherLongtermAssetsClassifiedAsInvestingActivities"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfCashFlowsAbstract_22de8d6b-c42c-42fb-9177-fa48ef8f1703" xlink:to="loc_ifrs-full_PurchaseOfOtherLongtermAssetsClassifiedAsInvestingActivities_dcf80412-a8ba-439c-aebe-704953e8b02d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_DisposalOfCurrentFinancialInstrumentsAndPaidInterestsClassifiedAsInvestingActivities_c40d1e0f-855d-4a62-8473-4457b0d53272" xlink:href="inpha-20260630.xsd#inpha_DisposalOfCurrentFinancialInstrumentsAndPaidInterestsClassifiedAsInvestingActivities"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfCashFlowsAbstract_22de8d6b-c42c-42fb-9177-fa48ef8f1703" xlink:to="loc_inpha_DisposalOfCurrentFinancialInstrumentsAndPaidInterestsClassifiedAsInvestingActivities_c40d1e0f-855d-4a62-8473-4457b0d53272" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_InterestReceivedAdjustmentClassifiedAsInvestingActivities_0c753c96-e5eb-427f-a654-af8f269c3c21" xlink:href="inpha-20260630.xsd#inpha_InterestReceivedAdjustmentClassifiedAsInvestingActivities"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfCashFlowsAbstract_22de8d6b-c42c-42fb-9177-fa48ef8f1703" xlink:to="loc_inpha_InterestReceivedAdjustmentClassifiedAsInvestingActivities_0c753c96-e5eb-427f-a654-af8f269c3c21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CashFlowsFromUsedInInvestingActivities_c09a74cd-58f7-43fc-80ee-38db941f5f40" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CashFlowsFromUsedInInvestingActivities"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfCashFlowsAbstract_22de8d6b-c42c-42fb-9177-fa48ef8f1703" xlink:to="loc_ifrs-full_CashFlowsFromUsedInInvestingActivities_c09a74cd-58f7-43fc-80ee-38db941f5f40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProceedsFromIssuingShares_9982cd46-e934-4ee3-913c-2b9edeaf5fe5" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProceedsFromIssuingShares"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfCashFlowsAbstract_22de8d6b-c42c-42fb-9177-fa48ef8f1703" xlink:to="loc_ifrs-full_ProceedsFromIssuingShares_9982cd46-e934-4ee3-913c-2b9edeaf5fe5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RepaymentsOfBorrowingsClassifiedAsFinancingActivities_aef1478a-8771-4a4f-8172-5fbef5f9c2a3" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RepaymentsOfBorrowingsClassifiedAsFinancingActivities"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfCashFlowsAbstract_22de8d6b-c42c-42fb-9177-fa48ef8f1703" xlink:to="loc_ifrs-full_RepaymentsOfBorrowingsClassifiedAsFinancingActivities_aef1478a-8771-4a4f-8172-5fbef5f9c2a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CashFlowsFromUsedInFinancingActivities_8129af86-a257-475e-ada9-c82ec5ab0855" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CashFlowsFromUsedInFinancingActivities"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfCashFlowsAbstract_22de8d6b-c42c-42fb-9177-fa48ef8f1703" xlink:to="loc_ifrs-full_CashFlowsFromUsedInFinancingActivities_8129af86-a257-475e-ada9-c82ec5ab0855" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents_e8855fe1-513a-491c-a590-ebbec937961c" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfCashFlowsAbstract_22de8d6b-c42c-42fb-9177-fa48ef8f1703" xlink:to="loc_ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents_e8855fe1-513a-491c-a590-ebbec937961c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncreaseDecreaseInCashAndCashEquivalents_fb6edc2b-2e53-4b00-a2a6-14aed3324843" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IncreaseDecreaseInCashAndCashEquivalents"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfCashFlowsAbstract_22de8d6b-c42c-42fb-9177-fa48ef8f1703" xlink:to="loc_ifrs-full_IncreaseDecreaseInCashAndCashEquivalents_fb6edc2b-2e53-4b00-a2a6-14aed3324843" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CashAndCashEquivalents_5cb413a0-9fc0-448f-8b0d-a2c66923eabf" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CashAndCashEquivalents"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfCashFlowsAbstract_22de8d6b-c42c-42fb-9177-fa48ef8f1703" xlink:to="loc_ifrs-full_CashAndCashEquivalents_5cb413a0-9fc0-448f-8b0d-a2c66923eabf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CashAndCashEquivalents_f295498b-3107-4a81-ae63-3ae86ef52b84" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CashAndCashEquivalents"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfCashFlowsAbstract_22de8d6b-c42c-42fb-9177-fa48ef8f1703" xlink:to="loc_ifrs-full_CashAndCashEquivalents_f295498b-3107-4a81-ae63-3ae86ef52b84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_SummaryOfChangesInWorkingCapitalAbstract_fbe70e42-2c43-4ed8-bf68-8659bb7d7f32" xlink:href="inpha-20260630.xsd#inpha_SummaryOfChangesInWorkingCapitalAbstract"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfCashFlowsAbstract_22de8d6b-c42c-42fb-9177-fa48ef8f1703" xlink:to="loc_inpha_SummaryOfChangesInWorkingCapitalAbstract_fbe70e42-2c43-4ed8-bf68-8659bb7d7f32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_TradeAndOtherReceivablesExcludingReceivablesRelatedToPropertyEquipment_01a03e1d-2d90-772e-b72d-ef9bf5de27ea" xlink:href="inpha-20260630.xsd#inpha_TradeAndOtherReceivablesExcludingReceivablesRelatedToPropertyEquipment"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inpha_SummaryOfChangesInWorkingCapitalAbstract_fbe70e42-2c43-4ed8-bf68-8659bb7d7f32" xlink:to="loc_inpha_TradeAndOtherReceivablesExcludingReceivablesRelatedToPropertyEquipment_01a03e1d-2d90-772e-b72d-ef9bf5de27ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables_6798f93e-35f0-4eed-95cf-b796999b4bc6" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inpha_SummaryOfChangesInWorkingCapitalAbstract_fbe70e42-2c43-4ed8-bf68-8659bb7d7f32" xlink:to="loc_ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables_6798f93e-35f0-4eed-95cf-b796999b4bc6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TradeAndOtherPayables_781fbbc6-c752-418a-9e65-fd1383ac8583" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TradeAndOtherPayables"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inpha_SummaryOfChangesInWorkingCapitalAbstract_fbe70e42-2c43-4ed8-bf68-8659bb7d7f32" xlink:to="loc_ifrs-full_TradeAndOtherPayables_781fbbc6-c752-418a-9e65-fd1383ac8583" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables_fec3008d-6ec4-434e-8df9-c5fe94795374" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inpha_SummaryOfChangesInWorkingCapitalAbstract_fbe70e42-2c43-4ed8-bf68-8659bb7d7f32" xlink:to="loc_ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables_fec3008d-6ec4-434e-8df9-c5fe94795374" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_CollaborationLiabilities_48d1ba93-a188-4500-bcd8-d899895b5452" xlink:href="inpha-20260630.xsd#inpha_CollaborationLiabilities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inpha_SummaryOfChangesInWorkingCapitalAbstract_fbe70e42-2c43-4ed8-bf68-8659bb7d7f32" xlink:to="loc_inpha_CollaborationLiabilities_48d1ba93-a188-4500-bcd8-d899895b5452" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_AdjustmentsForIncreaseDecreaseInCollaborationLiabilities_f977f9e3-e1fc-47da-b374-15ba76328f83" xlink:href="inpha-20260630.xsd#inpha_AdjustmentsForIncreaseDecreaseInCollaborationLiabilities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inpha_SummaryOfChangesInWorkingCapitalAbstract_fbe70e42-2c43-4ed8-bf68-8659bb7d7f32" xlink:to="loc_inpha_AdjustmentsForIncreaseDecreaseInCollaborationLiabilities_f977f9e3-e1fc-47da-b374-15ba76328f83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DeferredIncomeIncludingContractLiabilities_4b9f6be0-a0d0-4796-82ce-dda93dbf320c" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DeferredIncomeIncludingContractLiabilities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inpha_SummaryOfChangesInWorkingCapitalAbstract_fbe70e42-2c43-4ed8-bf68-8659bb7d7f32" xlink:to="loc_ifrs-full_DeferredIncomeIncludingContractLiabilities_4b9f6be0-a0d0-4796-82ce-dda93dbf320c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AdjustmentsForIncreaseDecreaseInDeferredIncomeIncludingContractLiabilities_40b2893d-eade-4edd-baa0-aa7119e9e4fe" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AdjustmentsForIncreaseDecreaseInDeferredIncomeIncludingContractLiabilities"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inpha_SummaryOfChangesInWorkingCapitalAbstract_fbe70e42-2c43-4ed8-bf68-8659bb7d7f32" xlink:to="loc_ifrs-full_AdjustmentsForIncreaseDecreaseInDeferredIncomeIncludingContractLiabilities_40b2893d-eade-4edd-baa0-aa7119e9e4fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_ChangeInWorkingCapital_e8b0398d-0088-4b3b-a6e8-b241d3a3bff0" xlink:href="inpha-20260630.xsd#inpha_ChangeInWorkingCapital"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inpha_SummaryOfChangesInWorkingCapitalAbstract_fbe70e42-2c43-4ed8-bf68-8659bb7d7f32" xlink:to="loc_inpha_ChangeInWorkingCapital_e8b0398d-0088-4b3b-a6e8-b241d3a3bff0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncreaseDecreaseInWorkingCapital_ee00b434-a930-4c2c-a5ba-efd1eead2a28" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IncreaseDecreaseInWorkingCapital"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inpha_SummaryOfChangesInWorkingCapitalAbstract_fbe70e42-2c43-4ed8-bf68-8659bb7d7f32" xlink:to="loc_ifrs-full_IncreaseDecreaseInWorkingCapital_ee00b434-a930-4c2c-a5ba-efd1eead2a28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.innate-pharma.com/role/InterimCondensedConsolidatedStatementsofCashFlowsParenthetical" xlink:type="simple" xlink:href="inpha-20260630.xsd#InterimCondensedConsolidatedStatementsofCashFlowsParenthetical"/>
  <link:presentationLink xlink:role="http://www.innate-pharma.com/role/InterimCondensedConsolidatedStatementsofCashFlowsParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_StatementOfCashFlowsAbstract_a580952a-1f75-4f73-9bf3-9f7edfb8ec0f" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_InterestPaidClassifiedAsOperatingActivities_3b30fbfd-038b-42ab-b936-8729fb26f23b" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_InterestPaidClassifiedAsOperatingActivities"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfCashFlowsAbstract_a580952a-1f75-4f73-9bf3-9f7edfb8ec0f" xlink:to="loc_ifrs-full_InterestPaidClassifiedAsOperatingActivities_3b30fbfd-038b-42ab-b936-8729fb26f23b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_InterestReceivedClassifiedAsOperatingActivities_72df6fb1-8f94-47bf-91de-542986d9eebc" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_InterestReceivedClassifiedAsOperatingActivities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfCashFlowsAbstract_a580952a-1f75-4f73-9bf3-9f7edfb8ec0f" xlink:to="loc_ifrs-full_InterestReceivedClassifiedAsOperatingActivities_72df6fb1-8f94-47bf-91de-542986d9eebc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_PercentageOfPreFinancedCIRCollected2023And2024_0573edf9-3c20-49b3-b134-0952df227a7f" xlink:href="inpha-20260630.xsd#inpha_PercentageOfPreFinancedCIRCollected2023And2024"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfCashFlowsAbstract_a580952a-1f75-4f73-9bf3-9f7edfb8ec0f" xlink:to="loc_inpha_PercentageOfPreFinancedCIRCollected2023And2024_0573edf9-3c20-49b3-b134-0952df227a7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_WithholdingRateCIR_a7cf5ddc-25f9-4a88-8470-5e30d70e8556" xlink:href="inpha-20260630.xsd#inpha_WithholdingRateCIR"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfCashFlowsAbstract_a580952a-1f75-4f73-9bf3-9f7edfb8ec0f" xlink:to="loc_inpha_WithholdingRateCIR_a7cf5ddc-25f9-4a88-8470-5e30d70e8556" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_TaxCreditRetentions2023CIR_019fb2e2-c569-7130-929e-ecba2cadc5af" xlink:href="inpha-20260630.xsd#inpha_TaxCreditRetentions2023CIR"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfCashFlowsAbstract_a580952a-1f75-4f73-9bf3-9f7edfb8ec0f" xlink:to="loc_inpha_TaxCreditRetentions2023CIR_019fb2e2-c569-7130-929e-ecba2cadc5af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_TaxCreditRetentions2024CIR_019fb2e3-d5b8-744c-bd74-18cccb77effd" xlink:href="inpha-20260630.xsd#inpha_TaxCreditRetentions2024CIR"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfCashFlowsAbstract_a580952a-1f75-4f73-9bf3-9f7edfb8ec0f" xlink:to="loc_inpha_TaxCreditRetentions2024CIR_019fb2e3-d5b8-744c-bd74-18cccb77effd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.innate-pharma.com/role/InterimConsolidatedStatementofChangesinShareholdersEquity" xlink:type="simple" xlink:href="inpha-20260630.xsd#InterimConsolidatedStatementofChangesinShareholdersEquity"/>
  <link:presentationLink xlink:role="http://www.innate-pharma.com/role/InterimConsolidatedStatementofChangesinShareholdersEquity" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_StatementOfChangesInEquityAbstract_8c2bdb29-8461-4718-9362-dc9143b8c088" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_StatementOfChangesInEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_StatementOfChangesInEquityTable_10dede90-c076-4733-83cd-b2cbba2ff3c1" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_StatementOfChangesInEquityTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityAbstract_8c2bdb29-8461-4718-9362-dc9143b8c088" xlink:to="loc_ifrs-full_StatementOfChangesInEquityTable_10dede90-c076-4733-83cd-b2cbba2ff3c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfShareCapitalAxis_5d541caf-15f8-4918-bc48-e37575cf119f" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfShareCapitalAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityTable_10dede90-c076-4733-83cd-b2cbba2ff3c1" xlink:to="loc_ifrs-full_ClassesOfShareCapitalAxis_5d541caf-15f8-4918-bc48-e37575cf119f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfShareCapitalDomain_ddb44216-9273-4008-aae5-f16b2468a5fa" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfShareCapitalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfShareCapitalAxis_5d541caf-15f8-4918-bc48-e37575cf119f" xlink:to="loc_ifrs-full_ClassesOfShareCapitalDomain_ddb44216-9273-4008-aae5-f16b2468a5fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OrdinarySharesMember_6fda5065-6e3b-4778-b6bd-8559bbfaa1c3" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OrdinarySharesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfShareCapitalDomain_ddb44216-9273-4008-aae5-f16b2468a5fa" xlink:to="loc_ifrs-full_OrdinarySharesMember_6fda5065-6e3b-4778-b6bd-8559bbfaa1c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PreferenceSharesMember_fb56410f-4fb5-4e37-8990-3abe242d9449" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_PreferenceSharesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfShareCapitalDomain_ddb44216-9273-4008-aae5-f16b2468a5fa" xlink:to="loc_ifrs-full_PreferenceSharesMember_fb56410f-4fb5-4e37-8990-3abe242d9449" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ComponentsOfEquityAxis_e92fd493-e080-4e1d-a29a-b5bb7b1c344b" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ComponentsOfEquityAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityTable_10dede90-c076-4733-83cd-b2cbba2ff3c1" xlink:to="loc_ifrs-full_ComponentsOfEquityAxis_e92fd493-e080-4e1d-a29a-b5bb7b1c344b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ComponentsOfEquityDomain_92517b71-c16e-44d2-b12f-b61c5d363ed4" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ComponentsOfEquityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ComponentsOfEquityAxis_e92fd493-e080-4e1d-a29a-b5bb7b1c344b" xlink:to="loc_ifrs-full_ComponentsOfEquityDomain_92517b71-c16e-44d2-b12f-b61c5d363ed4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IssuedCapitalMember_94d09b2a-a09e-4198-8327-52dbc1c4b49a" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IssuedCapitalMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ComponentsOfEquityDomain_92517b71-c16e-44d2-b12f-b61c5d363ed4" xlink:to="loc_ifrs-full_IssuedCapitalMember_94d09b2a-a09e-4198-8327-52dbc1c4b49a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SharePremiumMember_e0f84d39-6610-468c-983b-c2b02e0678f4" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_SharePremiumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ComponentsOfEquityDomain_92517b71-c16e-44d2-b12f-b61c5d363ed4" xlink:to="loc_ifrs-full_SharePremiumMember_e0f84d39-6610-468c-983b-c2b02e0678f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RetainedEarningsExcludingProfitLossForReportingPeriodMember_06151e08-fa65-4f38-a0f1-cac81330b83b" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RetainedEarningsExcludingProfitLossForReportingPeriodMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ComponentsOfEquityDomain_92517b71-c16e-44d2-b12f-b61c5d363ed4" xlink:to="loc_ifrs-full_RetainedEarningsExcludingProfitLossForReportingPeriodMember_06151e08-fa65-4f38-a0f1-cac81330b83b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AccumulatedOtherComprehensiveIncomeMember_c18cded4-2adf-432d-8ea1-54f118aaf5a9" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ComponentsOfEquityDomain_92517b71-c16e-44d2-b12f-b61c5d363ed4" xlink:to="loc_ifrs-full_AccumulatedOtherComprehensiveIncomeMember_c18cded4-2adf-432d-8ea1-54f118aaf5a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RetainedEarningsProfitLossForReportingPeriodMember_0984745b-27f8-4560-abab-69b9621241d1" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RetainedEarningsProfitLossForReportingPeriodMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ComponentsOfEquityDomain_92517b71-c16e-44d2-b12f-b61c5d363ed4" xlink:to="loc_ifrs-full_RetainedEarningsProfitLossForReportingPeriodMember_0984745b-27f8-4560-abab-69b9621241d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_StatementOfChangesInEquityLineItems_c7f5c90d-7334-4b7d-b732-de8f48f750f0" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_StatementOfChangesInEquityLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityTable_10dede90-c076-4733-83cd-b2cbba2ff3c1" xlink:to="loc_ifrs-full_StatementOfChangesInEquityLineItems_c7f5c90d-7334-4b7d-b732-de8f48f750f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NumberOfSharesIssued_9d63b65e-ee92-4177-9c51-b198e171d1f0" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NumberOfSharesIssued"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_c7f5c90d-7334-4b7d-b732-de8f48f750f0" xlink:to="loc_ifrs-full_NumberOfSharesIssued_9d63b65e-ee92-4177-9c51-b198e171d1f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_Equity_d26bd863-2918-4f53-9a19-958114ce8a55" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_Equity"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_c7f5c90d-7334-4b7d-b732-de8f48f750f0" xlink:to="loc_ifrs-full_Equity_d26bd863-2918-4f53-9a19-958114ce8a55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ChangesInEquityAbstract_bbc6f5eb-ae63-44c7-8c9e-c1efc3688565" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ChangesInEquityAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_c7f5c90d-7334-4b7d-b732-de8f48f750f0" xlink:to="loc_ifrs-full_ChangesInEquityAbstract_bbc6f5eb-ae63-44c7-8c9e-c1efc3688565" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProfitLoss_90f19a44-6f14-454d-9820-b7b6da2385be" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProfitLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ChangesInEquityAbstract_bbc6f5eb-ae63-44c7-8c9e-c1efc3688565" xlink:to="loc_ifrs-full_ProfitLoss_90f19a44-6f14-454d-9820-b7b6da2385be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans_3cedce0b-b3ba-4f63-aad9-bf4b048f1ade" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ChangesInEquityAbstract_bbc6f5eb-ae63-44c7-8c9e-c1efc3688565" xlink:to="loc_ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans_3cedce0b-b3ba-4f63-aad9-bf4b048f1ade" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation_00376dca-35bd-44e2-b32a-00005d19d94b" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ChangesInEquityAbstract_bbc6f5eb-ae63-44c7-8c9e-c1efc3688565" xlink:to="loc_ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation_00376dca-35bd-44e2-b32a-00005d19d94b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ComprehensiveIncome_a1c2e23f-9878-45f8-98ae-56cede08ca4f" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ComprehensiveIncome"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ChangesInEquityAbstract_bbc6f5eb-ae63-44c7-8c9e-c1efc3688565" xlink:to="loc_ifrs-full_ComprehensiveIncome_a1c2e23f-9878-45f8-98ae-56cede08ca4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughAppropriationOfRetainedEarnings_66936226-4b59-4383-9eef-f74f0badf65f" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IncreaseDecreaseThroughAppropriationOfRetainedEarnings"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ChangesInEquityAbstract_bbc6f5eb-ae63-44c7-8c9e-c1efc3688565" xlink:to="loc_ifrs-full_IncreaseDecreaseThroughAppropriationOfRetainedEarnings_66936226-4b59-4383-9eef-f74f0badf65f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_ExerciseAndSubscriptionOfEquityInstrumentsInShares_70fcb047-d2fe-4bbc-b5f5-56b66f269f33" xlink:href="inpha-20260630.xsd#inpha_ExerciseAndSubscriptionOfEquityInstrumentsInShares"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ChangesInEquityAbstract_bbc6f5eb-ae63-44c7-8c9e-c1efc3688565" xlink:to="loc_inpha_ExerciseAndSubscriptionOfEquityInstrumentsInShares_70fcb047-d2fe-4bbc-b5f5-56b66f269f33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_ExerciseAndSubscriptionOfEquityInstruments_933088f0-1f0f-4be5-91ca-95f05f2eb318" xlink:href="inpha-20260630.xsd#inpha_ExerciseAndSubscriptionOfEquityInstruments"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ChangesInEquityAbstract_bbc6f5eb-ae63-44c7-8c9e-c1efc3688565" xlink:to="loc_inpha_ExerciseAndSubscriptionOfEquityInstruments_933088f0-1f0f-4be5-91ca-95f05f2eb318" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_IncreaseCapitalNetInShares_01a07ba2-bafe-79dd-a253-dec4d0d4de70" xlink:href="inpha-20260630.xsd#inpha_IncreaseCapitalNetInShares"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ChangesInEquityAbstract_bbc6f5eb-ae63-44c7-8c9e-c1efc3688565" xlink:to="loc_inpha_IncreaseCapitalNetInShares_01a07ba2-bafe-79dd-a253-dec4d0d4de70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IssueOfEquity_0cf98917-2335-498c-8483-8faffcb43ee2" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IssueOfEquity"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ChangesInEquityAbstract_bbc6f5eb-ae63-44c7-8c9e-c1efc3688565" xlink:to="loc_ifrs-full_IssueOfEquity_0cf98917-2335-498c-8483-8faffcb43ee2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions_b82fdd2f-7eef-45f1-99d6-736ac77fd5dc" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ChangesInEquityAbstract_bbc6f5eb-ae63-44c7-8c9e-c1efc3688565" xlink:to="loc_ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions_b82fdd2f-7eef-45f1-99d6-736ac77fd5dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NumberOfSharesIssued_2e242003-e36e-45fc-87d8-9354f2f94014" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NumberOfSharesIssued"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_c7f5c90d-7334-4b7d-b732-de8f48f750f0" xlink:to="loc_ifrs-full_NumberOfSharesIssued_2e242003-e36e-45fc-87d8-9354f2f94014" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_Equity_dedac118-c362-40ea-9fcb-5d91a7726734" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_Equity"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_c7f5c90d-7334-4b7d-b732-de8f48f750f0" xlink:to="loc_ifrs-full_Equity_dedac118-c362-40ea-9fcb-5d91a7726734" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.innate-pharma.com/role/TheCompanyandkeyevents" xlink:type="simple" xlink:href="inpha-20260630.xsd#TheCompanyandkeyevents"/>
  <link:presentationLink xlink:role="http://www.innate-pharma.com/role/TheCompanyandkeyevents" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_inpha_CompanyInformationAbstract_978e44a0-2c73-4eb4-be4c-e2731206b445" xlink:href="inpha-20260630.xsd#inpha_CompanyInformationAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_DisclosureOfCompanySignificantAgreementsAndKeyEventsTextBlock_96f46ca5-c342-43a0-a47a-62da76b2ad5d" xlink:href="inpha-20260630.xsd#inpha_DisclosureOfCompanySignificantAgreementsAndKeyEventsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inpha_CompanyInformationAbstract_978e44a0-2c73-4eb4-be4c-e2731206b445" xlink:to="loc_inpha_DisclosureOfCompanySignificantAgreementsAndKeyEventsTextBlock_96f46ca5-c342-43a0-a47a-62da76b2ad5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.innate-pharma.com/role/Basisofpresentationandstatementofcompliance" xlink:type="simple" xlink:href="inpha-20260630.xsd#Basisofpresentationandstatementofcompliance"/>
  <link:presentationLink xlink:role="http://www.innate-pharma.com/role/Basisofpresentationandstatementofcompliance" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_inpha_SignificantAccountingPoliciesAbstract_37b88b0c-c607-42cf-bfc7-265e1e5ac494" xlink:href="inpha-20260630.xsd#inpha_SignificantAccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfMaterialAccountingPolicyInformationExplanatory_51b0571a-e41f-4127-98eb-49ec6e690e02" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfMaterialAccountingPolicyInformationExplanatory"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inpha_SignificantAccountingPoliciesAbstract_37b88b0c-c607-42cf-bfc7-265e1e5ac494" xlink:to="loc_ifrs-full_DisclosureOfMaterialAccountingPolicyInformationExplanatory_51b0571a-e41f-4127-98eb-49ec6e690e02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.innate-pharma.com/role/Managementoffinancialrisks" xlink:type="simple" xlink:href="inpha-20260630.xsd#Managementoffinancialrisks"/>
  <link:presentationLink xlink:role="http://www.innate-pharma.com/role/Managementoffinancialrisks" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfNatureAndExtentOfRisksArisingFromFinancialInstrumentsAbstract_e519f626-8bfa-479b-903e-257629820f8e" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfNatureAndExtentOfRisksArisingFromFinancialInstrumentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfNatureAndExtentOfRisksArisingFromFinancialInstrumentsExplanatory_5a562711-686b-49f8-a9cc-12110c1e8ae0" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfNatureAndExtentOfRisksArisingFromFinancialInstrumentsExplanatory"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfNatureAndExtentOfRisksArisingFromFinancialInstrumentsAbstract_e519f626-8bfa-479b-903e-257629820f8e" xlink:to="loc_ifrs-full_DisclosureOfNatureAndExtentOfRisksArisingFromFinancialInstrumentsExplanatory_5a562711-686b-49f8-a9cc-12110c1e8ae0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.innate-pharma.com/role/Cashcashequivalentsshortterminvestmentsandnoncurrentfinancialassets" xlink:type="simple" xlink:href="inpha-20260630.xsd#Cashcashequivalentsshortterminvestmentsandnoncurrentfinancialassets"/>
  <link:presentationLink xlink:role="http://www.innate-pharma.com/role/Cashcashequivalentsshortterminvestmentsandnoncurrentfinancialassets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract_2fa5de3b-6a02-4b73-9221-9b0eaad5e95f" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfFinancialAssetsExplanatory_8fc4ec5b-4f3d-4af0-bd88-9d38d3b9efa8" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfFinancialAssetsExplanatory"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract_2fa5de3b-6a02-4b73-9221-9b0eaad5e95f" xlink:to="loc_ifrs-full_DisclosureOfFinancialAssetsExplanatory_8fc4ec5b-4f3d-4af0-bd88-9d38d3b9efa8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.innate-pharma.com/role/Tradereceivablesandothers" xlink:type="simple" xlink:href="inpha-20260630.xsd#Tradereceivablesandothers"/>
  <link:presentationLink xlink:role="http://www.innate-pharma.com/role/Tradereceivablesandothers" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract_8460a760-a14b-4827-81b9-e21bdfe49cb9" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfTradeAndOtherReceivablesExplanatory_c9cadc59-086c-45ad-a56b-abb30c21bd03" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfTradeAndOtherReceivablesExplanatory"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract_8460a760-a14b-4827-81b9-e21bdfe49cb9" xlink:to="loc_ifrs-full_DisclosureOfTradeAndOtherReceivablesExplanatory_c9cadc59-086c-45ad-a56b-abb30c21bd03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.innate-pharma.com/role/Intangibleassets" xlink:type="simple" xlink:href="inpha-20260630.xsd#Intangibleassets"/>
  <link:presentationLink xlink:role="http://www.innate-pharma.com/role/Intangibleassets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IntangibleAssetsOtherThanGoodwillAbstract_f4a4c89b-e36c-4100-88f8-1e316e7006b4" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IntangibleAssetsOtherThanGoodwillAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfIntangibleAssetsExplanatory_77772004-8cc9-4fe0-a007-73c892aefb0a" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfIntangibleAssetsExplanatory"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IntangibleAssetsOtherThanGoodwillAbstract_f4a4c89b-e36c-4100-88f8-1e316e7006b4" xlink:to="loc_ifrs-full_DisclosureOfIntangibleAssetsExplanatory_77772004-8cc9-4fe0-a007-73c892aefb0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.innate-pharma.com/role/Propertyandequipment" xlink:type="simple" xlink:href="inpha-20260630.xsd#Propertyandequipment"/>
  <link:presentationLink xlink:role="http://www.innate-pharma.com/role/Propertyandequipment" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PropertyPlantAndEquipmentAbstract_b5e4863e-498b-418c-89c0-d39241dd841d" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentExplanatory_0bd9d45a-432c-42fa-ac51-51f51e8d6c8c" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfPropertyPlantAndEquipmentExplanatory"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_PropertyPlantAndEquipmentAbstract_b5e4863e-498b-418c-89c0-d39241dd841d" xlink:to="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentExplanatory_0bd9d45a-432c-42fa-ac51-51f51e8d6c8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.innate-pharma.com/role/Tradepayablesandothers" xlink:type="simple" xlink:href="inpha-20260630.xsd#Tradepayablesandothers"/>
  <link:presentationLink xlink:role="http://www.innate-pharma.com/role/Tradepayablesandothers" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract_8fa3033d-2c25-4a68-bc11-571cd3547c20" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfTradeAndOtherPayablesExplanatory_3476896f-cdef-4184-814b-40fb5e6ef380" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfTradeAndOtherPayablesExplanatory"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract_8fa3033d-2c25-4a68-bc11-571cd3547c20" xlink:to="loc_ifrs-full_DisclosureOfTradeAndOtherPayablesExplanatory_3476896f-cdef-4184-814b-40fb5e6ef380" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.innate-pharma.com/role/Financialliabilities" xlink:type="simple" xlink:href="inpha-20260630.xsd#Financialliabilities"/>
  <link:presentationLink xlink:role="http://www.innate-pharma.com/role/Financialliabilities" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract_78c7e85e-6e93-4afc-9286-3095b065916d" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfFinancialLiabilitiesExplanatory_5b9d1d8e-2166-43ac-a719-a9e7d2d06602" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfFinancialLiabilitiesExplanatory"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract_78c7e85e-6e93-4afc-9286-3095b065916d" xlink:to="loc_ifrs-full_DisclosureOfFinancialLiabilitiesExplanatory_5b9d1d8e-2166-43ac-a719-a9e7d2d06602" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.innate-pharma.com/role/Employeebenefit" xlink:type="simple" xlink:href="inpha-20260630.xsd#Employeebenefit"/>
  <link:presentationLink xlink:role="http://www.innate-pharma.com/role/Employeebenefit" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfInformationAboutDefinedBenefitPlansAbstract_35c3ff42-302d-486d-ba10-14eac11d1964" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfInformationAboutDefinedBenefitPlansAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfEmployeeBenefitsExplanatory_4f9bc50b-3a24-439f-b9fa-befc8bb7ad75" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfEmployeeBenefitsExplanatory"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfInformationAboutDefinedBenefitPlansAbstract_35c3ff42-302d-486d-ba10-14eac11d1964" xlink:to="loc_ifrs-full_DisclosureOfEmployeeBenefitsExplanatory_4f9bc50b-3a24-439f-b9fa-befc8bb7ad75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.innate-pharma.com/role/Capital" xlink:type="simple" xlink:href="inpha-20260630.xsd#Capital"/>
  <link:presentationLink xlink:role="http://www.innate-pharma.com/role/Capital" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_inpha_ShareCapitalAndShareBasePaymentsAbstract_73115d26-6250-4b93-9bea-127de6c27a38" xlink:href="inpha-20260630.xsd#inpha_ShareCapitalAndShareBasePaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfIssuedCapitalExplanatory_55b8394c-f4d0-4818-9b1b-543c65141217" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfIssuedCapitalExplanatory"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inpha_ShareCapitalAndShareBasePaymentsAbstract_73115d26-6250-4b93-9bea-127de6c27a38" xlink:to="loc_ifrs-full_DisclosureOfIssuedCapitalExplanatory_55b8394c-f4d0-4818-9b1b-543c65141217" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.innate-pharma.com/role/Financialinstrumentsrecognizedinthestatementoffinancialpositionandrelatedeffectontheincomestatement" xlink:type="simple" xlink:href="inpha-20260630.xsd#Financialinstrumentsrecognizedinthestatementoffinancialpositionandrelatedeffectontheincomestatement"/>
  <link:presentationLink xlink:role="http://www.innate-pharma.com/role/Financialinstrumentsrecognizedinthestatementoffinancialpositionandrelatedeffectontheincomestatement" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfFinancialInstrumentsAbstract_06ebcdfe-8a89-418c-bf62-5491f2aa1fa9" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfFinancialInstrumentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfFinancialInstrumentsExplanatory_2f63cc2d-ae9d-4579-9073-4f9fb6244d64" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfFinancialInstrumentsExplanatory"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsAbstract_06ebcdfe-8a89-418c-bf62-5491f2aa1fa9" xlink:to="loc_ifrs-full_DisclosureOfFinancialInstrumentsExplanatory_2f63cc2d-ae9d-4579-9073-4f9fb6244d64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.innate-pharma.com/role/Revenueandotherincome" xlink:type="simple" xlink:href="inpha-20260630.xsd#Revenueandotherincome"/>
  <link:presentationLink xlink:role="http://www.innate-pharma.com/role/Revenueandotherincome" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract_342bb921-9d82-4211-919c-c933c5915b4a" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfRevenueExplanatory_04bbc7f4-2147-4c87-821f-65fc29a09452" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfRevenueExplanatory"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract_342bb921-9d82-4211-919c-c933c5915b4a" xlink:to="loc_ifrs-full_DisclosureOfRevenueExplanatory_04bbc7f4-2147-4c87-821f-65fc29a09452" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.innate-pharma.com/role/Operatingexpenses" xlink:type="simple" xlink:href="inpha-20260630.xsd#Operatingexpenses"/>
  <link:presentationLink xlink:role="http://www.innate-pharma.com/role/Operatingexpenses" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AnalysisOfIncomeAndExpenseAbstract_1cdeca29-3b03-44f3-a919-60cc77b890d6" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AnalysisOfIncomeAndExpenseAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfExpensesExplanatory_c769bb65-ec9c-46e3-99cc-a0e049a5cd26" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfExpensesExplanatory"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AnalysisOfIncomeAndExpenseAbstract_1cdeca29-3b03-44f3-a919-60cc77b890d6" xlink:to="loc_ifrs-full_DisclosureOfExpensesExplanatory_c769bb65-ec9c-46e3-99cc-a0e049a5cd26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.innate-pharma.com/role/Netfinancialincomeloss" xlink:type="simple" xlink:href="inpha-20260630.xsd#Netfinancialincomeloss"/>
  <link:presentationLink xlink:role="http://www.innate-pharma.com/role/Netfinancialincomeloss" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AnalysisOfIncomeAndExpenseAbstract_a12a07a0-9377-4427-a614-bbe181c15927" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AnalysisOfIncomeAndExpenseAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfFinanceIncomeExpenseExplanatory_2232405e-e8d0-4874-a3d2-94c66f30c236" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfFinanceIncomeExpenseExplanatory"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AnalysisOfIncomeAndExpenseAbstract_a12a07a0-9377-4427-a614-bbe181c15927" xlink:to="loc_ifrs-full_DisclosureOfFinanceIncomeExpenseExplanatory_2232405e-e8d0-4874-a3d2-94c66f30c236" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.innate-pharma.com/role/Incometaxexpense" xlink:type="simple" xlink:href="inpha-20260630.xsd#Incometaxexpense"/>
  <link:presentationLink xlink:role="http://www.innate-pharma.com/role/Incometaxexpense" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_inpha_IncomeTaxAbstract_6e819a83-e572-4035-9e37-a1e50786c304" xlink:href="inpha-20260630.xsd#inpha_IncomeTaxAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfIncomeTaxExplanatory_6053ab45-2589-4eaa-8840-0ce31fa9dcc4" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfIncomeTaxExplanatory"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inpha_IncomeTaxAbstract_6e819a83-e572-4035-9e37-a1e50786c304" xlink:to="loc_ifrs-full_DisclosureOfIncomeTaxExplanatory_6053ab45-2589-4eaa-8840-0ce31fa9dcc4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.innate-pharma.com/role/Commitmentscontingenciesandlitigation" xlink:type="simple" xlink:href="inpha-20260630.xsd#Commitmentscontingenciesandlitigation"/>
  <link:presentationLink xlink:role="http://www.innate-pharma.com/role/Commitmentscontingenciesandlitigation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_inpha_CommitmentsContingenciesAndLitigationsAbstract_722fe134-dc0f-41c1-b5e3-03251873d0c3" xlink:href="inpha-20260630.xsd#inpha_CommitmentsContingenciesAndLitigationsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfCommitmentsAndContingentLiabilitiesExplanatory_1f2f1d11-9a6b-433a-a7c0-19c300cc4662" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfCommitmentsAndContingentLiabilitiesExplanatory"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inpha_CommitmentsContingenciesAndLitigationsAbstract_722fe134-dc0f-41c1-b5e3-03251873d0c3" xlink:to="loc_ifrs-full_DisclosureOfCommitmentsAndContingentLiabilitiesExplanatory_1f2f1d11-9a6b-433a-a7c0-19c300cc4662" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.innate-pharma.com/role/Relatedpartytransactions" xlink:type="simple" xlink:href="inpha-20260630.xsd#Relatedpartytransactions"/>
  <link:presentationLink xlink:role="http://www.innate-pharma.com/role/Relatedpartytransactions" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RelatedPartyTransactionsAbstract_0ee2f26f-aa46-4f26-93bd-85a69f20c9c9" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RelatedPartyTransactionsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfRelatedPartyExplanatory_1fd2c599-085f-47ab-9d76-cef0d774c930" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfRelatedPartyExplanatory"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RelatedPartyTransactionsAbstract_0ee2f26f-aa46-4f26-93bd-85a69f20c9c9" xlink:to="loc_ifrs-full_DisclosureOfRelatedPartyExplanatory_1fd2c599-085f-47ab-9d76-cef0d774c930" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.innate-pharma.com/role/Incomelosspershare" xlink:type="simple" xlink:href="inpha-20260630.xsd#Incomelosspershare"/>
  <link:presentationLink xlink:role="http://www.innate-pharma.com/role/Incomelosspershare" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_inpha_IncomeLossPerShareAbstract_bbbd5625-5fca-4470-817d-29e68f01ea90" xlink:href="inpha-20260630.xsd#inpha_IncomeLossPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfEarningsPerShareExplanatory_df05a201-aae8-4dd6-b449-f113fc296483" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfEarningsPerShareExplanatory"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inpha_IncomeLossPerShareAbstract_bbbd5625-5fca-4470-817d-29e68f01ea90" xlink:to="loc_ifrs-full_DisclosureOfEarningsPerShareExplanatory_df05a201-aae8-4dd6-b449-f113fc296483" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.innate-pharma.com/role/Eventsafterthereportingdate" xlink:type="simple" xlink:href="inpha-20260630.xsd#Eventsafterthereportingdate"/>
  <link:presentationLink xlink:role="http://www.innate-pharma.com/role/Eventsafterthereportingdate" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodAbstract_528f4884-1403-419f-bfe3-bffc08fd1f9d" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfEventsAfterReportingPeriodExplanatory_4def3fd8-a092-4ad2-816d-167ac7207ca3" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfEventsAfterReportingPeriodExplanatory"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodAbstract_528f4884-1403-419f-bfe3-bffc08fd1f9d" xlink:to="loc_ifrs-full_DisclosureOfEventsAfterReportingPeriodExplanatory_4def3fd8-a092-4ad2-816d-167ac7207ca3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.innate-pharma.com/role/BasisofpresentationandstatementofcompliancePolicies" xlink:type="simple" xlink:href="inpha-20260630.xsd#BasisofpresentationandstatementofcompliancePolicies"/>
  <link:presentationLink xlink:role="http://www.innate-pharma.com/role/BasisofpresentationandstatementofcompliancePolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_inpha_SignificantAccountingPoliciesAbstract_610ea3e2-d0de-48a0-ab71-e1b08132b4fc" xlink:href="inpha-20260630.xsd#inpha_SignificantAccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory_fb570389-5b49-4b27-aecb-7a6b3e467f81" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inpha_SignificantAccountingPoliciesAbstract_610ea3e2-d0de-48a0-ab71-e1b08132b4fc" xlink:to="loc_ifrs-full_DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory_fb570389-5b49-4b27-aecb-7a6b3e467f81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfAccountingJudgementsAndEstimatesExplanatory_f7350b01-96f1-400c-8137-d3c6df4c86ba" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfAccountingJudgementsAndEstimatesExplanatory"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inpha_SignificantAccountingPoliciesAbstract_610ea3e2-d0de-48a0-ab71-e1b08132b4fc" xlink:to="loc_ifrs-full_DisclosureOfAccountingJudgementsAndEstimatesExplanatory_f7350b01-96f1-400c-8137-d3c6df4c86ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretations_d70c3ca1-9d67-4705-88fb-b1c88edc8647" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretations"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inpha_SignificantAccountingPoliciesAbstract_610ea3e2-d0de-48a0-ab71-e1b08132b4fc" xlink:to="loc_ifrs-full_DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretations_d70c3ca1-9d67-4705-88fb-b1c88edc8647" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory_32583335-16aa-4037-b66a-4e2f81586116" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inpha_SignificantAccountingPoliciesAbstract_610ea3e2-d0de-48a0-ab71-e1b08132b4fc" xlink:to="loc_ifrs-full_DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory_32583335-16aa-4037-b66a-4e2f81586116" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.innate-pharma.com/role/BasisofpresentationandstatementofcomplianceTables" xlink:type="simple" xlink:href="inpha-20260630.xsd#BasisofpresentationandstatementofcomplianceTables"/>
  <link:presentationLink xlink:role="http://www.innate-pharma.com/role/BasisofpresentationandstatementofcomplianceTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_inpha_SignificantAccountingPoliciesAbstract_96eaf343-86c8-46b2-93b4-2e4721c65206" xlink:href="inpha-20260630.xsd#inpha_SignificantAccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfEffectOfChangesInForeignExchangeRatesExplanatory_f178b03b-e4a1-46b9-a657-de5dfa61f7ef" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfEffectOfChangesInForeignExchangeRatesExplanatory"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inpha_SignificantAccountingPoliciesAbstract_96eaf343-86c8-46b2-93b4-2e4721c65206" xlink:to="loc_ifrs-full_DisclosureOfEffectOfChangesInForeignExchangeRatesExplanatory_f178b03b-e4a1-46b9-a657-de5dfa61f7ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.innate-pharma.com/role/CashcashequivalentsshortterminvestmentsandnoncurrentfinancialassetsTables" xlink:type="simple" xlink:href="inpha-20260630.xsd#CashcashequivalentsshortterminvestmentsandnoncurrentfinancialassetsTables"/>
  <link:presentationLink xlink:role="http://www.innate-pharma.com/role/CashcashequivalentsshortterminvestmentsandnoncurrentfinancialassetsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract_5adaa977-db2d-44b5-984e-63fbf1155cf5" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_DisclosureOfCashCashEquivalentsAndFinancialAssetsTextBlock_72a28db9-a9af-4d6e-88bc-aacff0ba3d4b" xlink:href="inpha-20260630.xsd#inpha_DisclosureOfCashCashEquivalentsAndFinancialAssetsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract_5adaa977-db2d-44b5-984e-63fbf1155cf5" xlink:to="loc_inpha_DisclosureOfCashCashEquivalentsAndFinancialAssetsTextBlock_72a28db9-a9af-4d6e-88bc-aacff0ba3d4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfReconciliationOfChangesInLossAllowanceAndExplanationOfChangesInGrossCarryingAmountForFinancialInstrumentsExplanatory_74e6fcc6-2619-4d43-bd39-64eb5fe775b4" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfReconciliationOfChangesInLossAllowanceAndExplanationOfChangesInGrossCarryingAmountForFinancialInstrumentsExplanatory"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract_5adaa977-db2d-44b5-984e-63fbf1155cf5" xlink:to="loc_ifrs-full_DisclosureOfReconciliationOfChangesInLossAllowanceAndExplanationOfChangesInGrossCarryingAmountForFinancialInstrumentsExplanatory_74e6fcc6-2619-4d43-bd39-64eb5fe775b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.innate-pharma.com/role/TradereceivablesandothersTables" xlink:type="simple" xlink:href="inpha-20260630.xsd#TradereceivablesandothersTables"/>
  <link:presentationLink xlink:role="http://www.innate-pharma.com/role/TradereceivablesandothersTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract_9587c496-931e-4129-8c46-5b9b06a8a2cf" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_DisclosureOfTradeReceivablesAndOtherTableTextBlock_be64fb17-1f24-4410-8587-539181fb5a5b" xlink:href="inpha-20260630.xsd#inpha_DisclosureOfTradeReceivablesAndOtherTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract_9587c496-931e-4129-8c46-5b9b06a8a2cf" xlink:to="loc_inpha_DisclosureOfTradeReceivablesAndOtherTableTextBlock_be64fb17-1f24-4410-8587-539181fb5a5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.innate-pharma.com/role/PropertyandequipmentTables" xlink:type="simple" xlink:href="inpha-20260630.xsd#PropertyandequipmentTables"/>
  <link:presentationLink xlink:role="http://www.innate-pharma.com/role/PropertyandequipmentTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PropertyPlantAndEquipmentAbstract_4cc56176-26ca-4a08-bca3-51e876759c86" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory_8092a7a8-e2dd-4c1c-8af2-ef5ec2ae7175" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_PropertyPlantAndEquipmentAbstract_4cc56176-26ca-4a08-bca3-51e876759c86" xlink:to="loc_ifrs-full_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory_8092a7a8-e2dd-4c1c-8af2-ef5ec2ae7175" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.innate-pharma.com/role/TradepayablesandothersTables" xlink:type="simple" xlink:href="inpha-20260630.xsd#TradepayablesandothersTables"/>
  <link:presentationLink xlink:role="http://www.innate-pharma.com/role/TradepayablesandothersTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract_40518a40-7812-42bd-b423-66b16c70cd85" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_DisclosureOfTradePayablesAndOthersTextBlock_25df5799-dd30-4a0e-b2ab-f1501eae6cd0" xlink:href="inpha-20260630.xsd#inpha_DisclosureOfTradePayablesAndOthersTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract_40518a40-7812-42bd-b423-66b16c70cd85" xlink:to="loc_inpha_DisclosureOfTradePayablesAndOthersTextBlock_25df5799-dd30-4a0e-b2ab-f1501eae6cd0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.innate-pharma.com/role/FinancialliabilitiesTables" xlink:type="simple" xlink:href="inpha-20260630.xsd#FinancialliabilitiesTables"/>
  <link:presentationLink xlink:role="http://www.innate-pharma.com/role/FinancialliabilitiesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract_becfc623-542e-4b35-9ca4-f4e166bfd1ea" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_DisclosureOfFinancialLiabilitiesPerMaturityTableTextBlock_0f30bd21-9b7b-4e0d-bc7e-6564a4714eae" xlink:href="inpha-20260630.xsd#inpha_DisclosureOfFinancialLiabilitiesPerMaturityTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract_becfc623-542e-4b35-9ca4-f4e166bfd1ea" xlink:to="loc_inpha_DisclosureOfFinancialLiabilitiesPerMaturityTableTextBlock_0f30bd21-9b7b-4e0d-bc7e-6564a4714eae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_MaturityAnalysisForNonderivativeFinancialLiabilities_62da7e78-0478-4c03-a835-ec831fbdcf67" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_MaturityAnalysisForNonderivativeFinancialLiabilities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract_becfc623-542e-4b35-9ca4-f4e166bfd1ea" xlink:to="loc_ifrs-full_MaturityAnalysisForNonderivativeFinancialLiabilities_62da7e78-0478-4c03-a835-ec831fbdcf67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.innate-pharma.com/role/EmployeebenefitTables" xlink:type="simple" xlink:href="inpha-20260630.xsd#EmployeebenefitTables"/>
  <link:presentationLink xlink:role="http://www.innate-pharma.com/role/EmployeebenefitTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfInformationAboutDefinedBenefitPlansAbstract_f01ee831-3d53-4903-95b3-936ee04759e8" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfInformationAboutDefinedBenefitPlansAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfDefinedBenefitPlansExplanatory_b2925501-b749-48ac-b168-0c155557c93a" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfDefinedBenefitPlansExplanatory"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfInformationAboutDefinedBenefitPlansAbstract_f01ee831-3d53-4903-95b3-936ee04759e8" xlink:to="loc_ifrs-full_DisclosureOfDefinedBenefitPlansExplanatory_b2925501-b749-48ac-b168-0c155557c93a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetExplanatory_58e37812-f561-4034-95fc-ae213d417b32" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetExplanatory"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfInformationAboutDefinedBenefitPlansAbstract_f01ee831-3d53-4903-95b3-936ee04759e8" xlink:to="loc_ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetExplanatory_58e37812-f561-4034-95fc-ae213d417b32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.innate-pharma.com/role/CapitalTables" xlink:type="simple" xlink:href="inpha-20260630.xsd#CapitalTables"/>
  <link:presentationLink xlink:role="http://www.innate-pharma.com/role/CapitalTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_inpha_ShareCapitalAndShareBasePaymentsAbstract_ff187a10-5b48-4ac0-8fe9-45369e800ea0" xlink:href="inpha-20260630.xsd#inpha_ShareCapitalAndShareBasePaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfOtherEquityInstrumentsExplanatory_33ed3083-663e-4a8f-892e-4407710f36c0" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfOtherEquityInstrumentsExplanatory"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inpha_ShareCapitalAndShareBasePaymentsAbstract_ff187a10-5b48-4ac0-8fe9-45369e800ea0" xlink:to="loc_ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfOtherEquityInstrumentsExplanatory_33ed3083-663e-4a8f-892e-4407710f36c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.innate-pharma.com/role/FinancialinstrumentsrecognizedinthestatementoffinancialpositionandrelatedeffectontheincomestatementTables" xlink:type="simple" xlink:href="inpha-20260630.xsd#FinancialinstrumentsrecognizedinthestatementoffinancialpositionandrelatedeffectontheincomestatementTables"/>
  <link:presentationLink xlink:role="http://www.innate-pharma.com/role/FinancialinstrumentsrecognizedinthestatementoffinancialpositionandrelatedeffectontheincomestatementTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfFinancialInstrumentsAbstract_893fdc37-5f8d-48d5-bc32-de6569d3f08e" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfFinancialInstrumentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfDetailedInformationAboutFinancialInstrumentsExplanatory_18d856cd-f167-4570-8ae4-643dde66cb3d" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfDetailedInformationAboutFinancialInstrumentsExplanatory"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsAbstract_893fdc37-5f8d-48d5-bc32-de6569d3f08e" xlink:to="loc_ifrs-full_DisclosureOfDetailedInformationAboutFinancialInstrumentsExplanatory_18d856cd-f167-4570-8ae4-643dde66cb3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.innate-pharma.com/role/RevenueandotherincomeTables" xlink:type="simple" xlink:href="inpha-20260630.xsd#RevenueandotherincomeTables"/>
  <link:presentationLink xlink:role="http://www.innate-pharma.com/role/RevenueandotherincomeTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract_da5f5f2a-b6af-41d3-9d67-e9d73bb3d3a2" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersExplanatory_3ec654b3-5c41-41e3-917b-b2650261e684" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersExplanatory"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract_da5f5f2a-b6af-41d3-9d67-e9d73bb3d3a2" xlink:to="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersExplanatory_3ec654b3-5c41-41e3-917b-b2650261e684" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ExplanationOfSignificantChangesInContractAssetsAndContractLiabilitiesExplanatory_b3e8406c-0871-4227-a928-044a80b7c9ac" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ExplanationOfSignificantChangesInContractAssetsAndContractLiabilitiesExplanatory"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract_da5f5f2a-b6af-41d3-9d67-e9d73bb3d3a2" xlink:to="loc_ifrs-full_ExplanationOfSignificantChangesInContractAssetsAndContractLiabilitiesExplanatory_b3e8406c-0871-4227-a928-044a80b7c9ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_DisclosureOfVarianceOfDeferredRevenueTableTextBlock_44d516d8-5767-46cd-ab69-c3fbee2c3c8e" xlink:href="inpha-20260630.xsd#inpha_DisclosureOfVarianceOfDeferredRevenueTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract_da5f5f2a-b6af-41d3-9d67-e9d73bb3d3a2" xlink:to="loc_inpha_DisclosureOfVarianceOfDeferredRevenueTableTextBlock_44d516d8-5767-46cd-ab69-c3fbee2c3c8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_DisclosureOfGovernmentFinancingForResearchExpendituresTableTextBlock_e4e9b849-a7ed-4132-881d-bcbe965ea610" xlink:href="inpha-20260630.xsd#inpha_DisclosureOfGovernmentFinancingForResearchExpendituresTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract_da5f5f2a-b6af-41d3-9d67-e9d73bb3d3a2" xlink:to="loc_inpha_DisclosureOfGovernmentFinancingForResearchExpendituresTableTextBlock_e4e9b849-a7ed-4132-881d-bcbe965ea610" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.innate-pharma.com/role/OperatingexpensesTables" xlink:type="simple" xlink:href="inpha-20260630.xsd#OperatingexpensesTables"/>
  <link:presentationLink xlink:role="http://www.innate-pharma.com/role/OperatingexpensesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AnalysisOfIncomeAndExpenseAbstract_e7c52a25-0c5b-4d3c-8eb2-34eb0eace2f3" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AnalysisOfIncomeAndExpenseAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfExpensesByNatureExplanatory_7c260e39-1129-4238-ae5a-f8aae2fcf830" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfExpensesByNatureExplanatory"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AnalysisOfIncomeAndExpenseAbstract_e7c52a25-0c5b-4d3c-8eb2-34eb0eace2f3" xlink:to="loc_ifrs-full_DisclosureOfExpensesByNatureExplanatory_7c260e39-1129-4238-ae5a-f8aae2fcf830" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.innate-pharma.com/role/NetfinancialincomelossTables" xlink:type="simple" xlink:href="inpha-20260630.xsd#NetfinancialincomelossTables"/>
  <link:presentationLink xlink:role="http://www.innate-pharma.com/role/NetfinancialincomelossTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AnalysisOfIncomeAndExpenseAbstract_276773d9-f3ab-4ab6-a6a5-5a5452b7a661" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AnalysisOfIncomeAndExpenseAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_DisclosureOfNetFinancialIncomeLossTableTextBlock_9fcdce94-7b4a-41f5-80c4-c112ec16b8f4" xlink:href="inpha-20260630.xsd#inpha_DisclosureOfNetFinancialIncomeLossTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AnalysisOfIncomeAndExpenseAbstract_276773d9-f3ab-4ab6-a6a5-5a5452b7a661" xlink:to="loc_inpha_DisclosureOfNetFinancialIncomeLossTableTextBlock_9fcdce94-7b4a-41f5-80c4-c112ec16b8f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.innate-pharma.com/role/IncometaxexpenseTables" xlink:type="simple" xlink:href="inpha-20260630.xsd#IncometaxexpenseTables"/>
  <link:presentationLink xlink:role="http://www.innate-pharma.com/role/IncometaxexpenseTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_inpha_IncomeTaxAbstract_4721af93-fb35-4740-a58c-e5c73a4b3fb8" xlink:href="inpha-20260630.xsd#inpha_IncomeTaxAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsExplanatory_b1f206f6-183c-4da8-8aea-54790f340ce3" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsExplanatory"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inpha_IncomeTaxAbstract_4721af93-fb35-4740-a58c-e5c73a4b3fb8" xlink:to="loc_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsExplanatory_b1f206f6-183c-4da8-8aea-54790f340ce3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.innate-pharma.com/role/RelatedpartytransactionsTables" xlink:type="simple" xlink:href="inpha-20260630.xsd#RelatedpartytransactionsTables"/>
  <link:presentationLink xlink:role="http://www.innate-pharma.com/role/RelatedpartytransactionsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RelatedPartyTransactionsAbstract_45c581e9-b688-4c8b-9583-70b74f1772ea" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RelatedPartyTransactionsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_DisclosureOfKeyManagementPersonnelCompensationTableTextBlock_53b288a8-cb20-4822-8e53-c7c35424e6e8" xlink:href="inpha-20260630.xsd#inpha_DisclosureOfKeyManagementPersonnelCompensationTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RelatedPartyTransactionsAbstract_45c581e9-b688-4c8b-9583-70b74f1772ea" xlink:to="loc_inpha_DisclosureOfKeyManagementPersonnelCompensationTableTextBlock_53b288a8-cb20-4822-8e53-c7c35424e6e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesExplanatory_ff60d0ff-5500-42ee-8405-eb7e34f1c0a6" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesExplanatory"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RelatedPartyTransactionsAbstract_45c581e9-b688-4c8b-9583-70b74f1772ea" xlink:to="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesExplanatory_ff60d0ff-5500-42ee-8405-eb7e34f1c0a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.innate-pharma.com/role/IncomelosspershareTables" xlink:type="simple" xlink:href="inpha-20260630.xsd#IncomelosspershareTables"/>
  <link:presentationLink xlink:role="http://www.innate-pharma.com/role/IncomelosspershareTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_inpha_IncomeLossPerShareAbstract_048fe95d-5c80-48ba-8fc1-fafed4956fb1" xlink:href="inpha-20260630.xsd#inpha_IncomeLossPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EarningsPerShareExplanatory_62d870f9-21de-4a62-8fe7-7a3aa7701ebf" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_EarningsPerShareExplanatory"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inpha_IncomeLossPerShareAbstract_048fe95d-5c80-48ba-8fc1-fafed4956fb1" xlink:to="loc_ifrs-full_EarningsPerShareExplanatory_62d870f9-21de-4a62-8fe7-7a3aa7701ebf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.innate-pharma.com/role/TheCompanyandkeyeventsThecompanyDetails" xlink:type="simple" xlink:href="inpha-20260630.xsd#TheCompanyandkeyeventsThecompanyDetails"/>
  <link:presentationLink xlink:role="http://www.innate-pharma.com/role/TheCompanyandkeyeventsThecompanyDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_inpha_CompanyInformationAbstract_835c0037-5410-4c05-ae46-39e1bdb7b874" xlink:href="inpha-20260630.xsd#inpha_CompanyInformationAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_NumberOfTherapeuticApproaches_01eb9315-e7c7-4c38-b17f-12525253b0fd" xlink:href="inpha-20260630.xsd#inpha_NumberOfTherapeuticApproaches"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inpha_CompanyInformationAbstract_835c0037-5410-4c05-ae46-39e1bdb7b874" xlink:to="loc_inpha_NumberOfTherapeuticApproaches_01eb9315-e7c7-4c38-b17f-12525253b0fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProfitLoss_2d3c2003-c39b-4c69-8c00-6e7b7e0301d5" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProfitLoss"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inpha_CompanyInformationAbstract_835c0037-5410-4c05-ae46-39e1bdb7b874" xlink:to="loc_ifrs-full_ProfitLoss_2d3c2003-c39b-4c69-8c00-6e7b7e0301d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_Equity_fbaac6e4-1f0a-4d94-b26e-9e5e8734fb0a" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_Equity"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inpha_CompanyInformationAbstract_835c0037-5410-4c05-ae46-39e1bdb7b874" xlink:to="loc_ifrs-full_Equity_fbaac6e4-1f0a-4d94-b26e-9e5e8734fb0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_NumberOfWhollyOwnedSubsidiaries_563487b4-137a-4233-a067-40b6bec1c60e" xlink:href="inpha-20260630.xsd#inpha_NumberOfWhollyOwnedSubsidiaries"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inpha_CompanyInformationAbstract_835c0037-5410-4c05-ae46-39e1bdb7b874" xlink:to="loc_inpha_NumberOfWhollyOwnedSubsidiaries_563487b4-137a-4233-a067-40b6bec1c60e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NumberOfEmployees_a9fd879f-a0fd-483c-9cd9-c98577c5f2a9" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NumberOfEmployees"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inpha_CompanyInformationAbstract_835c0037-5410-4c05-ae46-39e1bdb7b874" xlink:to="loc_ifrs-full_NumberOfEmployees_a9fd879f-a0fd-483c-9cd9-c98577c5f2a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.innate-pharma.com/role/BasisofpresentationandstatementofcomplianceDetails" xlink:type="simple" xlink:href="inpha-20260630.xsd#BasisofpresentationandstatementofcomplianceDetails"/>
  <link:presentationLink xlink:role="http://www.innate-pharma.com/role/BasisofpresentationandstatementofcomplianceDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_inpha_SignificantAccountingPoliciesAbstract_01a08ba4-15b6-796b-8cf3-d8b4180fa98e" xlink:href="inpha-20260630.xsd#inpha_SignificantAccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable_01a08ba4-15b6-78fa-b17e-bf6fa3dca338" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inpha_SignificantAccountingPoliciesAbstract_01a08ba4-15b6-796b-8cf3-d8b4180fa98e" xlink:to="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable_01a08ba4-15b6-78fa-b17e-bf6fa3dca338" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_01a08ba4-15b6-73d2-94fa-8d42f896f764" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NonadjustingEventsAfterReportingPeriodAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable_01a08ba4-15b6-78fa-b17e-bf6fa3dca338" xlink:to="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_01a08ba4-15b6-73d2-94fa-8d42f896f764" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodDomain_01a08ba4-15b6-7aac-8f43-0828a6baa9f9" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NonadjustingEventsAfterReportingPeriodDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_01a08ba4-15b6-73d2-94fa-8d42f896f764" xlink:to="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodDomain_01a08ba4-15b6-7aac-8f43-0828a6baa9f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_StrategicPartnershipWithSwedishOrphanBiovitrumABMember_01a08ba4-15b6-74d0-9e2e-8c587ef0272f" xlink:href="inpha-20260630.xsd#inpha_StrategicPartnershipWithSwedishOrphanBiovitrumABMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodDomain_01a08ba4-15b6-7aac-8f43-0828a6baa9f9" xlink:to="loc_inpha_StrategicPartnershipWithSwedishOrphanBiovitrumABMember_01a08ba4-15b6-74d0-9e2e-8c587ef0272f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_CapitalIncreaseMember_01a08ba5-7e37-7761-8069-cf5c1ab87cea" xlink:href="inpha-20260630.xsd#inpha_CapitalIncreaseMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodDomain_01a08ba4-15b6-7aac-8f43-0828a6baa9f9" xlink:to="loc_inpha_CapitalIncreaseMember_01a08ba5-7e37-7761-8069-cf5c1ab87cea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ComponentsOfEquityAxis_01a08ba5-7e37-7210-822f-12434f1fc299" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ComponentsOfEquityAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable_01a08ba4-15b6-78fa-b17e-bf6fa3dca338" xlink:to="loc_ifrs-full_ComponentsOfEquityAxis_01a08ba5-7e37-7210-822f-12434f1fc299" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ComponentsOfEquityDomain_01a08ba5-7e37-78c1-b220-b22a8560a1d1" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ComponentsOfEquityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ComponentsOfEquityAxis_01a08ba5-7e37-7210-822f-12434f1fc299" xlink:to="loc_ifrs-full_ComponentsOfEquityDomain_01a08ba5-7e37-78c1-b220-b22a8560a1d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IssuedCapitalMember_01a08ba5-7e37-742c-9983-5a2577e8fcd8" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IssuedCapitalMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ComponentsOfEquityDomain_01a08ba5-7e37-78c1-b220-b22a8560a1d1" xlink:to="loc_ifrs-full_IssuedCapitalMember_01a08ba5-7e37-742c-9983-5a2577e8fcd8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_01a08ba4-15b6-7147-9d25-ddb58d8a364f" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable_01a08ba4-15b6-78fa-b17e-bf6fa3dca338" xlink:to="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_01a08ba4-15b6-7147-9d25-ddb58d8a364f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_UpfrontPaymentCommitment_01a08ba4-15b6-7405-847f-b0d61a5b49d3" xlink:href="inpha-20260630.xsd#inpha_UpfrontPaymentCommitment"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_01a08ba4-15b6-7147-9d25-ddb58d8a364f" xlink:to="loc_inpha_UpfrontPaymentCommitment_01a08ba4-15b6-7405-847f-b0d61a5b49d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProceedsFromIssueOfOrdinaryShares_01a08ba6-a915-7ce3-bbab-059d9ac26673" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProceedsFromIssueOfOrdinaryShares"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_01a08ba4-15b6-7147-9d25-ddb58d8a364f" xlink:to="loc_ifrs-full_ProceedsFromIssueOfOrdinaryShares_01a08ba6-a915-7ce3-bbab-059d9ac26673" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.innate-pharma.com/role/BasisofpresentationandstatementofcomplianceDisclosureofeffectofchangesinforeignexchangeratesDetails" xlink:type="simple" xlink:href="inpha-20260630.xsd#BasisofpresentationandstatementofcomplianceDisclosureofeffectofchangesinforeignexchangeratesDetails"/>
  <link:presentationLink xlink:role="http://www.innate-pharma.com/role/BasisofpresentationandstatementofcomplianceDisclosureofeffectofchangesinforeignexchangeratesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_inpha_SignificantAccountingPoliciesAbstract_56554927-b934-4417-8b01-7ac51f25e153" xlink:href="inpha-20260630.xsd#inpha_SignificantAccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AverageForeignExchangeRate_461b79d0-e7a8-4470-be60-9f2e12257ce7" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AverageForeignExchangeRate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inpha_SignificantAccountingPoliciesAbstract_56554927-b934-4417-8b01-7ac51f25e153" xlink:to="loc_ifrs-full_AverageForeignExchangeRate_461b79d0-e7a8-4470-be60-9f2e12257ce7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClosingForeignExchangeRate_b90027c2-9630-4d27-97c2-0e666251e7fb" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClosingForeignExchangeRate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inpha_SignificantAccountingPoliciesAbstract_56554927-b934-4417-8b01-7ac51f25e153" xlink:to="loc_ifrs-full_ClosingForeignExchangeRate_b90027c2-9630-4d27-97c2-0e666251e7fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.innate-pharma.com/role/CashcashequivalentsshortterminvestmentsandnoncurrentfinancialassetsDisclosureofcashcashequivalentsandfinancialassetsDetails" xlink:type="simple" xlink:href="inpha-20260630.xsd#CashcashequivalentsshortterminvestmentsandnoncurrentfinancialassetsDisclosureofcashcashequivalentsandfinancialassetsDetails"/>
  <link:presentationLink xlink:role="http://www.innate-pharma.com/role/CashcashequivalentsshortterminvestmentsandnoncurrentfinancialassetsDisclosureofcashcashequivalentsandfinancialassetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract_524eedd9-8f0f-417d-83a6-960f183704d2" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CashAndCashEquivalents_dcc7f7ae-96e6-4e09-921b-5f08aa6874e8" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CashAndCashEquivalents"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract_524eedd9-8f0f-417d-83a6-960f183704d2" xlink:to="loc_ifrs-full_CashAndCashEquivalents_dcc7f7ae-96e6-4e09-921b-5f08aa6874e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CurrentFinancialAssets_45a5fd46-4cdf-47c2-95c1-ccc9a61ceec3" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentFinancialAssets"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract_524eedd9-8f0f-417d-83a6-960f183704d2" xlink:to="loc_ifrs-full_CurrentFinancialAssets_45a5fd46-4cdf-47c2-95c1-ccc9a61ceec3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_CashCashEquivalentsAndShortTermInvestmentsAssets_e825fb3c-f4a5-4dd9-8b48-dc0db6341efc" xlink:href="inpha-20260630.xsd#inpha_CashCashEquivalentsAndShortTermInvestmentsAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract_524eedd9-8f0f-417d-83a6-960f183704d2" xlink:to="loc_inpha_CashCashEquivalentsAndShortTermInvestmentsAssets_e825fb3c-f4a5-4dd9-8b48-dc0db6341efc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NoncurrentFinancialAssets_787796dc-2d2e-4c72-8235-b3ba8cc7b897" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NoncurrentFinancialAssets"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract_524eedd9-8f0f-417d-83a6-960f183704d2" xlink:to="loc_ifrs-full_NoncurrentFinancialAssets_787796dc-2d2e-4c72-8235-b3ba8cc7b897" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_TotalCashCashEquivalentsAndFinancialAssets_15f6656e-2cc0-4a47-8b33-efd50f1a5599" xlink:href="inpha-20260630.xsd#inpha_TotalCashCashEquivalentsAndFinancialAssets"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract_524eedd9-8f0f-417d-83a6-960f183704d2" xlink:to="loc_inpha_TotalCashCashEquivalentsAndFinancialAssets_15f6656e-2cc0-4a47-8b33-efd50f1a5599" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.innate-pharma.com/role/CashcashequivalentsshortterminvestmentsandnoncurrentfinancialassetsAdditionalinformationDetails" xlink:type="simple" xlink:href="inpha-20260630.xsd#CashcashequivalentsshortterminvestmentsandnoncurrentfinancialassetsAdditionalinformationDetails"/>
  <link:presentationLink xlink:role="http://www.innate-pharma.com/role/CashcashequivalentsshortterminvestmentsandnoncurrentfinancialassetsAdditionalinformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract_1c92a880-058b-44db-9f61-dbccb9be82fd" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfFinancialAssetsTable_ead748a4-9890-4ba2-ac03-c2b373e874ad" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfFinancialAssetsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract_1c92a880-058b-44db-9f61-dbccb9be82fd" xlink:to="loc_ifrs-full_DisclosureOfFinancialAssetsTable_ead748a4-9890-4ba2-ac03-c2b373e874ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfFinancialAssetsAxis_30797e6e-44fe-4ee8-b599-de54aef00c70" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfFinancialAssetsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialAssetsTable_ead748a4-9890-4ba2-ac03-c2b373e874ad" xlink:to="loc_ifrs-full_ClassesOfFinancialAssetsAxis_30797e6e-44fe-4ee8-b599-de54aef00c70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfFinancialAssetsDomain_0210f806-c70a-41de-a854-f06b0da6c910" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfFinancialAssetsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfFinancialAssetsAxis_30797e6e-44fe-4ee8-b599-de54aef00c70" xlink:to="loc_ifrs-full_ClassesOfFinancialAssetsDomain_0210f806-c70a-41de-a854-f06b0da6c910" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_SICAVAndMutualFundsMember_b2f747d3-fa5b-4390-8a28-978c8c0ab958" xlink:href="inpha-20260630.xsd#inpha_SICAVAndMutualFundsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfFinancialAssetsDomain_0210f806-c70a-41de-a854-f06b0da6c910" xlink:to="loc_inpha_SICAVAndMutualFundsMember_b2f747d3-fa5b-4390-8a28-978c8c0ab958" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_CashCashEquivalentsAndFinancialAssetsDenominatedInUSDollarsMember_a22688ec-406f-49d8-b3cc-7aa3e938677c" xlink:href="inpha-20260630.xsd#inpha_CashCashEquivalentsAndFinancialAssetsDenominatedInUSDollarsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfFinancialAssetsDomain_0210f806-c70a-41de-a854-f06b0da6c910" xlink:to="loc_inpha_CashCashEquivalentsAndFinancialAssetsDenominatedInUSDollarsMember_a22688ec-406f-49d8-b3cc-7aa3e938677c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_5366f492-ee5e-4b59-9710-73734a95a1c6" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialAssetsTable_ead748a4-9890-4ba2-ac03-c2b373e874ad" xlink:to="loc_srt_RangeAxis_5366f492-ee5e-4b59-9710-73734a95a1c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_b60a120a-674c-41ae-b196-514222ef03cb" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_5366f492-ee5e-4b59-9710-73734a95a1c6" xlink:to="loc_srt_RangeMember_b60a120a-674c-41ae-b196-514222ef03cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_db3394eb-4874-4942-8285-2a8e33881a0c" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_b60a120a-674c-41ae-b196-514222ef03cb" xlink:to="loc_srt_MinimumMember_db3394eb-4874-4942-8285-2a8e33881a0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_acfbc0bf-dfde-44d2-9d76-c7a9ebf2a8b4" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_b60a120a-674c-41ae-b196-514222ef03cb" xlink:to="loc_srt_MaximumMember_acfbc0bf-dfde-44d2-9d76-c7a9ebf2a8b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfFinancialAssetsLineItems_5d1430df-2e1a-4779-bdf4-45eb07bb31f3" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfFinancialAssetsLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialAssetsTable_ead748a4-9890-4ba2-ac03-c2b373e874ad" xlink:to="loc_ifrs-full_DisclosureOfFinancialAssetsLineItems_5d1430df-2e1a-4779-bdf4-45eb07bb31f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_NumberOfMutualFundsInWhichTheEntityIsHoldingShares_7547c267-2e9c-48a1-b0a6-edabcd88caa5" xlink:href="inpha-20260630.xsd#inpha_NumberOfMutualFundsInWhichTheEntityIsHoldingShares"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialAssetsLineItems_5d1430df-2e1a-4779-bdf4-45eb07bb31f3" xlink:to="loc_inpha_NumberOfMutualFundsInWhichTheEntityIsHoldingShares_7547c267-2e9c-48a1-b0a6-edabcd88caa5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_RiskProfileRate_ed44d54b-5491-4b80-9836-b3fcbfe9d193" xlink:href="inpha-20260630.xsd#inpha_RiskProfileRate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialAssetsLineItems_5d1430df-2e1a-4779-bdf4-45eb07bb31f3" xlink:to="loc_inpha_RiskProfileRate_ed44d54b-5491-4b80-9836-b3fcbfe9d193" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_TotalCashCashEquivalentsAndFinancialAssets_d38313a5-7829-42d9-8cfe-a8ada324f405" xlink:href="inpha-20260630.xsd#inpha_TotalCashCashEquivalentsAndFinancialAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialAssetsLineItems_5d1430df-2e1a-4779-bdf4-45eb07bb31f3" xlink:to="loc_inpha_TotalCashCashEquivalentsAndFinancialAssets_d38313a5-7829-42d9-8cfe-a8ada324f405" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_NonCurrentFinancialAssetsVariationOfFairValueThroughTheConsolidatedStatementOfIncomeLoss_7789e850-f39a-4601-8d40-574a344eaef6" xlink:href="inpha-20260630.xsd#inpha_NonCurrentFinancialAssetsVariationOfFairValueThroughTheConsolidatedStatementOfIncomeLoss"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialAssetsLineItems_5d1430df-2e1a-4779-bdf4-45eb07bb31f3" xlink:to="loc_inpha_NonCurrentFinancialAssetsVariationOfFairValueThroughTheConsolidatedStatementOfIncomeLoss_7789e850-f39a-4601-8d40-574a344eaef6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_ShortTermInvestmentsVariationOfFairValueThroughTheConsolidatedStatementOfIncomeLoss_384fc846-e943-4a1e-a3c4-1da3afd1a076" xlink:href="inpha-20260630.xsd#inpha_ShortTermInvestmentsVariationOfFairValueThroughTheConsolidatedStatementOfIncomeLoss"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialAssetsLineItems_5d1430df-2e1a-4779-bdf4-45eb07bb31f3" xlink:to="loc_inpha_ShortTermInvestmentsVariationOfFairValueThroughTheConsolidatedStatementOfIncomeLoss_384fc846-e943-4a1e-a3c4-1da3afd1a076" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.innate-pharma.com/role/CashcashequivalentsshortterminvestmentsandnoncurrentfinancialassetsDisclosureofreconciliationofchangesinshortterminvestmentsandnoncurrentfinancialassetsDetails" xlink:type="simple" xlink:href="inpha-20260630.xsd#CashcashequivalentsshortterminvestmentsandnoncurrentfinancialassetsDisclosureofreconciliationofchangesinshortterminvestmentsandnoncurrentfinancialassetsDetails"/>
  <link:presentationLink xlink:role="http://www.innate-pharma.com/role/CashcashequivalentsshortterminvestmentsandnoncurrentfinancialassetsDisclosureofreconciliationofchangesinshortterminvestmentsandnoncurrentfinancialassetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract_401d8859-a948-4c8e-94ad-36528807ac97" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_ShortTermInvestments1Abstract_902f2e02-9c0e-4f2a-ad3f-9eb0587657ad" xlink:href="inpha-20260630.xsd#inpha_ShortTermInvestments1Abstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract_401d8859-a948-4c8e-94ad-36528807ac97" xlink:to="loc_inpha_ShortTermInvestments1Abstract_902f2e02-9c0e-4f2a-ad3f-9eb0587657ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CurrentInvestments_dee9b91a-da22-4f02-b89e-557797f191a2" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentInvestments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inpha_ShortTermInvestments1Abstract_902f2e02-9c0e-4f2a-ad3f-9eb0587657ad" xlink:to="loc_ifrs-full_CurrentInvestments_dee9b91a-da22-4f02-b89e-557797f191a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_ShortTermInvestmentsAcquisitions_9a489202-078a-4841-b176-80194ce204be" xlink:href="inpha-20260630.xsd#inpha_ShortTermInvestmentsAcquisitions"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inpha_ShortTermInvestments1Abstract_902f2e02-9c0e-4f2a-ad3f-9eb0587657ad" xlink:to="loc_inpha_ShortTermInvestmentsAcquisitions_9a489202-078a-4841-b176-80194ce204be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_DecreaseThroughDerecognitionShortTermInvestment_36488e96-01ea-4794-9301-58bc347c292d" xlink:href="inpha-20260630.xsd#inpha_DecreaseThroughDerecognitionShortTermInvestment"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inpha_ShortTermInvestments1Abstract_902f2e02-9c0e-4f2a-ad3f-9eb0587657ad" xlink:to="loc_inpha_DecreaseThroughDerecognitionShortTermInvestment_36488e96-01ea-4794-9301-58bc347c292d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_ShortTermInvestmentsVariationOfFairValueThroughTheConsolidatedStatementOfIncomeLoss_01c9281b-94e5-4085-961b-4702406c71c2" xlink:href="inpha-20260630.xsd#inpha_ShortTermInvestmentsVariationOfFairValueThroughTheConsolidatedStatementOfIncomeLoss"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inpha_ShortTermInvestments1Abstract_902f2e02-9c0e-4f2a-ad3f-9eb0587657ad" xlink:to="loc_inpha_ShortTermInvestmentsVariationOfFairValueThroughTheConsolidatedStatementOfIncomeLoss_01c9281b-94e5-4085-961b-4702406c71c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_IncreaseDecreaseInAccruedInterestForCurrentFinancialAssetsNotAtFairValueThroughProfitOrLoss_ad3c3e5b-0ca4-41dd-9873-0e872bd98597" xlink:href="inpha-20260630.xsd#inpha_IncreaseDecreaseInAccruedInterestForCurrentFinancialAssetsNotAtFairValueThroughProfitOrLoss"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inpha_ShortTermInvestments1Abstract_902f2e02-9c0e-4f2a-ad3f-9eb0587657ad" xlink:to="loc_inpha_IncreaseDecreaseInAccruedInterestForCurrentFinancialAssetsNotAtFairValueThroughProfitOrLoss_ad3c3e5b-0ca4-41dd-9873-0e872bd98597" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_ShortTermInvestmentsForeignCurrencyEffect_2c097089-420c-4a47-9471-a3d318476961" xlink:href="inpha-20260630.xsd#inpha_ShortTermInvestmentsForeignCurrencyEffect"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inpha_ShortTermInvestments1Abstract_902f2e02-9c0e-4f2a-ad3f-9eb0587657ad" xlink:to="loc_inpha_ShortTermInvestmentsForeignCurrencyEffect_2c097089-420c-4a47-9471-a3d318476961" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CurrentInvestments_ff4ffb7e-e413-42bc-9103-d9f4c03c0013" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentInvestments"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inpha_ShortTermInvestments1Abstract_902f2e02-9c0e-4f2a-ad3f-9eb0587657ad" xlink:to="loc_ifrs-full_CurrentInvestments_ff4ffb7e-e413-42bc-9103-d9f4c03c0013" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_NonCurrentFinancialAssetsAbstract_3f5f26b7-e14b-4c37-b683-21ec2c11f751" xlink:href="inpha-20260630.xsd#inpha_NonCurrentFinancialAssetsAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract_401d8859-a948-4c8e-94ad-36528807ac97" xlink:to="loc_inpha_NonCurrentFinancialAssetsAbstract_3f5f26b7-e14b-4c37-b683-21ec2c11f751" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NoncurrentFinancialAssets_bf7817c7-129f-46af-b91c-5a4612fba35f" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NoncurrentFinancialAssets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inpha_NonCurrentFinancialAssetsAbstract_3f5f26b7-e14b-4c37-b683-21ec2c11f751" xlink:to="loc_ifrs-full_NoncurrentFinancialAssets_bf7817c7-129f-46af-b91c-5a4612fba35f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_NonCurrentFinancialAssetsAcquisitions_9088ea6b-a7c2-4672-ba38-24d58d277acd" xlink:href="inpha-20260630.xsd#inpha_NonCurrentFinancialAssetsAcquisitions"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inpha_NonCurrentFinancialAssetsAbstract_3f5f26b7-e14b-4c37-b683-21ec2c11f751" xlink:to="loc_inpha_NonCurrentFinancialAssetsAcquisitions_9088ea6b-a7c2-4672-ba38-24d58d277acd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_DecreaseThroughDerecognitionNonCurrentFinancialAssets_64e3c462-2d35-4681-9364-5e00b04c436c" xlink:href="inpha-20260630.xsd#inpha_DecreaseThroughDerecognitionNonCurrentFinancialAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inpha_NonCurrentFinancialAssetsAbstract_3f5f26b7-e14b-4c37-b683-21ec2c11f751" xlink:to="loc_inpha_DecreaseThroughDerecognitionNonCurrentFinancialAssets_64e3c462-2d35-4681-9364-5e00b04c436c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_NonCurrentFinancialAssetsVariationOfFairValueThroughTheConsolidatedStatementOfIncomeLoss_decc57d3-4d3d-482f-955a-41f9030e1827" xlink:href="inpha-20260630.xsd#inpha_NonCurrentFinancialAssetsVariationOfFairValueThroughTheConsolidatedStatementOfIncomeLoss"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inpha_NonCurrentFinancialAssetsAbstract_3f5f26b7-e14b-4c37-b683-21ec2c11f751" xlink:to="loc_inpha_NonCurrentFinancialAssetsVariationOfFairValueThroughTheConsolidatedStatementOfIncomeLoss_decc57d3-4d3d-482f-955a-41f9030e1827" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_IncreaseDecreaseInAccruedInterestForNonCurrentFinancialAssetsNotAtFairValueThroughProfitOrLoss_8c5b042d-972f-429c-b2d2-e077eca47d6e" xlink:href="inpha-20260630.xsd#inpha_IncreaseDecreaseInAccruedInterestForNonCurrentFinancialAssetsNotAtFairValueThroughProfitOrLoss"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inpha_NonCurrentFinancialAssetsAbstract_3f5f26b7-e14b-4c37-b683-21ec2c11f751" xlink:to="loc_inpha_IncreaseDecreaseInAccruedInterestForNonCurrentFinancialAssetsNotAtFairValueThroughProfitOrLoss_8c5b042d-972f-429c-b2d2-e077eca47d6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_NonCurrentFinancialAssetsForeignCurrencyEffect_0616e49b-ee82-4d48-8bb4-bd1a93f22a1a" xlink:href="inpha-20260630.xsd#inpha_NonCurrentFinancialAssetsForeignCurrencyEffect"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inpha_NonCurrentFinancialAssetsAbstract_3f5f26b7-e14b-4c37-b683-21ec2c11f751" xlink:to="loc_inpha_NonCurrentFinancialAssetsForeignCurrencyEffect_0616e49b-ee82-4d48-8bb4-bd1a93f22a1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NoncurrentFinancialAssets_0dad2848-f5a1-4825-841b-33d45269aed7" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NoncurrentFinancialAssets"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inpha_NonCurrentFinancialAssetsAbstract_3f5f26b7-e14b-4c37-b683-21ec2c11f751" xlink:to="loc_ifrs-full_NoncurrentFinancialAssets_0dad2848-f5a1-4825-841b-33d45269aed7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_TotalShortTermInvestmentsAndNonCurrentFinancialAssetsAbstract_ac187087-4b4e-4081-a199-45fa9b604c61" xlink:href="inpha-20260630.xsd#inpha_TotalShortTermInvestmentsAndNonCurrentFinancialAssetsAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract_401d8859-a948-4c8e-94ad-36528807ac97" xlink:to="loc_inpha_TotalShortTermInvestmentsAndNonCurrentFinancialAssetsAbstract_ac187087-4b4e-4081-a199-45fa9b604c61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_ShortTermInvestmentsAndNonCurrentFinancialAssets_87d67b00-2750-4946-bbb7-b0b6f7054ede" xlink:href="inpha-20260630.xsd#inpha_ShortTermInvestmentsAndNonCurrentFinancialAssets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inpha_TotalShortTermInvestmentsAndNonCurrentFinancialAssetsAbstract_ac187087-4b4e-4081-a199-45fa9b604c61" xlink:to="loc_inpha_ShortTermInvestmentsAndNonCurrentFinancialAssets_87d67b00-2750-4946-bbb7-b0b6f7054ede" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_TotalAcquisitions_5e1c5b59-0a0a-4087-bfb8-71c7ac76e9ad" xlink:href="inpha-20260630.xsd#inpha_TotalAcquisitions"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inpha_TotalShortTermInvestmentsAndNonCurrentFinancialAssetsAbstract_ac187087-4b4e-4081-a199-45fa9b604c61" xlink:to="loc_inpha_TotalAcquisitions_5e1c5b59-0a0a-4087-bfb8-71c7ac76e9ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_DecreaseThroughDerecognitionShortTermInvestmentAndNonCurrentFinancialAssets_406d0e0a-2a19-43ae-875f-eda40cc09b6e" xlink:href="inpha-20260630.xsd#inpha_DecreaseThroughDerecognitionShortTermInvestmentAndNonCurrentFinancialAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inpha_TotalShortTermInvestmentsAndNonCurrentFinancialAssetsAbstract_ac187087-4b4e-4081-a199-45fa9b604c61" xlink:to="loc_inpha_DecreaseThroughDerecognitionShortTermInvestmentAndNonCurrentFinancialAssets_406d0e0a-2a19-43ae-875f-eda40cc09b6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_TotalVariationOfFairValueThroughTheConsolidatedStatementOfIncomeLoss_56396874-d180-46df-a313-545d19eb83eb" xlink:href="inpha-20260630.xsd#inpha_TotalVariationOfFairValueThroughTheConsolidatedStatementOfIncomeLoss"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inpha_TotalShortTermInvestmentsAndNonCurrentFinancialAssetsAbstract_ac187087-4b4e-4081-a199-45fa9b604c61" xlink:to="loc_inpha_TotalVariationOfFairValueThroughTheConsolidatedStatementOfIncomeLoss_56396874-d180-46df-a313-545d19eb83eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_IncreaseDecreaseInAccruedInterestForShortTermAndNonCurrentFinancialAssetsNotAtFairValueThroughProfitOrLoss_dec647a6-1250-484b-88e6-46729e728a7b" xlink:href="inpha-20260630.xsd#inpha_IncreaseDecreaseInAccruedInterestForShortTermAndNonCurrentFinancialAssetsNotAtFairValueThroughProfitOrLoss"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inpha_TotalShortTermInvestmentsAndNonCurrentFinancialAssetsAbstract_ac187087-4b4e-4081-a199-45fa9b604c61" xlink:to="loc_inpha_IncreaseDecreaseInAccruedInterestForShortTermAndNonCurrentFinancialAssetsNotAtFairValueThroughProfitOrLoss_dec647a6-1250-484b-88e6-46729e728a7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_TotalForeignCurrencyEffect_1297bf87-2a5b-48e2-8130-bf939e3c864f" xlink:href="inpha-20260630.xsd#inpha_TotalForeignCurrencyEffect"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inpha_TotalShortTermInvestmentsAndNonCurrentFinancialAssetsAbstract_ac187087-4b4e-4081-a199-45fa9b604c61" xlink:to="loc_inpha_TotalForeignCurrencyEffect_1297bf87-2a5b-48e2-8130-bf939e3c864f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_ShortTermInvestmentsAndNonCurrentFinancialAssets_6ed89eb5-67dc-4d58-911e-28f8c7b9bc0d" xlink:href="inpha-20260630.xsd#inpha_ShortTermInvestmentsAndNonCurrentFinancialAssets"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inpha_TotalShortTermInvestmentsAndNonCurrentFinancialAssetsAbstract_ac187087-4b4e-4081-a199-45fa9b604c61" xlink:to="loc_inpha_ShortTermInvestmentsAndNonCurrentFinancialAssets_6ed89eb5-67dc-4d58-911e-28f8c7b9bc0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.innate-pharma.com/role/TradereceivablesandothersDetails" xlink:type="simple" xlink:href="inpha-20260630.xsd#TradereceivablesandothersDetails"/>
  <link:presentationLink xlink:role="http://www.innate-pharma.com/role/TradereceivablesandothersDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract_4b3f4e7f-01c1-40fe-8908-3a55d3a3e198" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfFinancialAssetsTable_e9877401-aa08-4bff-8e33-36c00c136765" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfFinancialAssetsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract_4b3f4e7f-01c1-40fe-8908-3a55d3a3e198" xlink:to="loc_ifrs-full_DisclosureOfFinancialAssetsTable_e9877401-aa08-4bff-8e33-36c00c136765" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfFinancialAssetsAxis_761c464a-0d23-4802-a8fa-60298323f99e" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TypesOfFinancialAssetsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialAssetsTable_e9877401-aa08-4bff-8e33-36c00c136765" xlink:to="loc_ifrs-full_TypesOfFinancialAssetsAxis_761c464a-0d23-4802-a8fa-60298323f99e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfFinancialAssetsDomain_032c22ff-eff4-4849-b787-05d233b9dfb2" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TypesOfFinancialAssetsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfFinancialAssetsAxis_761c464a-0d23-4802-a8fa-60298323f99e" xlink:to="loc_ifrs-full_TypesOfFinancialAssetsDomain_032c22ff-eff4-4849-b787-05d233b9dfb2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GuaranteesMember_df1c3e30-e9fd-4378-8426-a97c694f8d61" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_GuaranteesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfFinancialAssetsDomain_032c22ff-eff4-4849-b787-05d233b9dfb2" xlink:to="loc_ifrs-full_GuaranteesMember_df1c3e30-e9fd-4378-8426-a97c694f8d61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BorrowingsByNameAxis_87e7b27f-9099-4f17-973f-599593ccb189" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BorrowingsByNameAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialAssetsTable_e9877401-aa08-4bff-8e33-36c00c136765" xlink:to="loc_ifrs-full_BorrowingsByNameAxis_87e7b27f-9099-4f17-973f-599593ccb189" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BorrowingsByNameDomain_0b274897-32b0-4164-b941-e7ff8cf273f8" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BorrowingsByNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_BorrowingsByNameAxis_87e7b27f-9099-4f17-973f-599593ccb189" xlink:to="loc_ifrs-full_BorrowingsByNameDomain_0b274897-32b0-4164-b941-e7ff8cf273f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_PGELoanAgreementSocieteGeneraleAndBNPParibasMember_40902843-e37d-4bd8-aa38-16797c14a687" xlink:href="inpha-20260630.xsd#inpha_PGELoanAgreementSocieteGeneraleAndBNPParibasMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_BorrowingsByNameDomain_0b274897-32b0-4164-b941-e7ff8cf273f8" xlink:to="loc_inpha_PGELoanAgreementSocieteGeneraleAndBNPParibasMember_40902843-e37d-4bd8-aa38-16797c14a687" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfFinancialAssetsLineItems_75de98d0-0ba6-4f5e-b679-61d675d71985" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfFinancialAssetsLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialAssetsTable_e9877401-aa08-4bff-8e33-36c00c136765" xlink:to="loc_ifrs-full_DisclosureOfFinancialAssetsLineItems_75de98d0-0ba6-4f5e-b679-61d675d71985" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherCurrentReceivables_69297cc5-6818-46e8-9f3e-cf714c3b8682" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherCurrentReceivables"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialAssetsLineItems_75de98d0-0ba6-4f5e-b679-61d675d71985" xlink:to="loc_ifrs-full_OtherCurrentReceivables_69297cc5-6818-46e8-9f3e-cf714c3b8682" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_ResearchTaxCreditReceivableCurrent_019fb2ff-c9d6-70f4-a1fc-1bd0dfde7fbc" xlink:href="inpha-20260630.xsd#inpha_ResearchTaxCreditReceivableCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialAssetsLineItems_75de98d0-0ba6-4f5e-b679-61d675d71985" xlink:to="loc_inpha_ResearchTaxCreditReceivableCurrent_019fb2ff-c9d6-70f4-a1fc-1bd0dfde7fbc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_OtherCurrentTaxCreditsReceivables_a0ce8204-02b9-40ee-8e20-75ed7f8cc9c6" xlink:href="inpha-20260630.xsd#inpha_OtherCurrentTaxCreditsReceivables"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialAssetsLineItems_75de98d0-0ba6-4f5e-b679-61d675d71985" xlink:to="loc_inpha_OtherCurrentTaxCreditsReceivables_a0ce8204-02b9-40ee-8e20-75ed7f8cc9c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CurrentPrepaidExpenses_826e424a-f003-44d7-bad3-4ca685a1cb57" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentPrepaidExpenses"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialAssetsLineItems_75de98d0-0ba6-4f5e-b679-61d675d71985" xlink:to="loc_ifrs-full_CurrentPrepaidExpenses_826e424a-f003-44d7-bad3-4ca685a1cb57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CurrentValueAddedTaxReceivables_eee5283a-e40e-4ce2-9ea1-612eaafc51f2" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentValueAddedTaxReceivables"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialAssetsLineItems_75de98d0-0ba6-4f5e-b679-61d675d71985" xlink:to="loc_ifrs-full_CurrentValueAddedTaxReceivables_eee5283a-e40e-4ce2-9ea1-612eaafc51f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CurrentTradeReceivables_d565c105-9c89-4693-8922-e72a3b35b9ca" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentTradeReceivables"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialAssetsLineItems_75de98d0-0ba6-4f5e-b679-61d675d71985" xlink:to="loc_ifrs-full_CurrentTradeReceivables_d565c105-9c89-4693-8922-e72a3b35b9ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CurrentAdvancesToSuppliers_8f9a407b-5c72-46cf-9d6c-38e5415bc6d9" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentAdvancesToSuppliers"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialAssetsLineItems_75de98d0-0ba6-4f5e-b679-61d675d71985" xlink:to="loc_ifrs-full_CurrentAdvancesToSuppliers_8f9a407b-5c72-46cf-9d6c-38e5415bc6d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TradeAndOtherCurrentReceivables_b3cd608d-4588-469d-96f2-c5c4884e29ac" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TradeAndOtherCurrentReceivables"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialAssetsLineItems_75de98d0-0ba6-4f5e-b679-61d675d71985" xlink:to="loc_ifrs-full_TradeAndOtherCurrentReceivables_b3cd608d-4588-469d-96f2-c5c4884e29ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_NonCurrentResearchTaxCredit_07cacafb-7a74-469e-b0ed-bf514cec25ee" xlink:href="inpha-20260630.xsd#inpha_NonCurrentResearchTaxCredit"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialAssetsLineItems_75de98d0-0ba6-4f5e-b679-61d675d71985" xlink:to="loc_inpha_NonCurrentResearchTaxCredit_07cacafb-7a74-469e-b0ed-bf514cec25ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_NonCurrentPrepaidExpenses_1d47e606-5c63-4ceb-a332-005ebdf28594" xlink:href="inpha-20260630.xsd#inpha_NonCurrentPrepaidExpenses"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialAssetsLineItems_75de98d0-0ba6-4f5e-b679-61d675d71985" xlink:to="loc_inpha_NonCurrentPrepaidExpenses_1d47e606-5c63-4ceb-a332-005ebdf28594" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NoncurrentPrepayments_930d50ef-96e6-44e7-a848-38d7c37a3eac" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NoncurrentPrepayments"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialAssetsLineItems_75de98d0-0ba6-4f5e-b679-61d675d71985" xlink:to="loc_ifrs-full_NoncurrentPrepayments_930d50ef-96e6-44e7-a848-38d7c37a3eac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NoncurrentReceivables_437c1697-bb86-4ca5-887d-a99358a6964f" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NoncurrentReceivables"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialAssetsLineItems_75de98d0-0ba6-4f5e-b679-61d675d71985" xlink:to="loc_ifrs-full_NoncurrentReceivables_437c1697-bb86-4ca5-887d-a99358a6964f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TradeAndOtherReceivables_21d2b5e5-0d62-4e73-9ed4-2c9922d3e9e6" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TradeAndOtherReceivables"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialAssetsLineItems_75de98d0-0ba6-4f5e-b679-61d675d71985" xlink:to="loc_ifrs-full_TradeAndOtherReceivables_21d2b5e5-0d62-4e73-9ed4-2c9922d3e9e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_NonCurrentResearchTaxCredit2025_af028f22-51eb-425d-a18c-9a04497afc3d" xlink:href="inpha-20260630.xsd#inpha_NonCurrentResearchTaxCredit2025"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialAssetsLineItems_75de98d0-0ba6-4f5e-b679-61d675d71985" xlink:to="loc_inpha_NonCurrentResearchTaxCredit2025_af028f22-51eb-425d-a18c-9a04497afc3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_BorrowingNumberOfLoanAgreement_ffdc004c-0ba9-4bac-a600-5c28b5e17d16" xlink:href="inpha-20260630.xsd#inpha_BorrowingNumberOfLoanAgreement"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialAssetsLineItems_75de98d0-0ba6-4f5e-b679-61d675d71985" xlink:to="loc_inpha_BorrowingNumberOfLoanAgreement_ffdc004c-0ba9-4bac-a600-5c28b5e17d16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_BorrowingMaturity_b44ca606-fc40-4b1c-9a66-0ef4fd53f4b5" xlink:href="inpha-20260630.xsd#inpha_BorrowingMaturity"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialAssetsLineItems_75de98d0-0ba6-4f5e-b679-61d675d71985" xlink:to="loc_inpha_BorrowingMaturity_b44ca606-fc40-4b1c-9a66-0ef4fd53f4b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.innate-pharma.com/role/IntangibleassetsAdditionalinformationDetails" xlink:type="simple" xlink:href="inpha-20260630.xsd#IntangibleassetsAdditionalinformationDetails"/>
  <link:presentationLink xlink:role="http://www.innate-pharma.com/role/IntangibleassetsAdditionalinformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IntangibleAssetsOtherThanGoodwillAbstract_18ac7225-3d0b-443c-bb5f-de0da8de7192" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IntangibleAssetsOtherThanGoodwillAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfIntangibleAssetsTable_4b72f019-a4bd-4c35-92d5-a98a17b3bd9a" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfIntangibleAssetsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IntangibleAssetsOtherThanGoodwillAbstract_18ac7225-3d0b-443c-bb5f-de0da8de7192" xlink:to="loc_ifrs-full_DisclosureOfIntangibleAssetsTable_4b72f019-a4bd-4c35-92d5-a98a17b3bd9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfContractsAxis_5866328e-0383-4dd7-83c4-8047d168970b" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TypesOfContractsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsTable_4b72f019-a4bd-4c35-92d5-a98a17b3bd9a" xlink:to="loc_ifrs-full_TypesOfContractsAxis_5866328e-0383-4dd7-83c4-8047d168970b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfContractsDomain_a9c8b0a7-31c7-4183-96c3-e2d6bbd323a3" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TypesOfContractsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfContractsAxis_5866328e-0383-4dd7-83c4-8047d168970b" xlink:to="loc_ifrs-full_TypesOfContractsDomain_a9c8b0a7-31c7-4183-96c3-e2d6bbd323a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_MonalizumabRightsUnderThe2014MonalizumabNKG2ANovoNordiskAgreementMember_d611244f-f1a4-49b4-8029-a3ea892f9065" xlink:href="inpha-20260630.xsd#inpha_MonalizumabRightsUnderThe2014MonalizumabNKG2ANovoNordiskAgreementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfContractsDomain_a9c8b0a7-31c7-4183-96c3-e2d6bbd323a3" xlink:to="loc_inpha_MonalizumabRightsUnderThe2014MonalizumabNKG2ANovoNordiskAgreementMember_d611244f-f1a4-49b4-8029-a3ea892f9065" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfIntangibleAssetsLineItems_e0d8894f-43d2-4937-9753-0562add4a61c" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfIntangibleAssetsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsTable_4b72f019-a4bd-4c35-92d5-a98a17b3bd9a" xlink:to="loc_ifrs-full_DisclosureOfIntangibleAssetsLineItems_e0d8894f-43d2-4937-9753-0562add4a61c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IntangibleAssetsOtherThanGoodwill_ff50820c-9c94-434e-9772-2d0a167fe790" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IntangibleAssetsOtherThanGoodwill"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsLineItems_e0d8894f-43d2-4937-9753-0562add4a61c" xlink:to="loc_ifrs-full_IntangibleAssetsOtherThanGoodwill_ff50820c-9c94-434e-9772-2d0a167fe790" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.innate-pharma.com/role/PropertyandequipmentDetails" xlink:type="simple" xlink:href="inpha-20260630.xsd#PropertyandequipmentDetails"/>
  <link:presentationLink xlink:role="http://www.innate-pharma.com/role/PropertyandequipmentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PropertyPlantAndEquipmentAbstract_7b17925c-1d80-47da-b15f-d75ad1520c43" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable_60501b91-b54c-43ce-96db-d829567b8763" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_PropertyPlantAndEquipmentAbstract_7b17925c-1d80-47da-b15f-d75ad1520c43" xlink:to="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable_60501b91-b54c-43ce-96db-d829567b8763" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_97a6a44d-a87b-4f14-807a-a00e16ecb514" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable_60501b91-b54c-43ce-96db-d829567b8763" xlink:to="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_97a6a44d-a87b-4f14-807a-a00e16ecb514" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentDomain_d1669a94-27cc-40ea-aa06-b956b8dffe47" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfPropertyPlantAndEquipmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_97a6a44d-a87b-4f14-807a-a00e16ecb514" xlink:to="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentDomain_d1669a94-27cc-40ea-aa06-b956b8dffe47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LandAndBuildingsMember_0b48f7e8-c15e-4304-acff-6b3e578d5cc1" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_LandAndBuildingsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentDomain_d1669a94-27cc-40ea-aa06-b956b8dffe47" xlink:to="loc_ifrs-full_LandAndBuildingsMember_0b48f7e8-c15e-4304-acff-6b3e578d5cc1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_LaboratoryEquipmentAndOtherMember_408b7d85-42b4-4860-9627-075b7e87d271" xlink:href="inpha-20260630.xsd#inpha_LaboratoryEquipmentAndOtherMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentDomain_d1669a94-27cc-40ea-aa06-b956b8dffe47" xlink:to="loc_inpha_LaboratoryEquipmentAndOtherMember_408b7d85-42b4-4860-9627-075b7e87d271" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ConstructionInProgressMember_80f5175a-d5c2-4ec5-bab2-b17d18c70c18" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ConstructionInProgressMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentDomain_d1669a94-27cc-40ea-aa06-b956b8dffe47" xlink:to="loc_ifrs-full_ConstructionInProgressMember_80f5175a-d5c2-4ec5-bab2-b17d18c70c18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PropertyPlantAndEquipmentIncludingRightofuseAssetsAxis_835391a2-f1b8-4f5d-9cc1-4b1cc1a62318" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_PropertyPlantAndEquipmentIncludingRightofuseAssetsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable_60501b91-b54c-43ce-96db-d829567b8763" xlink:to="loc_ifrs-full_PropertyPlantAndEquipmentIncludingRightofuseAssetsAxis_835391a2-f1b8-4f5d-9cc1-4b1cc1a62318" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PropertyPlantAndEquipmentIncludingRightofuseAssetsDomain_bbea9452-57fe-4be7-b41d-d6b05e37779c" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_PropertyPlantAndEquipmentIncludingRightofuseAssetsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_PropertyPlantAndEquipmentIncludingRightofuseAssetsAxis_835391a2-f1b8-4f5d-9cc1-4b1cc1a62318" xlink:to="loc_ifrs-full_PropertyPlantAndEquipmentIncludingRightofuseAssetsDomain_bbea9452-57fe-4be7-b41d-d6b05e37779c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RightofuseAssetsMember_07ef3c02-cc2b-4dec-8476-cfa58c18ff8b" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RightofuseAssetsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_PropertyPlantAndEquipmentIncludingRightofuseAssetsDomain_bbea9452-57fe-4be7-b41d-d6b05e37779c" xlink:to="loc_ifrs-full_RightofuseAssetsMember_07ef3c02-cc2b-4dec-8476-cfa58c18ff8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_35dfe0d6-33f8-4375-aaab-cb04f6491f1e" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable_60501b91-b54c-43ce-96db-d829567b8763" xlink:to="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_35dfe0d6-33f8-4375-aaab-cb04f6491f1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ReconciliationOfChangesInPropertyPlantAndEquipmentAbstract_63d60431-01b8-4222-bfd0-4695ed1a0f6f" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ReconciliationOfChangesInPropertyPlantAndEquipmentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_35dfe0d6-33f8-4375-aaab-cb04f6491f1e" xlink:to="loc_ifrs-full_ReconciliationOfChangesInPropertyPlantAndEquipmentAbstract_63d60431-01b8-4222-bfd0-4695ed1a0f6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PropertyPlantAndEquipmentIncludingRightofuseAssets_d240a521-4e52-4fb5-82e5-270a51e0c767" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_PropertyPlantAndEquipmentIncludingRightofuseAssets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ReconciliationOfChangesInPropertyPlantAndEquipmentAbstract_63d60431-01b8-4222-bfd0-4695ed1a0f6f" xlink:to="loc_ifrs-full_PropertyPlantAndEquipmentIncludingRightofuseAssets_d240a521-4e52-4fb5-82e5-270a51e0c767" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipmentIncludingRightofuseAssets_10a67a3b-4505-43d1-8587-c14f54349726" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipmentIncludingRightofuseAssets"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ReconciliationOfChangesInPropertyPlantAndEquipmentAbstract_63d60431-01b8-4222-bfd0-4695ed1a0f6f" xlink:to="loc_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipmentIncludingRightofuseAssets_10a67a3b-4505-43d1-8587-c14f54349726" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisposalsPropertyPlantAndEquipmentIncludingRightofuseAssets_2accfac5-f867-4b98-92cd-abf8c29f29e0" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisposalsPropertyPlantAndEquipmentIncludingRightofuseAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ReconciliationOfChangesInPropertyPlantAndEquipmentAbstract_63d60431-01b8-4222-bfd0-4695ed1a0f6f" xlink:to="loc_ifrs-full_DisposalsPropertyPlantAndEquipmentIncludingRightofuseAssets_2accfac5-f867-4b98-92cd-abf8c29f29e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DepreciationPropertyPlantAndEquipmentIncludingRightofuseAssets_74596127-c01d-4f51-b16f-0d692f957bd2" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DepreciationPropertyPlantAndEquipmentIncludingRightofuseAssets"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ReconciliationOfChangesInPropertyPlantAndEquipmentAbstract_63d60431-01b8-4222-bfd0-4695ed1a0f6f" xlink:to="loc_ifrs-full_DepreciationPropertyPlantAndEquipmentIncludingRightofuseAssets_74596127-c01d-4f51-b16f-0d692f957bd2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughTransfersFromConstructionInProgressPropertyPlantAndEquipmentIncludingRightofuseAssets_564e53f7-256f-4908-9419-24581a51d7c6" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IncreaseDecreaseThroughTransfersFromConstructionInProgressPropertyPlantAndEquipmentIncludingRightofuseAssets"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ReconciliationOfChangesInPropertyPlantAndEquipmentAbstract_63d60431-01b8-4222-bfd0-4695ed1a0f6f" xlink:to="loc_ifrs-full_IncreaseDecreaseThroughTransfersFromConstructionInProgressPropertyPlantAndEquipmentIncludingRightofuseAssets_564e53f7-256f-4908-9419-24581a51d7c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipmentIncludingRightofuseAssets_53ae509b-e291-4d73-ba99-2be6f20ef3a4" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipmentIncludingRightofuseAssets"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ReconciliationOfChangesInPropertyPlantAndEquipmentAbstract_63d60431-01b8-4222-bfd0-4695ed1a0f6f" xlink:to="loc_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipmentIncludingRightofuseAssets_53ae509b-e291-4d73-ba99-2be6f20ef3a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PropertyPlantAndEquipmentIncludingRightofuseAssets_17590963-32f3-43f4-af04-af54db1b9534" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_PropertyPlantAndEquipmentIncludingRightofuseAssets"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ReconciliationOfChangesInPropertyPlantAndEquipmentAbstract_63d60431-01b8-4222-bfd0-4695ed1a0f6f" xlink:to="loc_ifrs-full_PropertyPlantAndEquipmentIncludingRightofuseAssets_17590963-32f3-43f4-af04-af54db1b9534" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.innate-pharma.com/role/TradepayablesandothersDetails" xlink:type="simple" xlink:href="inpha-20260630.xsd#TradepayablesandothersDetails"/>
  <link:presentationLink xlink:role="http://www.innate-pharma.com/role/TradepayablesandothersDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract_4cb95a1d-9757-42c0-9229-6982df4e9666" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_DisclosureOfTradePayablesAndOthersTable_35b4c484-6d23-4872-83cc-d50ee2e9e033" xlink:href="inpha-20260630.xsd#inpha_DisclosureOfTradePayablesAndOthersTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract_4cb95a1d-9757-42c0-9229-6982df4e9666" xlink:to="loc_inpha_DisclosureOfTradePayablesAndOthersTable_35b4c484-6d23-4872-83cc-d50ee2e9e033" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BorrowingsByNameAxis_7039002a-8ba6-492d-b18a-1752d57d5096" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BorrowingsByNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inpha_DisclosureOfTradePayablesAndOthersTable_35b4c484-6d23-4872-83cc-d50ee2e9e033" xlink:to="loc_ifrs-full_BorrowingsByNameAxis_7039002a-8ba6-492d-b18a-1752d57d5096" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BorrowingsByNameDomain_fd4778f8-adb0-4a52-8af7-b456170a3322" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BorrowingsByNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_BorrowingsByNameAxis_7039002a-8ba6-492d-b18a-1752d57d5096" xlink:to="loc_ifrs-full_BorrowingsByNameDomain_fd4778f8-adb0-4a52-8af7-b456170a3322" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_PGELoanAgreementSocieteGeneraleAndBNPParibasMember_4e5e85c3-3ae5-4ae7-ab68-908f85a7b03d" xlink:href="inpha-20260630.xsd#inpha_PGELoanAgreementSocieteGeneraleAndBNPParibasMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_BorrowingsByNameDomain_fd4778f8-adb0-4a52-8af7-b456170a3322" xlink:to="loc_inpha_PGELoanAgreementSocieteGeneraleAndBNPParibasMember_4e5e85c3-3ae5-4ae7-ab68-908f85a7b03d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_DisclosureOfTradePayablesAndOthersLineItems_a26aa800-71de-4c08-8535-5f6ef3111953" xlink:href="inpha-20260630.xsd#inpha_DisclosureOfTradePayablesAndOthersLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inpha_DisclosureOfTradePayablesAndOthersTable_35b4c484-6d23-4872-83cc-d50ee2e9e033" xlink:to="loc_inpha_DisclosureOfTradePayablesAndOthersLineItems_a26aa800-71de-4c08-8535-5f6ef3111953" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TradeAndOtherCurrentPayablesToTradeSuppliers_ed9e568e-08f4-4acb-875d-af3d64b34fc5" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TradeAndOtherCurrentPayablesToTradeSuppliers"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inpha_DisclosureOfTradePayablesAndOthersLineItems_a26aa800-71de-4c08-8535-5f6ef3111953" xlink:to="loc_ifrs-full_TradeAndOtherCurrentPayablesToTradeSuppliers_ed9e568e-08f4-4acb-875d-af3d64b34fc5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PayablesOnSocialSecurityAndTaxesOtherThanIncomeTax_7c568f17-1237-4712-84cd-f2cd1521257b" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_PayablesOnSocialSecurityAndTaxesOtherThanIncomeTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inpha_DisclosureOfTradePayablesAndOthersLineItems_a26aa800-71de-4c08-8535-5f6ef3111953" xlink:to="loc_ifrs-full_PayablesOnSocialSecurityAndTaxesOtherThanIncomeTax_7c568f17-1237-4712-84cd-f2cd1521257b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherCurrentPayables_6e166f26-f95d-48dc-8009-4eeff478667e" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherCurrentPayables"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inpha_DisclosureOfTradePayablesAndOthersLineItems_a26aa800-71de-4c08-8535-5f6ef3111953" xlink:to="loc_ifrs-full_OtherCurrentPayables_6e166f26-f95d-48dc-8009-4eeff478667e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_CurrentTradePayablesAndOthersExcludingPayablesRelatedToCapitalExpenditures_b9537bf1-20f5-4e6d-b520-9ce4e6ca6559" xlink:href="inpha-20260630.xsd#inpha_CurrentTradePayablesAndOthersExcludingPayablesRelatedToCapitalExpenditures"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inpha_DisclosureOfTradePayablesAndOthersLineItems_a26aa800-71de-4c08-8535-5f6ef3111953" xlink:to="loc_inpha_CurrentTradePayablesAndOthersExcludingPayablesRelatedToCapitalExpenditures_b9537bf1-20f5-4e6d-b520-9ce4e6ca6559" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_CurrentPayablesRelatedToCapitalExpenditures_ed68416b-0bb2-4e12-8f1c-125ab1d0fa58" xlink:href="inpha-20260630.xsd#inpha_CurrentPayablesRelatedToCapitalExpenditures"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inpha_DisclosureOfTradePayablesAndOthersLineItems_a26aa800-71de-4c08-8535-5f6ef3111953" xlink:to="loc_inpha_CurrentPayablesRelatedToCapitalExpenditures_ed68416b-0bb2-4e12-8f1c-125ab1d0fa58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TradeAndOtherCurrentPayables_22534f09-bb87-4bae-af10-42158fed3b77" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TradeAndOtherCurrentPayables"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inpha_DisclosureOfTradePayablesAndOthersLineItems_a26aa800-71de-4c08-8535-5f6ef3111953" xlink:to="loc_ifrs-full_TradeAndOtherCurrentPayables_22534f09-bb87-4bae-af10-42158fed3b77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_BorrowingNumberOfLoanAgreement_5b37752f-5b7c-4863-9f29-491c43fd4007" xlink:href="inpha-20260630.xsd#inpha_BorrowingNumberOfLoanAgreement"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inpha_DisclosureOfTradePayablesAndOthersLineItems_a26aa800-71de-4c08-8535-5f6ef3111953" xlink:to="loc_inpha_BorrowingNumberOfLoanAgreement_5b37752f-5b7c-4863-9f29-491c43fd4007" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.innate-pharma.com/role/FinancialliabilitiesDisclosureoffinancialliabilitiespermaturityDetails" xlink:type="simple" xlink:href="inpha-20260630.xsd#FinancialliabilitiesDisclosureoffinancialliabilitiespermaturityDetails"/>
  <link:presentationLink xlink:role="http://www.innate-pharma.com/role/FinancialliabilitiesDisclosureoffinancialliabilitiespermaturityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract_831b1860-0f52-4cad-b48e-83622d0a4b38" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfFinancialLiabilitiesTable_ae118af0-00d0-47f2-9d1c-2ed2d37ffc26" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfFinancialLiabilitiesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract_831b1860-0f52-4cad-b48e-83622d0a4b38" xlink:to="loc_ifrs-full_DisclosureOfFinancialLiabilitiesTable_ae118af0-00d0-47f2-9d1c-2ed2d37ffc26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfFinancialLiabilitiesAxis_8aaf735d-cde5-449c-bfe9-26c241e51441" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfFinancialLiabilitiesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialLiabilitiesTable_ae118af0-00d0-47f2-9d1c-2ed2d37ffc26" xlink:to="loc_ifrs-full_ClassesOfFinancialLiabilitiesAxis_8aaf735d-cde5-449c-bfe9-26c241e51441" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_438bcdf8-d164-4a6a-9704-fc36fc644446" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfFinancialLiabilitiesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfFinancialLiabilitiesAxis_8aaf735d-cde5-449c-bfe9-26c241e51441" xlink:to="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_438bcdf8-d164-4a6a-9704-fc36fc644446" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_PGELoanAgreementSocieteGeneraleMember_f71dc83d-8627-423f-b3d8-d0f6d5b481e9" xlink:href="inpha-20260630.xsd#inpha_PGELoanAgreementSocieteGeneraleMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_438bcdf8-d164-4a6a-9704-fc36fc644446" xlink:to="loc_inpha_PGELoanAgreementSocieteGeneraleMember_f71dc83d-8627-423f-b3d8-d0f6d5b481e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_PGELoanAgreementBNPParibasMember_e71b2e74-8209-422d-8ff3-247d0120d178" xlink:href="inpha-20260630.xsd#inpha_PGELoanAgreementBNPParibasMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_438bcdf8-d164-4a6a-9704-fc36fc644446" xlink:to="loc_inpha_PGELoanAgreementBNPParibasMember_e71b2e74-8209-422d-8ff3-247d0120d178" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_PGELoanAgreementAccruedInterestMember_9b3a57a0-6ae5-4874-9cf4-0571bbac6073" xlink:href="inpha-20260630.xsd#inpha_PGELoanAgreementAccruedInterestMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_438bcdf8-d164-4a6a-9704-fc36fc644446" xlink:to="loc_inpha_PGELoanAgreementAccruedInterestMember_9b3a57a0-6ae5-4874-9cf4-0571bbac6073" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_LeaseFinancingObligationsBuildingLeVirageMember_bdd31207-414c-4086-abb5-80c25dfb8736" xlink:href="inpha-20260630.xsd#inpha_LeaseFinancingObligationsBuildingLeVirageMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_438bcdf8-d164-4a6a-9704-fc36fc644446" xlink:to="loc_inpha_LeaseFinancingObligationsBuildingLeVirageMember_bdd31207-414c-4086-abb5-80c25dfb8736" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_LeaseFinancingObligationsInnateIncPremisesMember_9af05b19-afd3-442b-9697-8d1662dceafb" xlink:href="inpha-20260630.xsd#inpha_LeaseFinancingObligationsInnateIncPremisesMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_438bcdf8-d164-4a6a-9704-fc36fc644446" xlink:to="loc_inpha_LeaseFinancingObligationsInnateIncPremisesMember_9af05b19-afd3-442b-9697-8d1662dceafb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_LeaseFinancingObligationsEquipmentMember_2d0921e4-81a5-49cf-93f5-bfc59acffa9f" xlink:href="inpha-20260630.xsd#inpha_LeaseFinancingObligationsEquipmentMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_438bcdf8-d164-4a6a-9704-fc36fc644446" xlink:to="loc_inpha_LeaseFinancingObligationsEquipmentMember_2d0921e4-81a5-49cf-93f5-bfc59acffa9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_LeaseFinancingObligationsVehiclesMember_633d5175-916d-43a8-bb71-969f83240dab" xlink:href="inpha-20260630.xsd#inpha_LeaseFinancingObligationsVehiclesMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_438bcdf8-d164-4a6a-9704-fc36fc644446" xlink:to="loc_inpha_LeaseFinancingObligationsVehiclesMember_633d5175-916d-43a8-bb71-969f83240dab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_LeaseFinancingObligationsPrintersMember_cd35b29d-23ee-45ac-bb21-fa64aa671c30" xlink:href="inpha-20260630.xsd#inpha_LeaseFinancingObligationsPrintersMember"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_438bcdf8-d164-4a6a-9704-fc36fc644446" xlink:to="loc_inpha_LeaseFinancingObligationsPrintersMember_cd35b29d-23ee-45ac-bb21-fa64aa671c30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_LeaseFinancingObligationsMerakiMember_b3bb3138-937e-422e-a974-ee5eacf94cbc" xlink:href="inpha-20260630.xsd#inpha_LeaseFinancingObligationsMerakiMember"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_438bcdf8-d164-4a6a-9704-fc36fc644446" xlink:to="loc_inpha_LeaseFinancingObligationsMerakiMember_b3bb3138-937e-422e-a974-ee5eacf94cbc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_LoanEquipmentMember_c10942b4-4bad-4178-8313-e4e8ea6d0eb9" xlink:href="inpha-20260630.xsd#inpha_LoanEquipmentMember"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_438bcdf8-d164-4a6a-9704-fc36fc644446" xlink:to="loc_inpha_LoanEquipmentMember_c10942b4-4bad-4178-8313-e4e8ea6d0eb9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_LoanBuildingMember_5d76161e-bd3e-4b54-81d8-d58041b3e2bb" xlink:href="inpha-20260630.xsd#inpha_LoanBuildingMember"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_438bcdf8-d164-4a6a-9704-fc36fc644446" xlink:to="loc_inpha_LoanBuildingMember_5d76161e-bd3e-4b54-81d8-d58041b3e2bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_PGELoanAgreementSocieteGeneraleAndBNPParibasMember_b713f8a0-ffe4-4135-93c2-2fb7457dbba8" xlink:href="inpha-20260630.xsd#inpha_PGELoanAgreementSocieteGeneraleAndBNPParibasMember"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_438bcdf8-d164-4a6a-9704-fc36fc644446" xlink:to="loc_inpha_PGELoanAgreementSocieteGeneraleAndBNPParibasMember_b713f8a0-ffe4-4135-93c2-2fb7457dbba8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_LoanAgreementWithSocitGnraleMember_64319950-cd6e-49f9-ae94-8c1732685340" xlink:href="inpha-20260630.xsd#inpha_LoanAgreementWithSocitGnraleMember"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_438bcdf8-d164-4a6a-9704-fc36fc644446" xlink:to="loc_inpha_LoanAgreementWithSocitGnraleMember_64319950-cd6e-49f9-ae94-8c1732685340" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BorrowingsByNameAxis_71458513-02f6-48e6-84cb-a1c7097c352b" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BorrowingsByNameAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialLiabilitiesTable_ae118af0-00d0-47f2-9d1c-2ed2d37ffc26" xlink:to="loc_ifrs-full_BorrowingsByNameAxis_71458513-02f6-48e6-84cb-a1c7097c352b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BorrowingsByNameDomain_4eb8f712-da57-40fa-9169-014c36dfaf88" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BorrowingsByNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_BorrowingsByNameAxis_71458513-02f6-48e6-84cb-a1c7097c352b" xlink:to="loc_ifrs-full_BorrowingsByNameDomain_4eb8f712-da57-40fa-9169-014c36dfaf88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_PGELoanAgreementSocieteGeneraleAndBNPParibasMember_c4d0c5e5-c45b-4bac-9d71-492101128c49" xlink:href="inpha-20260630.xsd#inpha_PGELoanAgreementSocieteGeneraleAndBNPParibasMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_BorrowingsByNameDomain_4eb8f712-da57-40fa-9169-014c36dfaf88" xlink:to="loc_inpha_PGELoanAgreementSocieteGeneraleAndBNPParibasMember_c4d0c5e5-c45b-4bac-9d71-492101128c49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_PGELoanAgreementSocieteGeneraleMember_b72eb74b-d7de-415a-ab0c-f9462cce3890" xlink:href="inpha-20260630.xsd#inpha_PGELoanAgreementSocieteGeneraleMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_BorrowingsByNameDomain_4eb8f712-da57-40fa-9169-014c36dfaf88" xlink:to="loc_inpha_PGELoanAgreementSocieteGeneraleMember_b72eb74b-d7de-415a-ab0c-f9462cce3890" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_PGELoanAgreementBNPParibasMember_b5bd6131-053f-4685-be63-cd4e27175e08" xlink:href="inpha-20260630.xsd#inpha_PGELoanAgreementBNPParibasMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_BorrowingsByNameDomain_4eb8f712-da57-40fa-9169-014c36dfaf88" xlink:to="loc_inpha_PGELoanAgreementBNPParibasMember_b5bd6131-053f-4685-be63-cd4e27175e08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfFinancialAssetsAxis_23535eb4-615d-4955-8be2-128185d57142" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TypesOfFinancialAssetsAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialLiabilitiesTable_ae118af0-00d0-47f2-9d1c-2ed2d37ffc26" xlink:to="loc_ifrs-full_TypesOfFinancialAssetsAxis_23535eb4-615d-4955-8be2-128185d57142" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfFinancialAssetsDomain_f2c0eeab-9ae9-4e34-8582-824998561827" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TypesOfFinancialAssetsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfFinancialAssetsAxis_23535eb4-615d-4955-8be2-128185d57142" xlink:to="loc_ifrs-full_TypesOfFinancialAssetsDomain_f2c0eeab-9ae9-4e34-8582-824998561827" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GuaranteesMember_3e84abd6-0315-4471-9fef-cff8f5b7255c" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_GuaranteesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfFinancialAssetsDomain_f2c0eeab-9ae9-4e34-8582-824998561827" xlink:to="loc_ifrs-full_GuaranteesMember_3e84abd6-0315-4471-9fef-cff8f5b7255c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfInterestRatesAxis_01a03d88-4a59-7718-ace7-3d1e5d8f35bb" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TypesOfInterestRatesAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialLiabilitiesTable_ae118af0-00d0-47f2-9d1c-2ed2d37ffc26" xlink:to="loc_ifrs-full_TypesOfInterestRatesAxis_01a03d88-4a59-7718-ace7-3d1e5d8f35bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfInterestRatesDomain_01a03d88-4a59-7d71-b39d-060e7eb87aad" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TypesOfInterestRatesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfInterestRatesAxis_01a03d88-4a59-7718-ace7-3d1e5d8f35bb" xlink:to="loc_ifrs-full_TypesOfInterestRatesDomain_01a03d88-4a59-7d71-b39d-060e7eb87aad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FixedInterestRateMember_01a03d88-8622-7717-962b-9253b70ea898" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_FixedInterestRateMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfInterestRatesDomain_01a03d88-4a59-7d71-b39d-060e7eb87aad" xlink:to="loc_ifrs-full_FixedInterestRateMember_01a03d88-8622-7717-962b-9253b70ea898" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfFinancialLiabilitiesLineItems_3aa53fe9-a38b-4d50-8e2a-266d3c22b086" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfFinancialLiabilitiesLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialLiabilitiesTable_ae118af0-00d0-47f2-9d1c-2ed2d37ffc26" xlink:to="loc_ifrs-full_DisclosureOfFinancialLiabilitiesLineItems_3aa53fe9-a38b-4d50-8e2a-266d3c22b086" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FinancialLiabilities_f3ef1dc8-23af-4ef7-9463-eb30284085c3" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_FinancialLiabilities"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialLiabilitiesLineItems_3aa53fe9-a38b-4d50-8e2a-266d3c22b086" xlink:to="loc_ifrs-full_FinancialLiabilities_f3ef1dc8-23af-4ef7-9463-eb30284085c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProceedsFromBorrowingsClassifiedAsFinancingActivities_2504362e-a520-4708-9c7b-1e4354fc59b4" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProceedsFromBorrowingsClassifiedAsFinancingActivities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialLiabilitiesLineItems_3aa53fe9-a38b-4d50-8e2a-266d3c22b086" xlink:to="loc_ifrs-full_ProceedsFromBorrowingsClassifiedAsFinancingActivities_2504362e-a520-4708-9c7b-1e4354fc59b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_ProceedsFromLeaseLiabilitiesClassifiedAsFinancingActivities_dcd4370b-58b0-4218-9f49-ad5b6d5a5946" xlink:href="inpha-20260630.xsd#inpha_ProceedsFromLeaseLiabilitiesClassifiedAsFinancingActivities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialLiabilitiesLineItems_3aa53fe9-a38b-4d50-8e2a-266d3c22b086" xlink:to="loc_inpha_ProceedsFromLeaseLiabilitiesClassifiedAsFinancingActivities_dcd4370b-58b0-4218-9f49-ad5b6d5a5946" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_RepaymentsOfBorrowingsNetOfExchangeRateVariationClassifiedAsFinancingActivities_447c8d18-c08c-4531-9e41-510ac09f6508" xlink:href="inpha-20260630.xsd#inpha_RepaymentsOfBorrowingsNetOfExchangeRateVariationClassifiedAsFinancingActivities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialLiabilitiesLineItems_3aa53fe9-a38b-4d50-8e2a-266d3c22b086" xlink:to="loc_inpha_RepaymentsOfBorrowingsNetOfExchangeRateVariationClassifiedAsFinancingActivities_447c8d18-c08c-4531-9e41-510ac09f6508" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_IncreaseDecreaseThroughForeignExchangeFinancialLiabilities_b2030dc8-9476-4784-820f-a1ade7c0bd1c" xlink:href="inpha-20260630.xsd#inpha_IncreaseDecreaseThroughForeignExchangeFinancialLiabilities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialLiabilitiesLineItems_3aa53fe9-a38b-4d50-8e2a-266d3c22b086" xlink:to="loc_inpha_IncreaseDecreaseThroughForeignExchangeFinancialLiabilities_b2030dc8-9476-4784-820f-a1ade7c0bd1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NotionalAmount_aa981cf2-8498-4bb5-86a1-5d54c8f25ee3" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NotionalAmount"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialLiabilitiesLineItems_3aa53fe9-a38b-4d50-8e2a-266d3c22b086" xlink:to="loc_ifrs-full_NotionalAmount_aa981cf2-8498-4bb5-86a1-5d54c8f25ee3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_BorrowingNumberOfLoanAgreement_7bcce214-4b23-45ff-998f-acf969f86582" xlink:href="inpha-20260630.xsd#inpha_BorrowingNumberOfLoanAgreement"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialLiabilitiesLineItems_3aa53fe9-a38b-4d50-8e2a-266d3c22b086" xlink:to="loc_inpha_BorrowingNumberOfLoanAgreement_7bcce214-4b23-45ff-998f-acf969f86582" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_BorrowingMaturity_f35639c3-139a-44ff-baf7-9f77c688aaf3" xlink:href="inpha-20260630.xsd#inpha_BorrowingMaturity"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialLiabilitiesLineItems_3aa53fe9-a38b-4d50-8e2a-266d3c22b086" xlink:to="loc_inpha_BorrowingMaturity_f35639c3-139a-44ff-baf7-9f77c688aaf3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_BorrowingMaturityExtensionPeriodOption_84f0c16e-1c41-4d93-a828-271dcf61171b" xlink:href="inpha-20260630.xsd#inpha_BorrowingMaturityExtensionPeriodOption"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialLiabilitiesLineItems_3aa53fe9-a38b-4d50-8e2a-266d3c22b086" xlink:to="loc_inpha_BorrowingMaturityExtensionPeriodOption_84f0c16e-1c41-4d93-a828-271dcf61171b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_BorrowingPercentageOfStateGuaranteedLoan_6869a205-3b2a-4ec9-a9b5-e38047022be2" xlink:href="inpha-20260630.xsd#inpha_BorrowingPercentageOfStateGuaranteedLoan"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialLiabilitiesLineItems_3aa53fe9-a38b-4d50-8e2a-266d3c22b086" xlink:to="loc_inpha_BorrowingPercentageOfStateGuaranteedLoan_6869a205-3b2a-4ec9-a9b5-e38047022be2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_BorrowingGracePeriod_c8668241-325d-4775-8421-741c9e4edf4b" xlink:href="inpha-20260630.xsd#inpha_BorrowingGracePeriod"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialLiabilitiesLineItems_3aa53fe9-a38b-4d50-8e2a-266d3c22b086" xlink:to="loc_inpha_BorrowingGracePeriod_c8668241-325d-4775-8421-741c9e4edf4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BorrowingsInterestRate_80d27526-afc4-458a-bb7c-e5b247f4d06b" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BorrowingsInterestRate"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialLiabilitiesLineItems_3aa53fe9-a38b-4d50-8e2a-266d3c22b086" xlink:to="loc_ifrs-full_BorrowingsInterestRate_80d27526-afc4-458a-bb7c-e5b247f4d06b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_NumberOfLoans_ce07d36b-623c-4141-af77-56acbed5a751" xlink:href="inpha-20260630.xsd#inpha_NumberOfLoans"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialLiabilitiesLineItems_3aa53fe9-a38b-4d50-8e2a-266d3c22b086" xlink:to="loc_inpha_NumberOfLoans_ce07d36b-623c-4141-af77-56acbed5a751" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CurrentPrepaidExpenses_124f8713-eae2-483b-81ae-9e89dc75b7b5" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentPrepaidExpenses"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialLiabilitiesLineItems_3aa53fe9-a38b-4d50-8e2a-266d3c22b086" xlink:to="loc_ifrs-full_CurrentPrepaidExpenses_124f8713-eae2-483b-81ae-9e89dc75b7b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_LoanAgreementMaximumBorrowingCapacity_25c9c92e-5bf6-4be2-bcdf-7898b0ddc245" xlink:href="inpha-20260630.xsd#inpha_LoanAgreementMaximumBorrowingCapacity"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialLiabilitiesLineItems_3aa53fe9-a38b-4d50-8e2a-266d3c22b086" xlink:to="loc_inpha_LoanAgreementMaximumBorrowingCapacity_25c9c92e-5bf6-4be2-bcdf-7898b0ddc245" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_LoanAgreementCollateral_60e49912-061f-4c64-aab4-4589b68cb9ae" xlink:href="inpha-20260630.xsd#inpha_LoanAgreementCollateral"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialLiabilitiesLineItems_3aa53fe9-a38b-4d50-8e2a-266d3c22b086" xlink:to="loc_inpha_LoanAgreementCollateral_60e49912-061f-4c64-aab4-4589b68cb9ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_BorrowingsMaturityPeriod_f5b6a70c-1b2b-47ee-87e2-b3edf4ed6bb0" xlink:href="inpha-20260630.xsd#inpha_BorrowingsMaturityPeriod"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialLiabilitiesLineItems_3aa53fe9-a38b-4d50-8e2a-266d3c22b086" xlink:to="loc_inpha_BorrowingsMaturityPeriod_f5b6a70c-1b2b-47ee-87e2-b3edf4ed6bb0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_SecurityInterestOnPledgeOfFinancialInstrumentsWillBeReleasedIn2024_116e5040-d212-4941-8596-29c7253764e1" xlink:href="inpha-20260630.xsd#inpha_SecurityInterestOnPledgeOfFinancialInstrumentsWillBeReleasedIn2024"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialLiabilitiesLineItems_3aa53fe9-a38b-4d50-8e2a-266d3c22b086" xlink:to="loc_inpha_SecurityInterestOnPledgeOfFinancialInstrumentsWillBeReleasedIn2024_116e5040-d212-4941-8596-29c7253764e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_SecurityInterestOnPledgeOfFinancialInstrumentsWillBeReleasedIn2027_848e666c-08f9-4c08-a3a6-cf7ded96fef3" xlink:href="inpha-20260630.xsd#inpha_SecurityInterestOnPledgeOfFinancialInstrumentsWillBeReleasedIn2027"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialLiabilitiesLineItems_3aa53fe9-a38b-4d50-8e2a-266d3c22b086" xlink:to="loc_inpha_SecurityInterestOnPledgeOfFinancialInstrumentsWillBeReleasedIn2027_848e666c-08f9-4c08-a3a6-cf7ded96fef3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_SecurityInterestOnPledgeOfFinancialInstrumentsWillBeReleasedIn2031_89c13375-8e31-4c44-801c-934b23efb7db" xlink:href="inpha-20260630.xsd#inpha_SecurityInterestOnPledgeOfFinancialInstrumentsWillBeReleasedIn2031"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialLiabilitiesLineItems_3aa53fe9-a38b-4d50-8e2a-266d3c22b086" xlink:to="loc_inpha_SecurityInterestOnPledgeOfFinancialInstrumentsWillBeReleasedIn2031_89c13375-8e31-4c44-801c-934b23efb7db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_SecurityInterestOnPledgeOfFinancialInstrumentsReleased_df1dadcd-dd82-403c-98ad-c47e5406b648" xlink:href="inpha-20260630.xsd#inpha_SecurityInterestOnPledgeOfFinancialInstrumentsReleased"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialLiabilitiesLineItems_3aa53fe9-a38b-4d50-8e2a-266d3c22b086" xlink:to="loc_inpha_SecurityInterestOnPledgeOfFinancialInstrumentsReleased_df1dadcd-dd82-403c-98ad-c47e5406b648" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_FinancialCovenantCapitalRiskMarginPercentage_01a03d9d-7527-7218-8378-1a5d6b6a867b" xlink:href="inpha-20260630.xsd#inpha_FinancialCovenantCapitalRiskMarginPercentage"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialLiabilitiesLineItems_3aa53fe9-a38b-4d50-8e2a-266d3c22b086" xlink:to="loc_inpha_FinancialCovenantCapitalRiskMarginPercentage_01a03d9d-7527-7218-8378-1a5d6b6a867b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_FinancialCovenantMinimumFinancialAssetsThreshold_01a03db1-49a1-7034-ad05-0cc5e051db07" xlink:href="inpha-20260630.xsd#inpha_FinancialCovenantMinimumFinancialAssetsThreshold"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialLiabilitiesLineItems_3aa53fe9-a38b-4d50-8e2a-266d3c22b086" xlink:to="loc_inpha_FinancialCovenantMinimumFinancialAssetsThreshold_01a03db1-49a1-7034-ad05-0cc5e051db07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.innate-pharma.com/role/FinancialliabilitiesAdditionalInformationDetails" xlink:type="simple" xlink:href="inpha-20260630.xsd#FinancialliabilitiesAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.innate-pharma.com/role/FinancialliabilitiesAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract_4063ce9e-0607-48c4-90d9-90d82255c71b" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CurrentBorrowingsAndCurrentPortionOfNoncurrentBorrowings_01a07bab-e2ec-7012-81b8-edafecb886fa" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentBorrowingsAndCurrentPortionOfNoncurrentBorrowings"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract_4063ce9e-0607-48c4-90d9-90d82255c71b" xlink:to="loc_ifrs-full_CurrentBorrowingsAndCurrentPortionOfNoncurrentBorrowings_01a07bab-e2ec-7012-81b8-edafecb886fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.innate-pharma.com/role/FinancialliabilitiesDisclosureofmaturityanalysisfornonderivativefinancialliabilitiesDetails" xlink:type="simple" xlink:href="inpha-20260630.xsd#FinancialliabilitiesDisclosureofmaturityanalysisfornonderivativefinancialliabilitiesDetails"/>
  <link:presentationLink xlink:role="http://www.innate-pharma.com/role/FinancialliabilitiesDisclosureofmaturityanalysisfornonderivativefinancialliabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract_a44210de-7bb3-4df5-a1ca-1e29ea7f8f5a" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfMaturityAnalysisForNonderivativeFinancialLiabilitiesTable_c77bf216-bf14-44be-9081-52287dcc87e2" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfMaturityAnalysisForNonderivativeFinancialLiabilitiesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract_a44210de-7bb3-4df5-a1ca-1e29ea7f8f5a" xlink:to="loc_ifrs-full_DisclosureOfMaturityAnalysisForNonderivativeFinancialLiabilitiesTable_c77bf216-bf14-44be-9081-52287dcc87e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfFinancialLiabilitiesAxis_492319ea-af70-4556-8db7-f30ce7d73c53" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfFinancialLiabilitiesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfMaturityAnalysisForNonderivativeFinancialLiabilitiesTable_c77bf216-bf14-44be-9081-52287dcc87e2" xlink:to="loc_ifrs-full_ClassesOfFinancialLiabilitiesAxis_492319ea-af70-4556-8db7-f30ce7d73c53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_ad365845-a296-4330-b91d-b53294d3386a" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfFinancialLiabilitiesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfFinancialLiabilitiesAxis_492319ea-af70-4556-8db7-f30ce7d73c53" xlink:to="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_ad365845-a296-4330-b91d-b53294d3386a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_PGELoanAgreementSocieteGeneraleMember_8dbb0547-1802-47e1-bc3f-9bb79e165b9c" xlink:href="inpha-20260630.xsd#inpha_PGELoanAgreementSocieteGeneraleMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_ad365845-a296-4330-b91d-b53294d3386a" xlink:to="loc_inpha_PGELoanAgreementSocieteGeneraleMember_8dbb0547-1802-47e1-bc3f-9bb79e165b9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_PGELoanAgreementBNPParibasMember_0cea7477-9486-4e83-abbd-185690f8d923" xlink:href="inpha-20260630.xsd#inpha_PGELoanAgreementBNPParibasMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_ad365845-a296-4330-b91d-b53294d3386a" xlink:to="loc_inpha_PGELoanAgreementBNPParibasMember_0cea7477-9486-4e83-abbd-185690f8d923" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_PGELoanAgreementAccruedInterestMember_151707bf-16be-431b-a216-f78e49bae839" xlink:href="inpha-20260630.xsd#inpha_PGELoanAgreementAccruedInterestMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_ad365845-a296-4330-b91d-b53294d3386a" xlink:to="loc_inpha_PGELoanAgreementAccruedInterestMember_151707bf-16be-431b-a216-f78e49bae839" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_LeaseFinancingObligationsBuildingLeVirageMember_15a92eec-ecd8-4e6c-9d3b-83a19515177d" xlink:href="inpha-20260630.xsd#inpha_LeaseFinancingObligationsBuildingLeVirageMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_ad365845-a296-4330-b91d-b53294d3386a" xlink:to="loc_inpha_LeaseFinancingObligationsBuildingLeVirageMember_15a92eec-ecd8-4e6c-9d3b-83a19515177d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_LeaseFinancingObligationsInnateIncPremisesMember_f7b4eaab-ebd1-4173-a6e5-450230cead94" xlink:href="inpha-20260630.xsd#inpha_LeaseFinancingObligationsInnateIncPremisesMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_ad365845-a296-4330-b91d-b53294d3386a" xlink:to="loc_inpha_LeaseFinancingObligationsInnateIncPremisesMember_f7b4eaab-ebd1-4173-a6e5-450230cead94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_LeaseFinancingObligationsEquipmentMember_f345a1ac-c067-4b84-80e1-7f5c3a002a4d" xlink:href="inpha-20260630.xsd#inpha_LeaseFinancingObligationsEquipmentMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_ad365845-a296-4330-b91d-b53294d3386a" xlink:to="loc_inpha_LeaseFinancingObligationsEquipmentMember_f345a1ac-c067-4b84-80e1-7f5c3a002a4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_LeaseFinancingObligationsVehiclesMember_0ff0aa9d-e059-4acb-a1f3-29c3f2346de0" xlink:href="inpha-20260630.xsd#inpha_LeaseFinancingObligationsVehiclesMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_ad365845-a296-4330-b91d-b53294d3386a" xlink:to="loc_inpha_LeaseFinancingObligationsVehiclesMember_0ff0aa9d-e059-4acb-a1f3-29c3f2346de0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_LeaseFinancingObligationsPrintersMember_314159ac-ccc6-4b40-9ed9-5e1ac07ea153" xlink:href="inpha-20260630.xsd#inpha_LeaseFinancingObligationsPrintersMember"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_ad365845-a296-4330-b91d-b53294d3386a" xlink:to="loc_inpha_LeaseFinancingObligationsPrintersMember_314159ac-ccc6-4b40-9ed9-5e1ac07ea153" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_LeaseFinancingObligationsMerakiMember_1119bdb5-7244-4f86-b283-e959432eb88f" xlink:href="inpha-20260630.xsd#inpha_LeaseFinancingObligationsMerakiMember"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_ad365845-a296-4330-b91d-b53294d3386a" xlink:to="loc_inpha_LeaseFinancingObligationsMerakiMember_1119bdb5-7244-4f86-b283-e959432eb88f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_LoanEquipmentMember_8f301fa7-784a-4fdd-b816-f088559f5aeb" xlink:href="inpha-20260630.xsd#inpha_LoanEquipmentMember"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_ad365845-a296-4330-b91d-b53294d3386a" xlink:to="loc_inpha_LoanEquipmentMember_8f301fa7-784a-4fdd-b816-f088559f5aeb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_LoanBuildingMember_d6db3c93-4a48-4417-83d9-e5fc2a757cca" xlink:href="inpha-20260630.xsd#inpha_LoanBuildingMember"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_ad365845-a296-4330-b91d-b53294d3386a" xlink:to="loc_inpha_LoanBuildingMember_d6db3c93-4a48-4417-83d9-e5fc2a757cca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_MaturityAxis_437f3b5f-95a8-4a34-9fb5-875386c0c3a4" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_MaturityAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfMaturityAnalysisForNonderivativeFinancialLiabilitiesTable_c77bf216-bf14-44be-9081-52287dcc87e2" xlink:to="loc_ifrs-full_MaturityAxis_437f3b5f-95a8-4a34-9fb5-875386c0c3a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_MaturityDomain_019695f4-73e0-4473-bd6d-55d52c6f67f9" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_MaturityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_MaturityAxis_437f3b5f-95a8-4a34-9fb5-875386c0c3a4" xlink:to="loc_ifrs-full_MaturityDomain_019695f4-73e0-4473-bd6d-55d52c6f67f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NotLaterThanOneYearMember_d39fee56-ea66-4e4b-a720-af8dcd58f2d1" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NotLaterThanOneYearMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_MaturityDomain_019695f4-73e0-4473-bd6d-55d52c6f67f9" xlink:to="loc_ifrs-full_NotLaterThanOneYearMember_d39fee56-ea66-4e4b-a720-af8dcd58f2d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember_e3c539f3-3ac2-4acf-8324-053e53cd5641" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_MaturityDomain_019695f4-73e0-4473-bd6d-55d52c6f67f9" xlink:to="loc_ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember_e3c539f3-3ac2-4acf-8324-053e53cd5641" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LaterThanTwoYearsAndNotLaterThanThreeYearsMember_b022b24c-dca1-47c7-81d4-a40e61a8f7b6" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_LaterThanTwoYearsAndNotLaterThanThreeYearsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_MaturityDomain_019695f4-73e0-4473-bd6d-55d52c6f67f9" xlink:to="loc_ifrs-full_LaterThanTwoYearsAndNotLaterThanThreeYearsMember_b022b24c-dca1-47c7-81d4-a40e61a8f7b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LaterThanThreeYearsAndNotLaterThanFourYearsMember_850ad475-f9a6-4d08-bd45-322e2b4638be" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_LaterThanThreeYearsAndNotLaterThanFourYearsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_MaturityDomain_019695f4-73e0-4473-bd6d-55d52c6f67f9" xlink:to="loc_ifrs-full_LaterThanThreeYearsAndNotLaterThanFourYearsMember_850ad475-f9a6-4d08-bd45-322e2b4638be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LaterThanFourYearsAndNotLaterThanFiveYearsMember_1030033b-5d9f-466e-8216-2cf123adcfb1" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_LaterThanFourYearsAndNotLaterThanFiveYearsMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_MaturityDomain_019695f4-73e0-4473-bd6d-55d52c6f67f9" xlink:to="loc_ifrs-full_LaterThanFourYearsAndNotLaterThanFiveYearsMember_1030033b-5d9f-466e-8216-2cf123adcfb1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LaterThanFiveYearsMember_4aa1c0a3-6b34-4078-b3c6-7ead48fa8bc6" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_LaterThanFiveYearsMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_MaturityDomain_019695f4-73e0-4473-bd6d-55d52c6f67f9" xlink:to="loc_ifrs-full_LaterThanFiveYearsMember_4aa1c0a3-6b34-4078-b3c6-7ead48fa8bc6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfMaturityAnalysisForNonderivativeFinancialLiabilitiesLineItems_823061b5-7ac0-4600-85af-81260b527ef6" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfMaturityAnalysisForNonderivativeFinancialLiabilitiesLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfMaturityAnalysisForNonderivativeFinancialLiabilitiesTable_c77bf216-bf14-44be-9081-52287dcc87e2" xlink:to="loc_ifrs-full_DisclosureOfMaturityAnalysisForNonderivativeFinancialLiabilitiesLineItems_823061b5-7ac0-4600-85af-81260b527ef6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BankBorrowingsUndiscountedCashFlows_11925eab-50f8-48f0-8357-3c2ad222517a" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BankBorrowingsUndiscountedCashFlows"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfMaturityAnalysisForNonderivativeFinancialLiabilitiesLineItems_823061b5-7ac0-4600-85af-81260b527ef6" xlink:to="loc_ifrs-full_BankBorrowingsUndiscountedCashFlows_11925eab-50f8-48f0-8357-3c2ad222517a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.innate-pharma.com/role/EmployeebenefitDisclosureofdefinedbenefitplansDetails" xlink:type="simple" xlink:href="inpha-20260630.xsd#EmployeebenefitDisclosureofdefinedbenefitplansDetails"/>
  <link:presentationLink xlink:role="http://www.innate-pharma.com/role/EmployeebenefitDisclosureofdefinedbenefitplansDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfInformationAboutDefinedBenefitPlansAbstract_e09f1c7d-281f-4895-93ca-da89b9a6afcc" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfInformationAboutDefinedBenefitPlansAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfDefinedBenefitPlansTable_3686345e-9256-4b11-b4cc-21506f38e2ed" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfDefinedBenefitPlansTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfInformationAboutDefinedBenefitPlansAbstract_e09f1c7d-281f-4895-93ca-da89b9a6afcc" xlink:to="loc_ifrs-full_DisclosureOfDefinedBenefitPlansTable_3686345e-9256-4b11-b4cc-21506f38e2ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CharacteristicsOfDefinedBenefitPlansAxis_5a009e4f-9c78-4e0e-b83c-ffdbe14d1370" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CharacteristicsOfDefinedBenefitPlansAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDefinedBenefitPlansTable_3686345e-9256-4b11-b4cc-21506f38e2ed" xlink:to="loc_ifrs-full_CharacteristicsOfDefinedBenefitPlansAxis_5a009e4f-9c78-4e0e-b83c-ffdbe14d1370" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CharacteristicsOfDefinedBenefitPlansDomain_71a83dce-51e9-4540-ab02-6320e9522ca3" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CharacteristicsOfDefinedBenefitPlansDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CharacteristicsOfDefinedBenefitPlansAxis_5a009e4f-9c78-4e0e-b83c-ffdbe14d1370" xlink:to="loc_ifrs-full_CharacteristicsOfDefinedBenefitPlansDomain_71a83dce-51e9-4540-ab02-6320e9522ca3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_RetirementDefinedBenefitMember_e3baa0fa-7f52-4538-a5cf-8c0c5c358a2b" xlink:href="inpha-20260630.xsd#inpha_RetirementDefinedBenefitMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CharacteristicsOfDefinedBenefitPlansDomain_71a83dce-51e9-4540-ab02-6320e9522ca3" xlink:to="loc_inpha_RetirementDefinedBenefitMember_e3baa0fa-7f52-4538-a5cf-8c0c5c358a2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_SeniorityAwardsMember_feb38de2-f91e-4e3b-a6f1-d78af6c251a2" xlink:href="inpha-20260630.xsd#inpha_SeniorityAwardsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CharacteristicsOfDefinedBenefitPlansDomain_71a83dce-51e9-4540-ab02-6320e9522ca3" xlink:to="loc_inpha_SeniorityAwardsMember_feb38de2-f91e-4e3b-a6f1-d78af6c251a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems_67977881-308f-4ff9-a4d5-2c593c29e938" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfDefinedBenefitPlansLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDefinedBenefitPlansTable_3686345e-9256-4b11-b4cc-21506f38e2ed" xlink:to="loc_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems_67977881-308f-4ff9-a4d5-2c593c29e938" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DefinedBenefitObligationAtPresentValue_79157611-c653-430e-a62a-4ad007c70ff9" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DefinedBenefitObligationAtPresentValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems_67977881-308f-4ff9-a4d5-2c593c29e938" xlink:to="loc_ifrs-full_DefinedBenefitObligationAtPresentValue_79157611-c653-430e-a62a-4ad007c70ff9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.innate-pharma.com/role/EmployeebenefitDisclosureofnetdefinedbenefitliabilityassetDetails" xlink:type="simple" xlink:href="inpha-20260630.xsd#EmployeebenefitDisclosureofnetdefinedbenefitliabilityassetDetails"/>
  <link:presentationLink xlink:role="http://www.innate-pharma.com/role/EmployeebenefitDisclosureofnetdefinedbenefitliabilityassetDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfInformationAboutDefinedBenefitPlansAbstract_9a9c2529-879e-41a7-9680-f68a0f305b80" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfInformationAboutDefinedBenefitPlansAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfDefinedBenefitPlansTable_4fd31d68-4ca6-4e01-bfaa-db253145a32d" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfDefinedBenefitPlansTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfInformationAboutDefinedBenefitPlansAbstract_9a9c2529-879e-41a7-9680-f68a0f305b80" xlink:to="loc_ifrs-full_DisclosureOfDefinedBenefitPlansTable_4fd31d68-4ca6-4e01-bfaa-db253145a32d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems_f07d964b-9329-4471-9075-f36534cd35f6" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfDefinedBenefitPlansLineItems"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDefinedBenefitPlansTable_4fd31d68-4ca6-4e01-bfaa-db253145a32d" xlink:to="loc_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems_f07d964b-9329-4471-9075-f36534cd35f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LiabilityAssetOfDefinedBenefitPlans_7c37e8c5-8e5e-458b-a089-ded987ca1571" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_LiabilityAssetOfDefinedBenefitPlans"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems_f07d964b-9329-4471-9075-f36534cd35f6" xlink:to="loc_ifrs-full_LiabilityAssetOfDefinedBenefitPlans_7c37e8c5-8e5e-458b-a089-ded987ca1571" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CurrentServiceCostNetDefinedBenefitLiabilityAsset_b618ca0f-b8e1-426d-89cc-600ac7748c04" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentServiceCostNetDefinedBenefitLiabilityAsset"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems_f07d964b-9329-4471-9075-f36534cd35f6" xlink:to="loc_ifrs-full_CurrentServiceCostNetDefinedBenefitLiabilityAsset_b618ca0f-b8e1-426d-89cc-600ac7748c04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ContributionsToPlanByEmployerNetDefinedBenefitLiabilityAsset_1a243c7b-3809-47b2-95b1-2d148cee702c" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ContributionsToPlanByEmployerNetDefinedBenefitLiabilityAsset"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems_f07d964b-9329-4471-9075-f36534cd35f6" xlink:to="loc_ifrs-full_ContributionsToPlanByEmployerNetDefinedBenefitLiabilityAsset_1a243c7b-3809-47b2-95b1-2d148cee702c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset_e6179aee-7546-42a0-8520-961ac6399591" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems_f07d964b-9329-4471-9075-f36534cd35f6" xlink:to="loc_ifrs-full_GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset_e6179aee-7546-42a0-8520-961ac6399591" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LiabilityAssetOfDefinedBenefitPlans_30dbe0bb-7aad-4728-b1ca-f71574c12ff5" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_LiabilityAssetOfDefinedBenefitPlans"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems_f07d964b-9329-4471-9075-f36534cd35f6" xlink:to="loc_ifrs-full_LiabilityAssetOfDefinedBenefitPlans_30dbe0bb-7aad-4728-b1ca-f71574c12ff5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.innate-pharma.com/role/EmployeebenefitAdditionalinformationDetails" xlink:type="simple" xlink:href="inpha-20260630.xsd#EmployeebenefitAdditionalinformationDetails"/>
  <link:presentationLink xlink:role="http://www.innate-pharma.com/role/EmployeebenefitAdditionalinformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfInformationAboutDefinedBenefitPlansAbstract_f1a36c36-f593-4587-a55a-762a587457c1" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfInformationAboutDefinedBenefitPlansAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfDefinedBenefitPlansTable_71198917-2e23-44b3-b375-007e684de8b7" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfDefinedBenefitPlansTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfInformationAboutDefinedBenefitPlansAbstract_f1a36c36-f593-4587-a55a-762a587457c1" xlink:to="loc_ifrs-full_DisclosureOfDefinedBenefitPlansTable_71198917-2e23-44b3-b375-007e684de8b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CharacteristicsOfDefinedBenefitPlansAxis_dbbf99bd-9609-40d0-b395-f953aa7384fa" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CharacteristicsOfDefinedBenefitPlansAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDefinedBenefitPlansTable_71198917-2e23-44b3-b375-007e684de8b7" xlink:to="loc_ifrs-full_CharacteristicsOfDefinedBenefitPlansAxis_dbbf99bd-9609-40d0-b395-f953aa7384fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CharacteristicsOfDefinedBenefitPlansDomain_20d07182-bf2a-4b36-a614-ac043a7793c0" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CharacteristicsOfDefinedBenefitPlansDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CharacteristicsOfDefinedBenefitPlansAxis_dbbf99bd-9609-40d0-b395-f953aa7384fa" xlink:to="loc_ifrs-full_CharacteristicsOfDefinedBenefitPlansDomain_20d07182-bf2a-4b36-a614-ac043a7793c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_RetirementDefinedBenefitMember_e3667799-0559-468c-be69-5e635dc4aed5" xlink:href="inpha-20260630.xsd#inpha_RetirementDefinedBenefitMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CharacteristicsOfDefinedBenefitPlansDomain_20d07182-bf2a-4b36-a614-ac043a7793c0" xlink:to="loc_inpha_RetirementDefinedBenefitMember_e3667799-0559-468c-be69-5e635dc4aed5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems_af0109c9-2506-4af0-ba3e-d8b18a7025d7" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfDefinedBenefitPlansLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDefinedBenefitPlansTable_71198917-2e23-44b3-b375-007e684de8b7" xlink:to="loc_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems_af0109c9-2506-4af0-ba3e-d8b18a7025d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RecognisedAssetsDefinedBenefitPlan_3b7fb51d-4fb3-4822-82ad-6df30837b081" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RecognisedAssetsDefinedBenefitPlan"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems_af0109c9-2506-4af0-ba3e-d8b18a7025d7" xlink:to="loc_ifrs-full_RecognisedAssetsDefinedBenefitPlan_3b7fb51d-4fb3-4822-82ad-6df30837b081" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ActuarialAssumptionOfDiscountRates_5aef88f9-04a0-4fdc-b585-f01a30ae2928" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ActuarialAssumptionOfDiscountRates"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems_af0109c9-2506-4af0-ba3e-d8b18a7025d7" xlink:to="loc_ifrs-full_ActuarialAssumptionOfDiscountRates_5aef88f9-04a0-4fdc-b585-f01a30ae2928" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.innate-pharma.com/role/CapitalAdditionalInformationDetails" xlink:type="simple" xlink:href="inpha-20260630.xsd#CapitalAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.innate-pharma.com/role/CapitalAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_inpha_ShareCapitalAndShareBasePaymentsAbstract_a432ac31-9de0-4213-89a1-e397e308b3dd" xlink:href="inpha-20260630.xsd#inpha_ShareCapitalAndShareBasePaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_ffa231bd-0773-4eb5-bc50-e497495cfa45" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inpha_ShareCapitalAndShareBasePaymentsAbstract_a432ac31-9de0-4213-89a1-e397e308b3dd" xlink:to="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_ffa231bd-0773-4eb5-bc50-e497495cfa45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ComponentsOfEquityAxis_1abd0c20-7797-4037-98a6-535e7543874e" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ComponentsOfEquityAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_ffa231bd-0773-4eb5-bc50-e497495cfa45" xlink:to="loc_ifrs-full_ComponentsOfEquityAxis_1abd0c20-7797-4037-98a6-535e7543874e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ComponentsOfEquityDomain_98ed710a-71a8-4f01-9394-472d915dbc0a" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ComponentsOfEquityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ComponentsOfEquityAxis_1abd0c20-7797-4037-98a6-535e7543874e" xlink:to="loc_ifrs-full_ComponentsOfEquityDomain_98ed710a-71a8-4f01-9394-472d915dbc0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IssuedCapitalMember_ba3b8dec-ed3e-4776-a677-8a6cc000920f" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IssuedCapitalMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ComponentsOfEquityDomain_98ed710a-71a8-4f01-9394-472d915dbc0a" xlink:to="loc_ifrs-full_IssuedCapitalMember_ba3b8dec-ed3e-4776-a677-8a6cc000920f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfShareCapitalAxis_fef6d5a3-b1c2-433a-a3a9-78d4870d0a8b" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfShareCapitalAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_ffa231bd-0773-4eb5-bc50-e497495cfa45" xlink:to="loc_ifrs-full_ClassesOfShareCapitalAxis_fef6d5a3-b1c2-433a-a3a9-78d4870d0a8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfShareCapitalDomain_c7f90305-a5e0-4aff-b409-81aecbf70d80" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfShareCapitalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfShareCapitalAxis_fef6d5a3-b1c2-433a-a3a9-78d4870d0a8b" xlink:to="loc_ifrs-full_ClassesOfShareCapitalDomain_c7f90305-a5e0-4aff-b409-81aecbf70d80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OrdinarySharesMember_2291a870-5f71-4eb2-aa6a-ef5dbb385013" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OrdinarySharesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfShareCapitalDomain_c7f90305-a5e0-4aff-b409-81aecbf70d80" xlink:to="loc_ifrs-full_OrdinarySharesMember_2291a870-5f71-4eb2-aa6a-ef5dbb385013" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_The2016FreePreferredSharesMember_002446d2-9fff-4e6a-8461-a5115510cc04" xlink:href="inpha-20260630.xsd#inpha_The2016FreePreferredSharesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfShareCapitalDomain_c7f90305-a5e0-4aff-b409-81aecbf70d80" xlink:to="loc_inpha_The2016FreePreferredSharesMember_002446d2-9fff-4e6a-8461-a5115510cc04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_The2017FreePreferredSharesMember_2b84eb5b-58d8-4364-9032-bf96b2b66e61" xlink:href="inpha-20260630.xsd#inpha_The2017FreePreferredSharesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfShareCapitalDomain_c7f90305-a5e0-4aff-b409-81aecbf70d80" xlink:to="loc_inpha_The2017FreePreferredSharesMember_2b84eb5b-58d8-4364-9032-bf96b2b66e61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_f833d74b-1dcf-4dfd-9175-60673600d02a" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_ffa231bd-0773-4eb5-bc50-e497495cfa45" xlink:to="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_f833d74b-1dcf-4dfd-9175-60673600d02a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_Equity_8a716ee9-0599-4a02-93c0-131602b9c2f7" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_Equity"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_f833d74b-1dcf-4dfd-9175-60673600d02a" xlink:to="loc_ifrs-full_Equity_8a716ee9-0599-4a02-93c0-131602b9c2f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NumberOfSharesOutstanding_0c1f37e6-5c4f-4c5e-b343-e159f36bdf0b" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NumberOfSharesOutstanding"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_f833d74b-1dcf-4dfd-9175-60673600d02a" xlink:to="loc_ifrs-full_NumberOfSharesOutstanding_0c1f37e6-5c4f-4c5e-b343-e159f36bdf0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ParValuePerShare_1655de85-4dbd-4451-bc12-062e21c5bed0" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ParValuePerShare"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_f833d74b-1dcf-4dfd-9175-60673600d02a" xlink:to="loc_ifrs-full_ParValuePerShare_1655de85-4dbd-4451-bc12-062e21c5bed0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NumberOfSharesIssued_663f27f6-fb92-40fe-98a5-0d13ea9acb86" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NumberOfSharesIssued"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_f833d74b-1dcf-4dfd-9175-60673600d02a" xlink:to="loc_ifrs-full_NumberOfSharesIssued_663f27f6-fb92-40fe-98a5-0d13ea9acb86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SharesInEntityHeldByEntityOrByItsSubsidiariesOrAssociates_df662046-1e33-4108-ba38-ba573738c1e5" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_SharesInEntityHeldByEntityOrByItsSubsidiariesOrAssociates"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_f833d74b-1dcf-4dfd-9175-60673600d02a" xlink:to="loc_ifrs-full_SharesInEntityHeldByEntityOrByItsSubsidiariesOrAssociates_df662046-1e33-4108-ba38-ba573738c1e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.innate-pharma.com/role/CapitalDisclosureofnumberandweightedaverageexercisepricesofotherequityinstrumentsDetails" xlink:type="simple" xlink:href="inpha-20260630.xsd#CapitalDisclosureofnumberandweightedaverageexercisepricesofotherequityinstrumentsDetails"/>
  <link:presentationLink xlink:role="http://www.innate-pharma.com/role/CapitalDisclosureofnumberandweightedaverageexercisepricesofotherequityinstrumentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_inpha_ShareCapitalAndShareBasePaymentsAbstract_49042960-3bbc-4656-92ac-4dd62c8d3a68" xlink:href="inpha-20260630.xsd#inpha_ShareCapitalAndShareBasePaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_7bb38951-e9bb-4977-9a61-b6c77cd9162d" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inpha_ShareCapitalAndShareBasePaymentsAbstract_49042960-3bbc-4656-92ac-4dd62c8d3a68" xlink:to="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_7bb38951-e9bb-4977-9a61-b6c77cd9162d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_e1df564b-4d14-42c6-86aa-1bd26dd298d4" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_7bb38951-e9bb-4977-9a61-b6c77cd9162d" xlink:to="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_e1df564b-4d14-42c6-86aa-1bd26dd298d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_957062e6-01ce-41f1-bd64-38b3cc084360" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_e1df564b-4d14-42c6-86aa-1bd26dd298d4" xlink:to="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_957062e6-01ce-41f1-bd64-38b3cc084360" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_WarrantsMember_ec4e1f5a-55a0-4360-96f4-f650a3f19fa1" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_WarrantsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_957062e6-01ce-41f1-bd64-38b3cc084360" xlink:to="loc_ifrs-full_WarrantsMember_ec4e1f5a-55a0-4360-96f4-f650a3f19fa1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_BSAAR2011Member_98427c1e-a39a-47cf-87c1-c38e96f6244c" xlink:href="inpha-20260630.xsd#inpha_BSAAR2011Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_WarrantsMember_ec4e1f5a-55a0-4360-96f4-f650a3f19fa1" xlink:to="loc_inpha_BSAAR2011Member_98427c1e-a39a-47cf-87c1-c38e96f6244c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_BSAAR2012Member_1527da13-789e-439f-b185-6791fe1a85b5" xlink:href="inpha-20260630.xsd#inpha_BSAAR2012Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_WarrantsMember_ec4e1f5a-55a0-4360-96f4-f650a3f19fa1" xlink:to="loc_inpha_BSAAR2012Member_1527da13-789e-439f-b185-6791fe1a85b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_BSAAR2015Member_819f10be-d11e-4d0f-8a68-a8f4d223459c" xlink:href="inpha-20260630.xsd#inpha_BSAAR2015Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_WarrantsMember_ec4e1f5a-55a0-4360-96f4-f650a3f19fa1" xlink:to="loc_inpha_BSAAR2015Member_819f10be-d11e-4d0f-8a68-a8f4d223459c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_AGAPManagement20161Member_8fa262a0-aa06-49ef-9f76-ff1771fb8aeb" xlink:href="inpha-20260630.xsd#inpha_AGAPManagement20161Member"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_WarrantsMember_ec4e1f5a-55a0-4360-96f4-f650a3f19fa1" xlink:to="loc_inpha_AGAPManagement20161Member_8fa262a0-aa06-49ef-9f76-ff1771fb8aeb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_AGAPEmployees20161Member_576fcb62-163d-4054-89f5-86bbafe3391b" xlink:href="inpha-20260630.xsd#inpha_AGAPEmployees20161Member"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_WarrantsMember_ec4e1f5a-55a0-4360-96f4-f650a3f19fa1" xlink:to="loc_inpha_AGAPEmployees20161Member_576fcb62-163d-4054-89f5-86bbafe3391b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_AGAManagement20161Member_9b4b97e4-8c85-4188-b945-9517a1dfd80b" xlink:href="inpha-20260630.xsd#inpha_AGAManagement20161Member"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_WarrantsMember_ec4e1f5a-55a0-4360-96f4-f650a3f19fa1" xlink:to="loc_inpha_AGAManagement20161Member_9b4b97e4-8c85-4188-b945-9517a1dfd80b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_AGAPManagement20162Member_4b6afd26-263b-4e52-92bb-4ee0e0be4042" xlink:href="inpha-20260630.xsd#inpha_AGAPManagement20162Member"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_WarrantsMember_ec4e1f5a-55a0-4360-96f4-f650a3f19fa1" xlink:to="loc_inpha_AGAPManagement20162Member_4b6afd26-263b-4e52-92bb-4ee0e0be4042" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_AGAManagement20162Member_eb60f369-9f28-408b-9661-afa09247db82" xlink:href="inpha-20260630.xsd#inpha_AGAManagement20162Member"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_WarrantsMember_ec4e1f5a-55a0-4360-96f4-f650a3f19fa1" xlink:to="loc_inpha_AGAManagement20162Member_eb60f369-9f28-408b-9661-afa09247db82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_AGAPEmployees20171Member_3b4797ce-82a6-496d-9897-d89c618e8375" xlink:href="inpha-20260630.xsd#inpha_AGAPEmployees20171Member"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_WarrantsMember_ec4e1f5a-55a0-4360-96f4-f650a3f19fa1" xlink:to="loc_inpha_AGAPEmployees20171Member_3b4797ce-82a6-496d-9897-d89c618e8375" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_AGAPManagement20171Member_f85b4037-6a9b-45ba-af32-f3e6e6382360" xlink:href="inpha-20260630.xsd#inpha_AGAPManagement20171Member"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_WarrantsMember_ec4e1f5a-55a0-4360-96f4-f650a3f19fa1" xlink:to="loc_inpha_AGAPManagement20171Member_f85b4037-6a9b-45ba-af32-f3e6e6382360" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_AGAEmployees2017Member_cc73c1ba-dd86-45ac-887d-64145d081e86" xlink:href="inpha-20260630.xsd#inpha_AGAEmployees2017Member"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_WarrantsMember_ec4e1f5a-55a0-4360-96f4-f650a3f19fa1" xlink:to="loc_inpha_AGAEmployees2017Member_cc73c1ba-dd86-45ac-887d-64145d081e86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_AGABonus20181Member_4548cc87-2c2e-4f13-8f5c-f99e9b2cf46e" xlink:href="inpha-20260630.xsd#inpha_AGABonus20181Member"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_WarrantsMember_ec4e1f5a-55a0-4360-96f4-f650a3f19fa1" xlink:to="loc_inpha_AGABonus20181Member_4548cc87-2c2e-4f13-8f5c-f99e9b2cf46e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_AGAPPerfEmployees20181Member_746f13a3-72cd-4792-b616-9eeceb7a32b0" xlink:href="inpha-20260630.xsd#inpha_AGAPPerfEmployees20181Member"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_WarrantsMember_ec4e1f5a-55a0-4360-96f4-f650a3f19fa1" xlink:to="loc_inpha_AGAPPerfEmployees20181Member_746f13a3-72cd-4792-b616-9eeceb7a32b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_AGAPPerfManagement20181Member_ada2a714-828e-4aa0-9995-48671645dc67" xlink:href="inpha-20260630.xsd#inpha_AGAPPerfManagement20181Member"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_WarrantsMember_ec4e1f5a-55a0-4360-96f4-f650a3f19fa1" xlink:to="loc_inpha_AGAPPerfManagement20181Member_ada2a714-828e-4aa0-9995-48671645dc67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_AGAEmployees2018Member_7aab6530-3746-42a2-808f-06090b6d0c5f" xlink:href="inpha-20260630.xsd#inpha_AGAEmployees2018Member"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_WarrantsMember_ec4e1f5a-55a0-4360-96f4-f650a3f19fa1" xlink:to="loc_inpha_AGAEmployees2018Member_7aab6530-3746-42a2-808f-06090b6d0c5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_AGANewMembers20171Member_454bca69-f1f7-4224-b6fb-b71d4e7bda80" xlink:href="inpha-20260630.xsd#inpha_AGANewMembers20171Member"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_WarrantsMember_ec4e1f5a-55a0-4360-96f4-f650a3f19fa1" xlink:to="loc_inpha_AGANewMembers20171Member_454bca69-f1f7-4224-b6fb-b71d4e7bda80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_AGABonus20191Member_27a95dc1-6ca0-4c06-b57b-e5582fa9ddce" xlink:href="inpha-20260630.xsd#inpha_AGABonus20191Member"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_WarrantsMember_ec4e1f5a-55a0-4360-96f4-f650a3f19fa1" xlink:to="loc_inpha_AGABonus20191Member_27a95dc1-6ca0-4c06-b57b-e5582fa9ddce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_AGAP2019Employees2019Member_0e191098-71d3-4f17-9662-97e1bf5a66bf" xlink:href="inpha-20260630.xsd#inpha_AGAP2019Employees2019Member"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_WarrantsMember_ec4e1f5a-55a0-4360-96f4-f650a3f19fa1" xlink:to="loc_inpha_AGAP2019Employees2019Member_0e191098-71d3-4f17-9662-97e1bf5a66bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_AGAP2019Management2019Member_317ffbf7-95b3-47b2-9ba1-51da80b3dba2" xlink:href="inpha-20260630.xsd#inpha_AGAP2019Management2019Member"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_WarrantsMember_ec4e1f5a-55a0-4360-96f4-f650a3f19fa1" xlink:to="loc_inpha_AGAP2019Management2019Member_317ffbf7-95b3-47b2-9ba1-51da80b3dba2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_AGABonus202012Member_366ae427-ebd5-4d78-a25c-a5952879cc56" xlink:href="inpha-20260630.xsd#inpha_AGABonus202012Member"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_WarrantsMember_ec4e1f5a-55a0-4360-96f4-f650a3f19fa1" xlink:to="loc_inpha_AGABonus202012Member_366ae427-ebd5-4d78-a25c-a5952879cc56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_AGAPEmployees20201Member_a10fb4cf-c2a4-45f5-b1b5-4d30024c9539" xlink:href="inpha-20260630.xsd#inpha_AGAPEmployees20201Member"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_WarrantsMember_ec4e1f5a-55a0-4360-96f4-f650a3f19fa1" xlink:to="loc_inpha_AGAPEmployees20201Member_a10fb4cf-c2a4-45f5-b1b5-4d30024c9539" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_AGAPManagement20201Member_b612a587-f185-47d5-9222-4b01a7749c8f" xlink:href="inpha-20260630.xsd#inpha_AGAPManagement20201Member"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_WarrantsMember_ec4e1f5a-55a0-4360-96f4-f650a3f19fa1" xlink:to="loc_inpha_AGAPManagement20201Member_b612a587-f185-47d5-9222-4b01a7749c8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_AGABonus20211Member_cb5bfe5b-4faa-443b-9e13-88ec3b647671" xlink:href="inpha-20260630.xsd#inpha_AGABonus20211Member"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_WarrantsMember_ec4e1f5a-55a0-4360-96f4-f650a3f19fa1" xlink:to="loc_inpha_AGABonus20211Member_cb5bfe5b-4faa-443b-9e13-88ec3b647671" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_AGAPEmployees20211Member_ab415eda-9eba-4c60-9579-da72c45e0749" xlink:href="inpha-20260630.xsd#inpha_AGAPEmployees20211Member"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_WarrantsMember_ec4e1f5a-55a0-4360-96f4-f650a3f19fa1" xlink:to="loc_inpha_AGAPEmployees20211Member_ab415eda-9eba-4c60-9579-da72c45e0749" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_AGAPManagement20211Member_f62f1e0e-5018-46e7-b7c1-267e19b045b7" xlink:href="inpha-20260630.xsd#inpha_AGAPManagement20211Member"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_WarrantsMember_ec4e1f5a-55a0-4360-96f4-f650a3f19fa1" xlink:to="loc_inpha_AGAPManagement20211Member_f62f1e0e-5018-46e7-b7c1-267e19b045b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_AGAPlanEpargneEntreprise2022Member_cc73df23-33b7-4ba9-a174-8ed21a59b3a6" xlink:href="inpha-20260630.xsd#inpha_AGAPlanEpargneEntreprise2022Member"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_WarrantsMember_ec4e1f5a-55a0-4360-96f4-f650a3f19fa1" xlink:to="loc_inpha_AGAPlanEpargneEntreprise2022Member_cc73df23-33b7-4ba9-a174-8ed21a59b3a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_AGABonus20221Member_13e8eefa-fb0d-4886-9fcd-7c1f1726813c" xlink:href="inpha-20260630.xsd#inpha_AGABonus20221Member"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_WarrantsMember_ec4e1f5a-55a0-4360-96f4-f650a3f19fa1" xlink:to="loc_inpha_AGABonus20221Member_13e8eefa-fb0d-4886-9fcd-7c1f1726813c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_AGAPerfEmployees20221Member_fd3f8053-5c77-4f5d-ae99-1e048d7af778" xlink:href="inpha-20260630.xsd#inpha_AGAPerfEmployees20221Member"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_WarrantsMember_ec4e1f5a-55a0-4360-96f4-f650a3f19fa1" xlink:to="loc_inpha_AGAPerfEmployees20221Member_fd3f8053-5c77-4f5d-ae99-1e048d7af778" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_AGAPerfManagement20221Member_aa29f609-93c5-44a7-a6b3-86be0d3aab47" xlink:href="inpha-20260630.xsd#inpha_AGAPerfManagement20221Member"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_WarrantsMember_ec4e1f5a-55a0-4360-96f4-f650a3f19fa1" xlink:to="loc_inpha_AGAPerfManagement20221Member_aa29f609-93c5-44a7-a6b3-86be0d3aab47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_AGAPlanEpargneEntreprise2023Member_f6913a6b-dfab-419f-9cfc-ad9daa29e58a" xlink:href="inpha-20260630.xsd#inpha_AGAPlanEpargneEntreprise2023Member"/>
    <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_WarrantsMember_ec4e1f5a-55a0-4360-96f4-f650a3f19fa1" xlink:to="loc_inpha_AGAPlanEpargneEntreprise2023Member_f6913a6b-dfab-419f-9cfc-ad9daa29e58a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_AGANewMembers20231Member_ab978c02-4624-484f-aa27-b07aab027be3" xlink:href="inpha-20260630.xsd#inpha_AGANewMembers20231Member"/>
    <link:presentationArc order="31" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_WarrantsMember_ec4e1f5a-55a0-4360-96f4-f650a3f19fa1" xlink:to="loc_inpha_AGANewMembers20231Member_ab978c02-4624-484f-aa27-b07aab027be3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_AGAPerfEmployees20231Member_6600bf61-c1d1-4a8b-970d-022f1c79790b" xlink:href="inpha-20260630.xsd#inpha_AGAPerfEmployees20231Member"/>
    <link:presentationArc order="32" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_WarrantsMember_ec4e1f5a-55a0-4360-96f4-f650a3f19fa1" xlink:to="loc_inpha_AGAPerfEmployees20231Member_6600bf61-c1d1-4a8b-970d-022f1c79790b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_AGAPerfManagement20231Member_7985410e-2e18-481d-a918-7404c7cdef70" xlink:href="inpha-20260630.xsd#inpha_AGAPerfManagement20231Member"/>
    <link:presentationArc order="33" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_WarrantsMember_ec4e1f5a-55a0-4360-96f4-f650a3f19fa1" xlink:to="loc_inpha_AGAPerfManagement20231Member_7985410e-2e18-481d-a918-7404c7cdef70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_AGANewMembers20241Member_a2b9a0a3-39c5-4528-b9d2-da694de1b299" xlink:href="inpha-20260630.xsd#inpha_AGANewMembers20241Member"/>
    <link:presentationArc order="34" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_WarrantsMember_ec4e1f5a-55a0-4360-96f4-f650a3f19fa1" xlink:to="loc_inpha_AGANewMembers20241Member_a2b9a0a3-39c5-4528-b9d2-da694de1b299" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_AGAPlanEpargneEntreprise2024Member_7dcd0329-cd05-47f7-9f11-0c57489ca93f" xlink:href="inpha-20260630.xsd#inpha_AGAPlanEpargneEntreprise2024Member"/>
    <link:presentationArc order="35" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_WarrantsMember_ec4e1f5a-55a0-4360-96f4-f650a3f19fa1" xlink:to="loc_inpha_AGAPlanEpargneEntreprise2024Member_7dcd0329-cd05-47f7-9f11-0c57489ca93f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_AGAPerfManagement20241Member_d2cc1435-16fb-460a-83c0-1fd2d8879159" xlink:href="inpha-20260630.xsd#inpha_AGAPerfManagement20241Member"/>
    <link:presentationArc order="36" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_WarrantsMember_ec4e1f5a-55a0-4360-96f4-f650a3f19fa1" xlink:to="loc_inpha_AGAPerfManagement20241Member_d2cc1435-16fb-460a-83c0-1fd2d8879159" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_AGAEmployees20241Member_12845b9b-b45b-469a-a80e-711098f13af7" xlink:href="inpha-20260630.xsd#inpha_AGAEmployees20241Member"/>
    <link:presentationArc order="37" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_WarrantsMember_ec4e1f5a-55a0-4360-96f4-f650a3f19fa1" xlink:to="loc_inpha_AGAEmployees20241Member_12845b9b-b45b-469a-a80e-711098f13af7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_AGAPerfEmployees20241Member_5f225759-cd84-4f3f-a4f4-2b3186b04943" xlink:href="inpha-20260630.xsd#inpha_AGAPerfEmployees20241Member"/>
    <link:presentationArc order="38" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_WarrantsMember_ec4e1f5a-55a0-4360-96f4-f650a3f19fa1" xlink:to="loc_inpha_AGAPerfEmployees20241Member_5f225759-cd84-4f3f-a4f4-2b3186b04943" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_AGAPerfManagement20242Member_03463610-a3c8-42ff-8629-73c0273299dd" xlink:href="inpha-20260630.xsd#inpha_AGAPerfManagement20242Member"/>
    <link:presentationArc order="39" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_WarrantsMember_ec4e1f5a-55a0-4360-96f4-f650a3f19fa1" xlink:to="loc_inpha_AGAPerfManagement20242Member_03463610-a3c8-42ff-8629-73c0273299dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_AGAManagement20241Member_84bc5a8e-a74b-4322-a645-2a15f8e3e654" xlink:href="inpha-20260630.xsd#inpha_AGAManagement20241Member"/>
    <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_WarrantsMember_ec4e1f5a-55a0-4360-96f4-f650a3f19fa1" xlink:to="loc_inpha_AGAManagement20241Member_84bc5a8e-a74b-4322-a645-2a15f8e3e654" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_AGA202501Member_dddac77c-1fd3-4e9d-b83f-fbb6517c6ebb" xlink:href="inpha-20260630.xsd#inpha_AGA202501Member"/>
    <link:presentationArc order="41" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_WarrantsMember_ec4e1f5a-55a0-4360-96f4-f650a3f19fa1" xlink:to="loc_inpha_AGA202501Member_dddac77c-1fd3-4e9d-b83f-fbb6517c6ebb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_AGA202502Member_019ff15b-ce1c-744d-97c3-97659190a66a" xlink:href="inpha-20260630.xsd#inpha_AGA202502Member"/>
    <link:presentationArc order="42" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_WarrantsMember_ec4e1f5a-55a0-4360-96f4-f650a3f19fa1" xlink:to="loc_inpha_AGA202502Member_019ff15b-ce1c-744d-97c3-97659190a66a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_AGAManagement2025Member_019ff15c-0867-7acc-8437-cb9736be67fe" xlink:href="inpha-20260630.xsd#inpha_AGAManagement2025Member"/>
    <link:presentationArc order="43" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_WarrantsMember_ec4e1f5a-55a0-4360-96f4-f650a3f19fa1" xlink:to="loc_inpha_AGAManagement2025Member_019ff15c-0867-7acc-8437-cb9736be67fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_AGAPerfEmployees20251Member_019ff15c-4276-74d0-a006-385da951c7d3" xlink:href="inpha-20260630.xsd#inpha_AGAPerfEmployees20251Member"/>
    <link:presentationArc order="44" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_WarrantsMember_ec4e1f5a-55a0-4360-96f4-f650a3f19fa1" xlink:to="loc_inpha_AGAPerfEmployees20251Member_019ff15c-4276-74d0-a006-385da951c7d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_AGAPerfManagement20252Member_019ff15c-6bc3-739d-a9c1-07e4786e5e26" xlink:href="inpha-20260630.xsd#inpha_AGAPerfManagement20252Member"/>
    <link:presentationArc order="45" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_WarrantsMember_ec4e1f5a-55a0-4360-96f4-f650a3f19fa1" xlink:to="loc_inpha_AGAPerfManagement20252Member_019ff15c-6bc3-739d-a9c1-07e4786e5e26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_StockOptions20201Member_da445de7-09c8-4e66-a9f4-3a560322cab2" xlink:href="inpha-20260630.xsd#inpha_StockOptions20201Member"/>
    <link:presentationArc order="46" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_WarrantsMember_ec4e1f5a-55a0-4360-96f4-f650a3f19fa1" xlink:to="loc_inpha_StockOptions20201Member_da445de7-09c8-4e66-a9f4-3a560322cab2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_StockOptions20241Member_c4f818b1-92b7-46ee-b7cd-0784855682d0" xlink:href="inpha-20260630.xsd#inpha_StockOptions20241Member"/>
    <link:presentationArc order="47" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_WarrantsMember_ec4e1f5a-55a0-4360-96f4-f650a3f19fa1" xlink:to="loc_inpha_StockOptions20241Member_c4f818b1-92b7-46ee-b7cd-0784855682d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_BSA20112Member_d015633e-0090-4416-87d2-b49225bf38bb" xlink:href="inpha-20260630.xsd#inpha_BSA20112Member"/>
    <link:presentationArc order="48" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_WarrantsMember_ec4e1f5a-55a0-4360-96f4-f650a3f19fa1" xlink:to="loc_inpha_BSA20112Member_d015633e-0090-4416-87d2-b49225bf38bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_BSA2013Member_3077c0de-238b-4fcb-86b1-8a0f0c002b54" xlink:href="inpha-20260630.xsd#inpha_BSA2013Member"/>
    <link:presentationArc order="49" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_WarrantsMember_ec4e1f5a-55a0-4360-96f4-f650a3f19fa1" xlink:to="loc_inpha_BSA2013Member_3077c0de-238b-4fcb-86b1-8a0f0c002b54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_BSA2014Member_7c999bfe-d091-4557-9fc9-4e002c31b02a" xlink:href="inpha-20260630.xsd#inpha_BSA2014Member"/>
    <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_WarrantsMember_ec4e1f5a-55a0-4360-96f4-f650a3f19fa1" xlink:to="loc_inpha_BSA2014Member_7c999bfe-d091-4557-9fc9-4e002c31b02a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_BSA20151Member_cce2744e-9e74-4dff-8a6d-1f395ff7aa05" xlink:href="inpha-20260630.xsd#inpha_BSA20151Member"/>
    <link:presentationArc order="51" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_WarrantsMember_ec4e1f5a-55a0-4360-96f4-f650a3f19fa1" xlink:to="loc_inpha_BSA20151Member_cce2744e-9e74-4dff-8a6d-1f395ff7aa05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_BSA20152Member_9b373f0d-e0a5-4226-8f93-b19963da99d3" xlink:href="inpha-20260630.xsd#inpha_BSA20152Member"/>
    <link:presentationArc order="52" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_WarrantsMember_ec4e1f5a-55a0-4360-96f4-f650a3f19fa1" xlink:to="loc_inpha_BSA20152Member_9b373f0d-e0a5-4226-8f93-b19963da99d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_BSA2017Member_d6cd1fb2-7a27-4b64-8e5d-326fa1c68fd6" xlink:href="inpha-20260630.xsd#inpha_BSA2017Member"/>
    <link:presentationArc order="53" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_WarrantsMember_ec4e1f5a-55a0-4360-96f4-f650a3f19fa1" xlink:to="loc_inpha_BSA2017Member_d6cd1fb2-7a27-4b64-8e5d-326fa1c68fd6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_BSA20221Member_5e83dc36-59c4-4c5e-92c2-598327d7a8b9" xlink:href="inpha-20260630.xsd#inpha_BSA20221Member"/>
    <link:presentationArc order="54" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_WarrantsMember_ec4e1f5a-55a0-4360-96f4-f650a3f19fa1" xlink:to="loc_inpha_BSA20221Member_5e83dc36-59c4-4c5e-92c2-598327d7a8b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_BSA20231Member_a6f3a3ff-053b-496b-9c65-4c923bf89ddd" xlink:href="inpha-20260630.xsd#inpha_BSA20231Member"/>
    <link:presentationArc order="55" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_WarrantsMember_ec4e1f5a-55a0-4360-96f4-f650a3f19fa1" xlink:to="loc_inpha_BSA20231Member_a6f3a3ff-053b-496b-9c65-4c923bf89ddd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_BSA20251Member_019ff15c-fa82-7dc8-8d75-3f36b18c1e1a" xlink:href="inpha-20260630.xsd#inpha_BSA20251Member"/>
    <link:presentationArc order="56" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_WarrantsMember_ec4e1f5a-55a0-4360-96f4-f650a3f19fa1" xlink:to="loc_inpha_BSA20251Member_019ff15c-fa82-7dc8-8d75-3f36b18c1e1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_f7d08a78-aa6f-4c4b-b5d1-e13c9c53f485" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_7bb38951-e9bb-4977-9a61-b6c77cd9162d" xlink:to="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_f7d08a78-aa6f-4c4b-b5d1-e13c9c53f485" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted_963c2b0b-05e0-4b08-82c8-834a5f98a4df" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_f7d08a78-aa6f-4c4b-b5d1-e13c9c53f485" xlink:to="loc_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted_963c2b0b-05e0-4b08-82c8-834a5f98a4df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NumberOfOtherEquityInstrumentsForfeitedInSharebasedPaymentArrangement_c6a83436-a8ca-4d7b-bd15-c311a6529280" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NumberOfOtherEquityInstrumentsForfeitedInSharebasedPaymentArrangement"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_f7d08a78-aa6f-4c4b-b5d1-e13c9c53f485" xlink:to="loc_ifrs-full_NumberOfOtherEquityInstrumentsForfeitedInSharebasedPaymentArrangement_c6a83436-a8ca-4d7b-bd15-c311a6529280" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement_bf6af620-fd4a-419c-b355-92ef96f93c66" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_f7d08a78-aa6f-4c4b-b5d1-e13c9c53f485" xlink:to="loc_ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement_bf6af620-fd4a-419c-b355-92ef96f93c66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_38d7e898-eac0-4e50-8e53-c5a54d0bae27" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_f7d08a78-aa6f-4c4b-b5d1-e13c9c53f485" xlink:to="loc_ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_38d7e898-eac0-4e50-8e53-c5a54d0bae27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NumberOfOtherEquityInstrumentsExercisableInSharebasedPaymentArrangement_ca2e7ab8-199c-49c3-aad5-f6c8881562a6" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NumberOfOtherEquityInstrumentsExercisableInSharebasedPaymentArrangement"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_f7d08a78-aa6f-4c4b-b5d1-e13c9c53f485" xlink:to="loc_ifrs-full_NumberOfOtherEquityInstrumentsExercisableInSharebasedPaymentArrangement_ca2e7ab8-199c-49c3-aad5-f6c8881562a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement2019_52fc5aa4-f1ea-4332-a2b2-1309844b8e7c" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement2019"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_f7d08a78-aa6f-4c4b-b5d1-e13c9c53f485" xlink:to="loc_ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement2019_52fc5aa4-f1ea-4332-a2b2-1309844b8e7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.innate-pharma.com/role/FinancialinstrumentsrecognizedinthestatementoffinancialpositionandrelatedeffectontheincomestatementDisclosureofdetailedinformationaboutfinancialinstrumentsDetails" xlink:type="simple" xlink:href="inpha-20260630.xsd#FinancialinstrumentsrecognizedinthestatementoffinancialpositionandrelatedeffectontheincomestatementDisclosureofdetailedinformationaboutfinancialinstrumentsDetails"/>
  <link:presentationLink xlink:role="http://www.innate-pharma.com/role/FinancialinstrumentsrecognizedinthestatementoffinancialpositionandrelatedeffectontheincomestatementDisclosureofdetailedinformationaboutfinancialinstrumentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfFinancialInstrumentsAbstract_e5efdb86-b625-4c08-b1cf-dc66c1a409b0" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfFinancialInstrumentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_e75bbf3f-7a2e-46a7-9148-5b2f59b99a77" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfFinancialInstrumentsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsAbstract_e5efdb86-b625-4c08-b1cf-dc66c1a409b0" xlink:to="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_e75bbf3f-7a2e-46a7-9148-5b2f59b99a77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfFinancialAssetsAxis_b5d8c656-6c46-4588-aa81-d6ff410ca872" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfFinancialAssetsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_e75bbf3f-7a2e-46a7-9148-5b2f59b99a77" xlink:to="loc_ifrs-full_ClassesOfFinancialAssetsAxis_b5d8c656-6c46-4588-aa81-d6ff410ca872" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfFinancialAssetsDomain_7049a846-1f3a-48ea-a015-b106e1e603c9" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfFinancialAssetsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfFinancialAssetsAxis_b5d8c656-6c46-4588-aa81-d6ff410ca872" xlink:to="loc_ifrs-full_ClassesOfFinancialAssetsDomain_7049a846-1f3a-48ea-a015-b106e1e603c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_NonCurrentFinancialAssetsMember_68064f64-3084-4c05-8c4a-66f9a8b190b7" xlink:href="inpha-20260630.xsd#inpha_NonCurrentFinancialAssetsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfFinancialAssetsDomain_7049a846-1f3a-48ea-a015-b106e1e603c9" xlink:to="loc_inpha_NonCurrentFinancialAssetsMember_68064f64-3084-4c05-8c4a-66f9a8b190b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_TradeReceivablesAndOthersMember_b262e496-c765-401d-bad2-ca11eac2ad7b" xlink:href="inpha-20260630.xsd#inpha_TradeReceivablesAndOthersMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfFinancialAssetsDomain_7049a846-1f3a-48ea-a015-b106e1e603c9" xlink:to="loc_inpha_TradeReceivablesAndOthersMember_b262e496-c765-401d-bad2-ca11eac2ad7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_FinancialAssetsShortTermInvestmentsMember_8c568fc1-6506-4989-8f6f-7d52169e6a8a" xlink:href="inpha-20260630.xsd#inpha_FinancialAssetsShortTermInvestmentsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfFinancialAssetsDomain_7049a846-1f3a-48ea-a015-b106e1e603c9" xlink:to="loc_inpha_FinancialAssetsShortTermInvestmentsMember_8c568fc1-6506-4989-8f6f-7d52169e6a8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_FinancialAssetsCashAndCashEquivalentsMember_7e59bc11-397c-4cfa-a22b-26a18b82f91d" xlink:href="inpha-20260630.xsd#inpha_FinancialAssetsCashAndCashEquivalentsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfFinancialAssetsDomain_7049a846-1f3a-48ea-a015-b106e1e603c9" xlink:to="loc_inpha_FinancialAssetsCashAndCashEquivalentsMember_7e59bc11-397c-4cfa-a22b-26a18b82f91d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CategoriesOfFinancialAssetsAxis_023b07bf-0cd6-40da-b753-99bd74fa87ec" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CategoriesOfFinancialAssetsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_e75bbf3f-7a2e-46a7-9148-5b2f59b99a77" xlink:to="loc_ifrs-full_CategoriesOfFinancialAssetsAxis_023b07bf-0cd6-40da-b753-99bd74fa87ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CategoriesOfFinancialAssetsDomain_6249010f-70eb-44c3-8262-25eaf6b7a5d9" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CategoriesOfFinancialAssetsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CategoriesOfFinancialAssetsAxis_023b07bf-0cd6-40da-b753-99bd74fa87ec" xlink:to="loc_ifrs-full_CategoriesOfFinancialAssetsDomain_6249010f-70eb-44c3-8262-25eaf6b7a5d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember_71280aba-469b-4711-a8ba-b66ce8b3b49c" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CategoriesOfFinancialAssetsDomain_6249010f-70eb-44c3-8262-25eaf6b7a5d9" xlink:to="loc_ifrs-full_FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember_71280aba-469b-4711-a8ba-b66ce8b3b49c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FinancialAssetsAtAmortisedCostCategoryMember_3b279491-159b-4650-915e-632bfef1157e" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_FinancialAssetsAtAmortisedCostCategoryMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CategoriesOfFinancialAssetsDomain_6249010f-70eb-44c3-8262-25eaf6b7a5d9" xlink:to="loc_ifrs-full_FinancialAssetsAtAmortisedCostCategoryMember_3b279491-159b-4650-915e-632bfef1157e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfFinancialLiabilitiesAxis_68593793-23a8-4fe6-9acc-933fcf12dc03" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfFinancialLiabilitiesAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_e75bbf3f-7a2e-46a7-9148-5b2f59b99a77" xlink:to="loc_ifrs-full_ClassesOfFinancialLiabilitiesAxis_68593793-23a8-4fe6-9acc-933fcf12dc03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_39ab4cf1-7abf-4ed1-aa11-556e894288e9" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfFinancialLiabilitiesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfFinancialLiabilitiesAxis_68593793-23a8-4fe6-9acc-933fcf12dc03" xlink:to="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_39ab4cf1-7abf-4ed1-aa11-556e894288e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_FinancialLiabilitiesNonCurrentPortionMember_c16707c0-5da2-4ab1-b13e-769279084f47" xlink:href="inpha-20260630.xsd#inpha_FinancialLiabilitiesNonCurrentPortionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_39ab4cf1-7abf-4ed1-aa11-556e894288e9" xlink:to="loc_inpha_FinancialLiabilitiesNonCurrentPortionMember_c16707c0-5da2-4ab1-b13e-769279084f47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_FinancialLiabilitiesCurrentPortionMember_90c16dfd-d645-4694-b15b-091609fe23ca" xlink:href="inpha-20260630.xsd#inpha_FinancialLiabilitiesCurrentPortionMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_39ab4cf1-7abf-4ed1-aa11-556e894288e9" xlink:to="loc_inpha_FinancialLiabilitiesCurrentPortionMember_90c16dfd-d645-4694-b15b-091609fe23ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_TradePayablesAndOthersMember_5d146702-90ed-47f9-8742-61702b3a84ec" xlink:href="inpha-20260630.xsd#inpha_TradePayablesAndOthersMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_39ab4cf1-7abf-4ed1-aa11-556e894288e9" xlink:to="loc_inpha_TradePayablesAndOthersMember_5d146702-90ed-47f9-8742-61702b3a84ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CategoriesOfFinancialLiabilitiesAxis_8883135a-12eb-4525-b44c-cd2dcacd51f0" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CategoriesOfFinancialLiabilitiesAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_e75bbf3f-7a2e-46a7-9148-5b2f59b99a77" xlink:to="loc_ifrs-full_CategoriesOfFinancialLiabilitiesAxis_8883135a-12eb-4525-b44c-cd2dcacd51f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CategoriesOfFinancialLiabilitiesDomain_f2bf81f9-6c0b-47b9-841b-43436d38bf3a" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CategoriesOfFinancialLiabilitiesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CategoriesOfFinancialLiabilitiesAxis_8883135a-12eb-4525-b44c-cd2dcacd51f0" xlink:to="loc_ifrs-full_CategoriesOfFinancialLiabilitiesDomain_f2bf81f9-6c0b-47b9-841b-43436d38bf3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FinancialLiabilitiesAtFairValueThroughProfitOrLossCategoryMember_c68ebb74-b407-469d-aa9f-9609e5b28e20" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_FinancialLiabilitiesAtFairValueThroughProfitOrLossCategoryMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CategoriesOfFinancialLiabilitiesDomain_f2bf81f9-6c0b-47b9-841b-43436d38bf3a" xlink:to="loc_ifrs-full_FinancialLiabilitiesAtFairValueThroughProfitOrLossCategoryMember_c68ebb74-b407-469d-aa9f-9609e5b28e20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FinancialLiabilitiesAtAmortisedCostCategoryMember_70ad439a-345a-448e-9843-624b103b67c8" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_FinancialLiabilitiesAtAmortisedCostCategoryMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CategoriesOfFinancialLiabilitiesDomain_f2bf81f9-6c0b-47b9-841b-43436d38bf3a" xlink:to="loc_ifrs-full_FinancialLiabilitiesAtAmortisedCostCategoryMember_70ad439a-345a-448e-9843-624b103b67c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_95b00fc5-b640-4eac-877d-96bceec8ad30" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfFinancialInstrumentsLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_e75bbf3f-7a2e-46a7-9148-5b2f59b99a77" xlink:to="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_95b00fc5-b640-4eac-877d-96bceec8ad30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FinancialAssets_f0713dcd-7e87-4416-be22-2bc1dea50b86" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_FinancialAssets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_95b00fc5-b640-4eac-877d-96bceec8ad30" xlink:to="loc_ifrs-full_FinancialAssets_f0713dcd-7e87-4416-be22-2bc1dea50b86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FinancialAssetsAtFairValue_0bde9a63-ceab-400a-8103-dd75dbcf0e8c" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_FinancialAssetsAtFairValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_95b00fc5-b640-4eac-877d-96bceec8ad30" xlink:to="loc_ifrs-full_FinancialAssetsAtFairValue_0bde9a63-ceab-400a-8103-dd75dbcf0e8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_FinancialLiabilitiesTradePayablesAndOthers_593db11d-9f62-49eb-a37e-22e5ca1e66fe" xlink:href="inpha-20260630.xsd#inpha_FinancialLiabilitiesTradePayablesAndOthers"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_95b00fc5-b640-4eac-877d-96bceec8ad30" xlink:to="loc_inpha_FinancialLiabilitiesTradePayablesAndOthers_593db11d-9f62-49eb-a37e-22e5ca1e66fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_FinancialLiabilitiesTradePayablesAndOthersAtFairValue_900a63cc-5096-4600-a9b1-544c8c8009e2" xlink:href="inpha-20260630.xsd#inpha_FinancialLiabilitiesTradePayablesAndOthersAtFairValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_95b00fc5-b640-4eac-877d-96bceec8ad30" xlink:to="loc_inpha_FinancialLiabilitiesTradePayablesAndOthersAtFairValue_900a63cc-5096-4600-a9b1-544c8c8009e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.innate-pharma.com/role/RevenueandotherincomeDisclosureofrevenuefromcollaborationandlicensingagreementsDetails" xlink:type="simple" xlink:href="inpha-20260630.xsd#RevenueandotherincomeDisclosureofrevenuefromcollaborationandlicensingagreementsDetails"/>
  <link:presentationLink xlink:role="http://www.innate-pharma.com/role/RevenueandotherincomeDisclosureofrevenuefromcollaborationandlicensingagreementsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract_e69f7c32-1991-4ca7-b55f-b3318c6a0baa" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable_fee70675-56a1-46ab-9b85-3f504ff2eaec" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract_e69f7c32-1991-4ca7-b55f-b3318c6a0baa" xlink:to="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable_fee70675-56a1-46ab-9b85-3f504ff2eaec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfContractsAxis_e5eab6cf-9846-42ec-adbf-5b424fee7295" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TypesOfContractsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable_fee70675-56a1-46ab-9b85-3f504ff2eaec" xlink:to="loc_ifrs-full_TypesOfContractsAxis_e5eab6cf-9846-42ec-adbf-5b424fee7295" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfContractsDomain_2edc54e6-8911-48cd-81b3-124b0e90e146" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TypesOfContractsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfContractsAxis_e5eab6cf-9846-42ec-adbf-5b424fee7295" xlink:to="loc_ifrs-full_TypesOfContractsDomain_2edc54e6-8911-48cd-81b3-124b0e90e146" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_CollaborationAndLicensingAgreementsMember_b6065aa4-4225-4b84-82d0-948e53ef7b15" xlink:href="inpha-20260630.xsd#inpha_CollaborationAndLicensingAgreementsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfContractsDomain_2edc54e6-8911-48cd-81b3-124b0e90e146" xlink:to="loc_inpha_CollaborationAndLicensingAgreementsMember_b6065aa4-4225-4b84-82d0-948e53ef7b15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_MonalizumabAgreementMember_c7685f56-96cc-419d-b977-a23caa720dd2" xlink:href="inpha-20260630.xsd#inpha_MonalizumabAgreementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inpha_CollaborationAndLicensingAgreementsMember_b6065aa4-4225-4b84-82d0-948e53ef7b15" xlink:to="loc_inpha_MonalizumabAgreementMember_c7685f56-96cc-419d-b977-a23caa720dd2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_AgreementRelatedToIPH6101WithSanofiMember_23ab17d1-bc3c-4a55-ba81-5637da62a15d" xlink:href="inpha-20260630.xsd#inpha_AgreementRelatedToIPH6101WithSanofiMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inpha_CollaborationAndLicensingAgreementsMember_b6065aa4-4225-4b84-82d0-948e53ef7b15" xlink:to="loc_inpha_AgreementRelatedToIPH6101WithSanofiMember_23ab17d1-bc3c-4a55-ba81-5637da62a15d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_AgreementWithSanofi2022ANKETIPH62Member_f4c20949-7a31-4a26-8760-c7a7cd9f477d" xlink:href="inpha-20260630.xsd#inpha_AgreementWithSanofi2022ANKETIPH62Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inpha_CollaborationAndLicensingAgreementsMember_b6065aa4-4225-4b84-82d0-948e53ef7b15" xlink:to="loc_inpha_AgreementWithSanofi2022ANKETIPH62Member_f4c20949-7a31-4a26-8760-c7a7cd9f477d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_AgreementWithSanofi2022ANKETIPH67Member_fba7fd1a-0aa7-429d-8643-60b4c62aaebc" xlink:href="inpha-20260630.xsd#inpha_AgreementWithSanofi2022ANKETIPH67Member"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inpha_CollaborationAndLicensingAgreementsMember_b6065aa4-4225-4b84-82d0-948e53ef7b15" xlink:to="loc_inpha_AgreementWithSanofi2022ANKETIPH67Member_fba7fd1a-0aa7-429d-8643-60b4c62aaebc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_OtherAgreementsMember_4e26af0f-5de8-459a-b729-3f1ddde12de0" xlink:href="inpha-20260630.xsd#inpha_OtherAgreementsMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inpha_CollaborationAndLicensingAgreementsMember_b6065aa4-4225-4b84-82d0-948e53ef7b15" xlink:to="loc_inpha_OtherAgreementsMember_4e26af0f-5de8-459a-b729-3f1ddde12de0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_InvoicingResearchAndDevelopmentCostsIPH5201Member_9a238549-6553-494f-be9a-512df822e91c" xlink:href="inpha-20260630.xsd#inpha_InvoicingResearchAndDevelopmentCostsIPH5201Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfContractsDomain_2edc54e6-8911-48cd-81b3-124b0e90e146" xlink:to="loc_inpha_InvoicingResearchAndDevelopmentCostsIPH5201Member_9a238549-6553-494f-be9a-512df822e91c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_ea9c8f51-e62c-4471-b069-e7846d103e59" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable_fee70675-56a1-46ab-9b85-3f504ff2eaec" xlink:to="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_ea9c8f51-e62c-4471-b069-e7846d103e59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RevenueFromContractsWithCustomers_ce911046-eee4-4234-9add-a1a2f9e4e73d" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RevenueFromContractsWithCustomers"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_ea9c8f51-e62c-4471-b069-e7846d103e59" xlink:to="loc_ifrs-full_RevenueFromContractsWithCustomers_ce911046-eee4-4234-9add-a1a2f9e4e73d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.innate-pharma.com/role/RevenueandotherincomeAdditionalinformationDetails" xlink:type="simple" xlink:href="inpha-20260630.xsd#RevenueandotherincomeAdditionalinformationDetails"/>
  <link:presentationLink xlink:role="http://www.innate-pharma.com/role/RevenueandotherincomeAdditionalinformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract_e6204afb-0ff8-4591-b7a0-535e63e0658e" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable_b7323a06-3dae-4712-a46e-cfb4aa4f7328" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract_e6204afb-0ff8-4591-b7a0-535e63e0658e" xlink:to="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable_b7323a06-3dae-4712-a46e-cfb4aa4f7328" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfContractsAxis_733d520d-cac0-4d46-a9dc-62425c23ecdf" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TypesOfContractsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable_b7323a06-3dae-4712-a46e-cfb4aa4f7328" xlink:to="loc_ifrs-full_TypesOfContractsAxis_733d520d-cac0-4d46-a9dc-62425c23ecdf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfContractsDomain_98c382c5-def5-4bbf-a7b9-c2ec5517f6fd" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TypesOfContractsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfContractsAxis_733d520d-cac0-4d46-a9dc-62425c23ecdf" xlink:to="loc_ifrs-full_TypesOfContractsDomain_98c382c5-def5-4bbf-a7b9-c2ec5517f6fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_MonalizumabAgreementMember_b1ccafed-2214-498b-bfd1-8dd18f2aef0b" xlink:href="inpha-20260630.xsd#inpha_MonalizumabAgreementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfContractsDomain_98c382c5-def5-4bbf-a7b9-c2ec5517f6fd" xlink:to="loc_inpha_MonalizumabAgreementMember_b1ccafed-2214-498b-bfd1-8dd18f2aef0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_A2018AstraZenecaIPH5201AgreementMember_9f85eab4-0194-4cb1-9e2b-910ac46183b7" xlink:href="inpha-20260630.xsd#inpha_A2018AstraZenecaIPH5201AgreementMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfContractsDomain_98c382c5-def5-4bbf-a7b9-c2ec5517f6fd" xlink:to="loc_inpha_A2018AstraZenecaIPH5201AgreementMember_9f85eab4-0194-4cb1-9e2b-910ac46183b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_InvoicingResearchAndDevelopmentCostsIPH5201Member_482a128d-02a0-4000-ab33-71a80389c399" xlink:href="inpha-20260630.xsd#inpha_InvoicingResearchAndDevelopmentCostsIPH5201Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfContractsDomain_98c382c5-def5-4bbf-a7b9-c2ec5517f6fd" xlink:to="loc_inpha_InvoicingResearchAndDevelopmentCostsIPH5201Member_482a128d-02a0-4000-ab33-71a80389c399" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_AgreementRelatedToIPH6101WithSanofiMember_bd13b59a-1173-4e3c-926f-795c12ded866" xlink:href="inpha-20260630.xsd#inpha_AgreementRelatedToIPH6101WithSanofiMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfContractsDomain_98c382c5-def5-4bbf-a7b9-c2ec5517f6fd" xlink:to="loc_inpha_AgreementRelatedToIPH6101WithSanofiMember_bd13b59a-1173-4e3c-926f-795c12ded866" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_AgreementsWithGenzymeForNKCellEngagesMember_605cafa6-cd6d-47da-aa26-352000d0b94e" xlink:href="inpha-20260630.xsd#inpha_AgreementsWithGenzymeForNKCellEngagesMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfContractsDomain_98c382c5-def5-4bbf-a7b9-c2ec5517f6fd" xlink:to="loc_inpha_AgreementsWithGenzymeForNKCellEngagesMember_605cafa6-cd6d-47da-aa26-352000d0b94e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_AgreementsWithSanofiForNKCellEngagesMember_06c082e9-5c40-483b-90b8-b11cb273697e" xlink:href="inpha-20260630.xsd#inpha_AgreementsWithSanofiForNKCellEngagesMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfContractsDomain_98c382c5-def5-4bbf-a7b9-c2ec5517f6fd" xlink:to="loc_inpha_AgreementsWithSanofiForNKCellEngagesMember_06c082e9-5c40-483b-90b8-b11cb273697e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_43ee8e46-91b9-4493-b72c-5817e07b0a60" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable_b7323a06-3dae-4712-a46e-cfb4aa4f7328" xlink:to="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_43ee8e46-91b9-4493-b72c-5817e07b0a60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_IncreaseDecreaseInRevenueFromContractsWithCustomers_d67b1c82-80fa-4b9a-8f96-166b860e5dfd" xlink:href="inpha-20260630.xsd#inpha_IncreaseDecreaseInRevenueFromContractsWithCustomers"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_43ee8e46-91b9-4493-b72c-5817e07b0a60" xlink:to="loc_inpha_IncreaseDecreaseInRevenueFromContractsWithCustomers_d67b1c82-80fa-4b9a-8f96-166b860e5dfd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RevenueFromContractsWithCustomers_fcd38d2d-612c-4fa8-bd9e-dc9b7467a714" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RevenueFromContractsWithCustomers"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_43ee8e46-91b9-4493-b72c-5817e07b0a60" xlink:to="loc_ifrs-full_RevenueFromContractsWithCustomers_fcd38d2d-612c-4fa8-bd9e-dc9b7467a714" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_RevenueFromContractsWithCustomersMilestonePaymentReceived_c746967f-5a46-4024-8df9-b55c96d9885e" xlink:href="inpha-20260630.xsd#inpha_RevenueFromContractsWithCustomersMilestonePaymentReceived"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_43ee8e46-91b9-4493-b72c-5817e07b0a60" xlink:to="loc_inpha_RevenueFromContractsWithCustomersMilestonePaymentReceived_c746967f-5a46-4024-8df9-b55c96d9885e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_NumberOfTargetOptions_255a7fb3-9d1d-4184-8292-e02a5e25020e" xlink:href="inpha-20260630.xsd#inpha_NumberOfTargetOptions"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_43ee8e46-91b9-4493-b72c-5817e07b0a60" xlink:to="loc_inpha_NumberOfTargetOptions_255a7fb3-9d1d-4184-8292-e02a5e25020e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_RevenueFromContractsWithCustomersAdvancePaymentReceived_09a0d504-b4b5-431b-984a-1f35dc49860d" xlink:href="inpha-20260630.xsd#inpha_RevenueFromContractsWithCustomersAdvancePaymentReceived"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_43ee8e46-91b9-4493-b72c-5817e07b0a60" xlink:to="loc_inpha_RevenueFromContractsWithCustomersAdvancePaymentReceived_09a0d504-b4b5-431b-984a-1f35dc49860d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_RevenueFromContractsWithCustomersAdvancePaymentReceivedLicenses_964e2b1d-7858-4bf1-8d3d-195b9f735a53" xlink:href="inpha-20260630.xsd#inpha_RevenueFromContractsWithCustomersAdvancePaymentReceivedLicenses"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_43ee8e46-91b9-4493-b72c-5817e07b0a60" xlink:to="loc_inpha_RevenueFromContractsWithCustomersAdvancePaymentReceivedLicenses_964e2b1d-7858-4bf1-8d3d-195b9f735a53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_RevenueFromContractsWithCustomersAdvancePaymentReceivedResearch_97880e06-481e-4182-b740-76283f22df5a" xlink:href="inpha-20260630.xsd#inpha_RevenueFromContractsWithCustomersAdvancePaymentReceivedResearch"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_43ee8e46-91b9-4493-b72c-5817e07b0a60" xlink:to="loc_inpha_RevenueFromContractsWithCustomersAdvancePaymentReceivedResearch_97880e06-481e-4182-b740-76283f22df5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_ResearchActivitiesPerformancePeriod_019ff177-5078-749b-a3a7-dbd5192f7c1a" xlink:href="inpha-20260630.xsd#inpha_ResearchActivitiesPerformancePeriod"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_43ee8e46-91b9-4493-b72c-5817e07b0a60" xlink:to="loc_inpha_ResearchActivitiesPerformancePeriod_019ff177-5078-749b-a3a7-dbd5192f7c1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_RevenueFromContractsWithCustomersAdvancePaymentReceivedTargetOptions_73d2d331-93aa-45c9-ac75-bb0059e91f7c" xlink:href="inpha-20260630.xsd#inpha_RevenueFromContractsWithCustomersAdvancePaymentReceivedTargetOptions"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_43ee8e46-91b9-4493-b72c-5817e07b0a60" xlink:to="loc_inpha_RevenueFromContractsWithCustomersAdvancePaymentReceivedTargetOptions_73d2d331-93aa-45c9-ac75-bb0059e91f7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_NumberOfExclusiveOptionsGranted_38816756-43c0-45e4-b5f5-7ce0b0000fef" xlink:href="inpha-20260630.xsd#inpha_NumberOfExclusiveOptionsGranted"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_43ee8e46-91b9-4493-b72c-5817e07b0a60" xlink:to="loc_inpha_NumberOfExclusiveOptionsGranted_38816756-43c0-45e4-b5f5-7ce0b0000fef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_RevenueFromContractsWithCustomersMilestonePaymentReceivedOptionExercised_817f01a9-95b7-4ea8-80ca-ae3a1b8d668f" xlink:href="inpha-20260630.xsd#inpha_RevenueFromContractsWithCustomersMilestonePaymentReceivedOptionExercised"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_43ee8e46-91b9-4493-b72c-5817e07b0a60" xlink:to="loc_inpha_RevenueFromContractsWithCustomersMilestonePaymentReceivedOptionExercised_817f01a9-95b7-4ea8-80ca-ae3a1b8d668f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.innate-pharma.com/role/RevenueandotherincomeDisclosureofchangeindeferredrevenueandcollaborationliabilitiesDetails" xlink:type="simple" xlink:href="inpha-20260630.xsd#RevenueandotherincomeDisclosureofchangeindeferredrevenueandcollaborationliabilitiesDetails"/>
  <link:presentationLink xlink:role="http://www.innate-pharma.com/role/RevenueandotherincomeDisclosureofchangeindeferredrevenueandcollaborationliabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract_7f3fe7ae-9147-4444-965a-65c1b62d0788" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable_beacea4b-6517-4496-a32c-1f0a3c3d341e" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract_7f3fe7ae-9147-4444-965a-65c1b62d0788" xlink:to="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable_beacea4b-6517-4496-a32c-1f0a3c3d341e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfLiabilitiesAxis_085a45a1-f4d4-49d7-8d33-c398b56c6a82" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfLiabilitiesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable_beacea4b-6517-4496-a32c-1f0a3c3d341e" xlink:to="loc_ifrs-full_ClassesOfLiabilitiesAxis_085a45a1-f4d4-49d7-8d33-c398b56c6a82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfLiabilitiesDomain_af023b2a-64d9-4207-a5aa-dcc58a08c1cc" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfLiabilitiesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfLiabilitiesAxis_085a45a1-f4d4-49d7-8d33-c398b56c6a82" xlink:to="loc_ifrs-full_ClassesOfLiabilitiesDomain_af023b2a-64d9-4207-a5aa-dcc58a08c1cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_DeferredRevenueMember_c4c5bf97-4f03-4f88-b154-5da9a8f115a3" xlink:href="inpha-20260630.xsd#inpha_DeferredRevenueMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfLiabilitiesDomain_af023b2a-64d9-4207-a5aa-dcc58a08c1cc" xlink:to="loc_inpha_DeferredRevenueMember_c4c5bf97-4f03-4f88-b154-5da9a8f115a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_CollaborationLiabilitiesMember_be1aa3ad-171f-4ac6-a9a0-087197f1f903" xlink:href="inpha-20260630.xsd#inpha_CollaborationLiabilitiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfLiabilitiesDomain_af023b2a-64d9-4207-a5aa-dcc58a08c1cc" xlink:to="loc_inpha_CollaborationLiabilitiesMember_be1aa3ad-171f-4ac6-a9a0-087197f1f903" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfContractsAxis_47582791-17c9-4b8f-86a6-05b6f8c95959" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TypesOfContractsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable_beacea4b-6517-4496-a32c-1f0a3c3d341e" xlink:to="loc_ifrs-full_TypesOfContractsAxis_47582791-17c9-4b8f-86a6-05b6f8c95959" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfContractsDomain_cc31680c-31b0-4360-ad9f-54cd7bb711a8" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TypesOfContractsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfContractsAxis_47582791-17c9-4b8f-86a6-05b6f8c95959" xlink:to="loc_ifrs-full_TypesOfContractsDomain_cc31680c-31b0-4360-ad9f-54cd7bb711a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_A2015AstraZenecaMonalizumabAgreementsMember_3cac2dbe-bca3-4aac-b2c3-b868840ce07d" xlink:href="inpha-20260630.xsd#inpha_A2015AstraZenecaMonalizumabAgreementsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfContractsDomain_cc31680c-31b0-4360-ad9f-54cd7bb711a8" xlink:to="loc_inpha_A2015AstraZenecaMonalizumabAgreementsMember_3cac2dbe-bca3-4aac-b2c3-b868840ce07d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_SanofiResearchCollaborationAndLicensingAgreementMember_019ff67a-d349-7d03-8991-c069091a1607" xlink:href="inpha-20260630.xsd#inpha_SanofiResearchCollaborationAndLicensingAgreementMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfContractsDomain_cc31680c-31b0-4360-ad9f-54cd7bb711a8" xlink:to="loc_inpha_SanofiResearchCollaborationAndLicensingAgreementMember_019ff67a-d349-7d03-8991-c069091a1607" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_714c1421-1040-48ed-8652-d79f810e393e" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable_beacea4b-6517-4496-a32c-1f0a3c3d341e" xlink:to="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_714c1421-1040-48ed-8652-d79f810e393e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_DeferredRevenueAndCollaborationLiabilitiesRollForward_945b620b-ca38-47c9-9c1e-d53b499b4061" xlink:href="inpha-20260630.xsd#inpha_DeferredRevenueAndCollaborationLiabilitiesRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_714c1421-1040-48ed-8652-d79f810e393e" xlink:to="loc_inpha_DeferredRevenueAndCollaborationLiabilitiesRollForward_945b620b-ca38-47c9-9c1e-d53b499b4061" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CurrentContractLiabilitiesAbstract_67039204-ac51-468d-a65c-47e9f6346298" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentContractLiabilitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inpha_DeferredRevenueAndCollaborationLiabilitiesRollForward_945b620b-ca38-47c9-9c1e-d53b499b4061" xlink:to="loc_ifrs-full_CurrentContractLiabilitiesAbstract_67039204-ac51-468d-a65c-47e9f6346298" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CurrentContractLiabilities_6c1683ce-69ee-4414-a078-3a95a1c62a5c" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentContractLiabilities"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CurrentContractLiabilitiesAbstract_67039204-ac51-468d-a65c-47e9f6346298" xlink:to="loc_ifrs-full_CurrentContractLiabilities_6c1683ce-69ee-4414-a078-3a95a1c62a5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_DecreaseThroughPerformanceObligationBeingSatisfiedCurrentContractLiabilities_78e956a1-9b55-41b3-86c5-8f32c3a6e3de" xlink:href="inpha-20260630.xsd#inpha_DecreaseThroughPerformanceObligationBeingSatisfiedCurrentContractLiabilities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CurrentContractLiabilitiesAbstract_67039204-ac51-468d-a65c-47e9f6346298" xlink:to="loc_inpha_DecreaseThroughPerformanceObligationBeingSatisfiedCurrentContractLiabilities_78e956a1-9b55-41b3-86c5-8f32c3a6e3de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_TransferFromToCollaborationCurrentLiabilities_60baa025-9e25-4069-9950-e783ef19ba14" xlink:href="inpha-20260630.xsd#inpha_TransferFromToCollaborationCurrentLiabilities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CurrentContractLiabilitiesAbstract_67039204-ac51-468d-a65c-47e9f6346298" xlink:to="loc_inpha_TransferFromToCollaborationCurrentLiabilities_60baa025-9e25-4069-9950-e783ef19ba14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_IncreaseThroughPerformanceObligationBeingSatisfiedCurrentContractLiabilities_6db5b9cf-e9b3-4199-a671-2e35756e8af0" xlink:href="inpha-20260630.xsd#inpha_IncreaseThroughPerformanceObligationBeingSatisfiedCurrentContractLiabilities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CurrentContractLiabilitiesAbstract_67039204-ac51-468d-a65c-47e9f6346298" xlink:to="loc_inpha_IncreaseThroughPerformanceObligationBeingSatisfiedCurrentContractLiabilities_6db5b9cf-e9b3-4199-a671-2e35756e8af0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_DecreaseThroughRepaymentsCurrentContractLiabilities_5003c643-67d7-4f98-b98c-20bee3686ff8" xlink:href="inpha-20260630.xsd#inpha_DecreaseThroughRepaymentsCurrentContractLiabilities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CurrentContractLiabilitiesAbstract_67039204-ac51-468d-a65c-47e9f6346298" xlink:to="loc_inpha_DecreaseThroughRepaymentsCurrentContractLiabilities_5003c643-67d7-4f98-b98c-20bee3686ff8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_ForeignExchangeGainLossCurrentContractLiabilities_6003d7d1-12c9-4e41-926a-9e1b343d9187" xlink:href="inpha-20260630.xsd#inpha_ForeignExchangeGainLossCurrentContractLiabilities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CurrentContractLiabilitiesAbstract_67039204-ac51-468d-a65c-47e9f6346298" xlink:to="loc_inpha_ForeignExchangeGainLossCurrentContractLiabilities_6003d7d1-12c9-4e41-926a-9e1b343d9187" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_ReclassificationCurrentContractLiabilities_01a07bd0-ab96-74b6-b9ca-bd2bc616e172" xlink:href="inpha-20260630.xsd#inpha_ReclassificationCurrentContractLiabilities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CurrentContractLiabilitiesAbstract_67039204-ac51-468d-a65c-47e9f6346298" xlink:to="loc_inpha_ReclassificationCurrentContractLiabilities_01a07bd0-ab96-74b6-b9ca-bd2bc616e172" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CurrentContractLiabilities_18a71f51-3224-4db0-b764-abe2b2976a51" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentContractLiabilities"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CurrentContractLiabilitiesAbstract_67039204-ac51-468d-a65c-47e9f6346298" xlink:to="loc_ifrs-full_CurrentContractLiabilities_18a71f51-3224-4db0-b764-abe2b2976a51" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NoncurrentContractLiabilitiesAbstract_3ef7427d-f79f-4a58-ab5a-15a87826fab9" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NoncurrentContractLiabilitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inpha_DeferredRevenueAndCollaborationLiabilitiesRollForward_945b620b-ca38-47c9-9c1e-d53b499b4061" xlink:to="loc_ifrs-full_NoncurrentContractLiabilitiesAbstract_3ef7427d-f79f-4a58-ab5a-15a87826fab9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NoncurrentContractLiabilities_9a10df6a-f65e-408e-99b1-82eb976567bb" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NoncurrentContractLiabilities"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_NoncurrentContractLiabilitiesAbstract_3ef7427d-f79f-4a58-ab5a-15a87826fab9" xlink:to="loc_ifrs-full_NoncurrentContractLiabilities_9a10df6a-f65e-408e-99b1-82eb976567bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_DecreaseThroughPerformanceObligationBeingSatisfiedNonCurrentContractLiabilities_7e033363-3d56-427d-9cc6-6d038a0af994" xlink:href="inpha-20260630.xsd#inpha_DecreaseThroughPerformanceObligationBeingSatisfiedNonCurrentContractLiabilities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_NoncurrentContractLiabilitiesAbstract_3ef7427d-f79f-4a58-ab5a-15a87826fab9" xlink:to="loc_inpha_DecreaseThroughPerformanceObligationBeingSatisfiedNonCurrentContractLiabilities_7e033363-3d56-427d-9cc6-6d038a0af994" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_TransferToFromCollaborationNonCurrentLiabilities_061d4a56-4277-43b5-a8e4-580652d32dcb" xlink:href="inpha-20260630.xsd#inpha_TransferToFromCollaborationNonCurrentLiabilities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_NoncurrentContractLiabilitiesAbstract_3ef7427d-f79f-4a58-ab5a-15a87826fab9" xlink:to="loc_inpha_TransferToFromCollaborationNonCurrentLiabilities_061d4a56-4277-43b5-a8e4-580652d32dcb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_IncreaseThroughPerformanceObligationBeingSatisfiedNonCurrentContractLiabilities_4b44c554-eff8-4b5a-bc24-418e7af3c745" xlink:href="inpha-20260630.xsd#inpha_IncreaseThroughPerformanceObligationBeingSatisfiedNonCurrentContractLiabilities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_NoncurrentContractLiabilitiesAbstract_3ef7427d-f79f-4a58-ab5a-15a87826fab9" xlink:to="loc_inpha_IncreaseThroughPerformanceObligationBeingSatisfiedNonCurrentContractLiabilities_4b44c554-eff8-4b5a-bc24-418e7af3c745" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_DecreaseThroughRepaymentsNonCurrentContractLiabilities_09977123-d90d-4af4-bee6-8971e8724750" xlink:href="inpha-20260630.xsd#inpha_DecreaseThroughRepaymentsNonCurrentContractLiabilities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_NoncurrentContractLiabilitiesAbstract_3ef7427d-f79f-4a58-ab5a-15a87826fab9" xlink:to="loc_inpha_DecreaseThroughRepaymentsNonCurrentContractLiabilities_09977123-d90d-4af4-bee6-8971e8724750" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_ForeignExchangeGainLossNonCurrentContractLiabilities_3f3dd496-2c87-456e-b7cc-9351a64f9139" xlink:href="inpha-20260630.xsd#inpha_ForeignExchangeGainLossNonCurrentContractLiabilities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_NoncurrentContractLiabilitiesAbstract_3ef7427d-f79f-4a58-ab5a-15a87826fab9" xlink:to="loc_inpha_ForeignExchangeGainLossNonCurrentContractLiabilities_3f3dd496-2c87-456e-b7cc-9351a64f9139" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_ReclassificationNonCurrentContractLiabilities_01a07bd1-037a-7ff4-abfe-4cf571b5d295" xlink:href="inpha-20260630.xsd#inpha_ReclassificationNonCurrentContractLiabilities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_NoncurrentContractLiabilitiesAbstract_3ef7427d-f79f-4a58-ab5a-15a87826fab9" xlink:to="loc_inpha_ReclassificationNonCurrentContractLiabilities_01a07bd1-037a-7ff4-abfe-4cf571b5d295" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NoncurrentContractLiabilities_84beed97-f4e9-44df-a794-0936202ada12" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NoncurrentContractLiabilities"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_NoncurrentContractLiabilitiesAbstract_3ef7427d-f79f-4a58-ab5a-15a87826fab9" xlink:to="loc_ifrs-full_NoncurrentContractLiabilities_84beed97-f4e9-44df-a794-0936202ada12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ContractLiabilitiesAbstract_88f20708-a41b-46a2-a79f-86e5879bb539" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ContractLiabilitiesAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inpha_DeferredRevenueAndCollaborationLiabilitiesRollForward_945b620b-ca38-47c9-9c1e-d53b499b4061" xlink:to="loc_ifrs-full_ContractLiabilitiesAbstract_88f20708-a41b-46a2-a79f-86e5879bb539" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ContractLiabilities_16934146-bcef-4610-98fc-c8f0ffec7e36" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ContractLiabilities"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ContractLiabilitiesAbstract_88f20708-a41b-46a2-a79f-86e5879bb539" xlink:to="loc_ifrs-full_ContractLiabilities_16934146-bcef-4610-98fc-c8f0ffec7e36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DecreaseThroughPerformanceObligationBeingSatisfiedContractLiabilities_a5d5225e-d800-4c6a-a30c-c01053d46a38" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DecreaseThroughPerformanceObligationBeingSatisfiedContractLiabilities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ContractLiabilitiesAbstract_88f20708-a41b-46a2-a79f-86e5879bb539" xlink:to="loc_ifrs-full_DecreaseThroughPerformanceObligationBeingSatisfiedContractLiabilities_a5d5225e-d800-4c6a-a30c-c01053d46a38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_TransferToFromCollaborationLiabilities_95cb5c40-2ef3-4b47-9831-92225eec3254" xlink:href="inpha-20260630.xsd#inpha_TransferToFromCollaborationLiabilities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ContractLiabilitiesAbstract_88f20708-a41b-46a2-a79f-86e5879bb539" xlink:to="loc_inpha_TransferToFromCollaborationLiabilities_95cb5c40-2ef3-4b47-9831-92225eec3254" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_IncreaseThroughPerformanceObligationBeingSatisfiedContractLiabilities_7dd3b86a-0296-413c-b94b-fdf79d7b9445" xlink:href="inpha-20260630.xsd#inpha_IncreaseThroughPerformanceObligationBeingSatisfiedContractLiabilities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ContractLiabilitiesAbstract_88f20708-a41b-46a2-a79f-86e5879bb539" xlink:to="loc_inpha_IncreaseThroughPerformanceObligationBeingSatisfiedContractLiabilities_7dd3b86a-0296-413c-b94b-fdf79d7b9445" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_DecreaseThroughRepaymentsContractLiabilities_41f09795-d918-4236-a34c-8096e364f46d" xlink:href="inpha-20260630.xsd#inpha_DecreaseThroughRepaymentsContractLiabilities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ContractLiabilitiesAbstract_88f20708-a41b-46a2-a79f-86e5879bb539" xlink:to="loc_inpha_DecreaseThroughRepaymentsContractLiabilities_41f09795-d918-4236-a34c-8096e364f46d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_ForeignExchangeGainLossContractLiabilities_41622441-bf22-4d21-a0ab-35e2fd7166c8" xlink:href="inpha-20260630.xsd#inpha_ForeignExchangeGainLossContractLiabilities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ContractLiabilitiesAbstract_88f20708-a41b-46a2-a79f-86e5879bb539" xlink:to="loc_inpha_ForeignExchangeGainLossContractLiabilities_41622441-bf22-4d21-a0ab-35e2fd7166c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_ReclassificationContractLiabilities_01a07bd1-5060-780d-9853-a2bb31a86461" xlink:href="inpha-20260630.xsd#inpha_ReclassificationContractLiabilities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ContractLiabilitiesAbstract_88f20708-a41b-46a2-a79f-86e5879bb539" xlink:to="loc_inpha_ReclassificationContractLiabilities_01a07bd1-5060-780d-9853-a2bb31a86461" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ContractLiabilities_538e454a-4184-48d6-8ca4-b3380a47e5b7" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ContractLiabilities"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ContractLiabilitiesAbstract_88f20708-a41b-46a2-a79f-86e5879bb539" xlink:to="loc_ifrs-full_ContractLiabilities_538e454a-4184-48d6-8ca4-b3380a47e5b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.innate-pharma.com/role/RevenueandotherincomeDisclosureofvarianceofdeferredrevenueDetails" xlink:type="simple" xlink:href="inpha-20260630.xsd#RevenueandotherincomeDisclosureofvarianceofdeferredrevenueDetails"/>
  <link:presentationLink xlink:role="http://www.innate-pharma.com/role/RevenueandotherincomeDisclosureofvarianceofdeferredrevenueDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract_f3f0e8a3-f5b6-4afe-b137-e3a70b71c6f2" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable_78abe7dc-2ed9-42b3-9f55-66259b86096a" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract_f3f0e8a3-f5b6-4afe-b137-e3a70b71c6f2" xlink:to="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable_78abe7dc-2ed9-42b3-9f55-66259b86096a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfLiabilitiesAxis_e3ca74b6-e0cb-499c-adbb-9b9a210a88f9" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfLiabilitiesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable_78abe7dc-2ed9-42b3-9f55-66259b86096a" xlink:to="loc_ifrs-full_ClassesOfLiabilitiesAxis_e3ca74b6-e0cb-499c-adbb-9b9a210a88f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfLiabilitiesDomain_52b533ad-44da-4f4d-aff0-194e5b9d8916" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfLiabilitiesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfLiabilitiesAxis_e3ca74b6-e0cb-499c-adbb-9b9a210a88f9" xlink:to="loc_ifrs-full_ClassesOfLiabilitiesDomain_52b533ad-44da-4f4d-aff0-194e5b9d8916" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_DeferredRevenueMember_d3594a63-6427-4172-a83b-d96d4313692c" xlink:href="inpha-20260630.xsd#inpha_DeferredRevenueMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfLiabilitiesDomain_52b533ad-44da-4f4d-aff0-194e5b9d8916" xlink:to="loc_inpha_DeferredRevenueMember_d3594a63-6427-4172-a83b-d96d4313692c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProductsAndServicesAxis_518e2d0e-cd69-4ed3-abbe-52607f366c81" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProductsAndServicesAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable_78abe7dc-2ed9-42b3-9f55-66259b86096a" xlink:to="loc_ifrs-full_ProductsAndServicesAxis_518e2d0e-cd69-4ed3-abbe-52607f366c81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProductsAndServicesDomain_723c3af4-3530-4053-9b6d-7c0e45ec2cfc" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ProductsAndServicesAxis_518e2d0e-cd69-4ed3-abbe-52607f366c81" xlink:to="loc_ifrs-full_ProductsAndServicesDomain_723c3af4-3530-4053-9b6d-7c0e45ec2cfc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_MonalizumabMember_4b7d1d76-3c16-41a0-9036-1f9a600407fb" xlink:href="inpha-20260630.xsd#inpha_MonalizumabMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ProductsAndServicesDomain_723c3af4-3530-4053-9b6d-7c0e45ec2cfc" xlink:to="loc_inpha_MonalizumabMember_4b7d1d76-3c16-41a0-9036-1f9a600407fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_SanofiOptionsMember_9c06c55e-8cb5-403b-9d23-8d994bd597e3" xlink:href="inpha-20260630.xsd#inpha_SanofiOptionsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ProductsAndServicesDomain_723c3af4-3530-4053-9b6d-7c0e45ec2cfc" xlink:to="loc_inpha_SanofiOptionsMember_9c06c55e-8cb5-403b-9d23-8d994bd597e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_SanofiServicesMember_f16c0e77-44f9-4eea-a45f-982a5f8ed991" xlink:href="inpha-20260630.xsd#inpha_SanofiServicesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ProductsAndServicesDomain_723c3af4-3530-4053-9b6d-7c0e45ec2cfc" xlink:to="loc_inpha_SanofiServicesMember_f16c0e77-44f9-4eea-a45f-982a5f8ed991" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_4e8ace4a-bb2a-4f90-b90a-46de42a53c57" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable_78abe7dc-2ed9-42b3-9f55-66259b86096a" xlink:to="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_4e8ace4a-bb2a-4f90-b90a-46de42a53c57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ContractLiabilities_9c424bcd-965b-4f4a-b7fe-b53273b9216c" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ContractLiabilities"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_4e8ace4a-bb2a-4f90-b90a-46de42a53c57" xlink:to="loc_ifrs-full_ContractLiabilities_9c424bcd-965b-4f4a-b7fe-b53273b9216c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DecreaseThroughPerformanceObligationBeingSatisfiedContractLiabilities_023c78ae-cfbe-49e0-a870-73992022282a" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DecreaseThroughPerformanceObligationBeingSatisfiedContractLiabilities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_4e8ace4a-bb2a-4f90-b90a-46de42a53c57" xlink:to="loc_ifrs-full_DecreaseThroughPerformanceObligationBeingSatisfiedContractLiabilities_023c78ae-cfbe-49e0-a870-73992022282a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_IncreaseThroughUpfrontPaymentContractLiabilities_944ddbe4-c1f9-4fbc-a207-dfc44c05b38f" xlink:href="inpha-20260630.xsd#inpha_IncreaseThroughUpfrontPaymentContractLiabilities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_4e8ace4a-bb2a-4f90-b90a-46de42a53c57" xlink:to="loc_inpha_IncreaseThroughUpfrontPaymentContractLiabilities_944ddbe4-c1f9-4fbc-a207-dfc44c05b38f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_TransferFromToCollaborationLiabilities_903c9cac-332a-4cff-b247-04f37e3d3083" xlink:href="inpha-20260630.xsd#inpha_TransferFromToCollaborationLiabilities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_4e8ace4a-bb2a-4f90-b90a-46de42a53c57" xlink:to="loc_inpha_TransferFromToCollaborationLiabilities_903c9cac-332a-4cff-b247-04f37e3d3083" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ContractLiabilities_12c67e4b-24ff-4101-be55-41ac9bc52201" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ContractLiabilities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_4e8ace4a-bb2a-4f90-b90a-46de42a53c57" xlink:to="loc_ifrs-full_ContractLiabilities_12c67e4b-24ff-4101-be55-41ac9bc52201" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.innate-pharma.com/role/RevenueandotherincomeDisclosureofgovernmentfinancingforresearchexpendituresDetails" xlink:type="simple" xlink:href="inpha-20260630.xsd#RevenueandotherincomeDisclosureofgovernmentfinancingforresearchexpendituresDetails"/>
  <link:presentationLink xlink:role="http://www.innate-pharma.com/role/RevenueandotherincomeDisclosureofgovernmentfinancingforresearchexpendituresDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract_81838d56-a14b-481c-b0f7-b8a1cd1139a5" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_IncomeFromResearchTaxCredit_5a832477-b328-4080-9c48-c62654e1f601" xlink:href="inpha-20260630.xsd#inpha_IncomeFromResearchTaxCredit"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract_81838d56-a14b-481c-b0f7-b8a1cd1139a5" xlink:to="loc_inpha_IncomeFromResearchTaxCredit_5a832477-b328-4080-9c48-c62654e1f601" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RevenueFromGovernmentGrants_84190bc5-5942-4369-b8cc-90acacaf7519" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RevenueFromGovernmentGrants"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract_81838d56-a14b-481c-b0f7-b8a1cd1139a5" xlink:to="loc_ifrs-full_RevenueFromGovernmentGrants_84190bc5-5942-4369-b8cc-90acacaf7519" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_GovernmentFinancingForResearchExpenditures_3f37b6a5-d123-4a51-8111-e207c5892682" xlink:href="inpha-20260630.xsd#inpha_GovernmentFinancingForResearchExpenditures"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract_81838d56-a14b-481c-b0f7-b8a1cd1139a5" xlink:to="loc_inpha_GovernmentFinancingForResearchExpenditures_3f37b6a5-d123-4a51-8111-e207c5892682" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.innate-pharma.com/role/OperatingexpensesDisclosureofexpensesbynatureDetails" xlink:type="simple" xlink:href="inpha-20260630.xsd#OperatingexpensesDisclosureofexpensesbynatureDetails"/>
  <link:presentationLink xlink:role="http://www.innate-pharma.com/role/OperatingexpensesDisclosureofexpensesbynatureDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AnalysisOfIncomeAndExpenseAbstract_20e320eb-eb76-442b-b7e2-b31ff4fdaf9b" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AnalysisOfIncomeAndExpenseAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfOperatingSegmentsTable_6c290e39-05ec-4262-b649-349ec29d390b" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfOperatingSegmentsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AnalysisOfIncomeAndExpenseAbstract_20e320eb-eb76-442b-b7e2-b31ff4fdaf9b" xlink:to="loc_ifrs-full_DisclosureOfOperatingSegmentsTable_6c290e39-05ec-4262-b649-349ec29d390b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis_44f4222c-420a-47aa-a795-22192195e058" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsTable_6c290e39-05ec-4262-b649-349ec29d390b" xlink:to="loc_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis_44f4222c-420a-47aa-a795-22192195e058" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionDomain_4770ab43-ccd2-4d68-b3fa-4fe1f8524eeb" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AttributionOfExpensesByNatureToTheirFunctionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis_44f4222c-420a-47aa-a795-22192195e058" xlink:to="loc_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionDomain_4770ab43-ccd2-4d68-b3fa-4fe1f8524eeb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_ResearchAndDevelopmentMember_c42e991e-981a-4269-bd79-b82a07ec2da4" xlink:href="inpha-20260630.xsd#inpha_ResearchAndDevelopmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionDomain_4770ab43-ccd2-4d68-b3fa-4fe1f8524eeb" xlink:to="loc_inpha_ResearchAndDevelopmentMember_c42e991e-981a-4269-bd79-b82a07ec2da4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SellingGeneralAndAdministrativeExpenseMember_9e3c4033-1f9b-4a42-8cd6-c59cc324f7af" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_SellingGeneralAndAdministrativeExpenseMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionDomain_4770ab43-ccd2-4d68-b3fa-4fe1f8524eeb" xlink:to="loc_ifrs-full_SellingGeneralAndAdministrativeExpenseMember_9e3c4033-1f9b-4a42-8cd6-c59cc324f7af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfOperatingSegmentsLineItems_4aa095d4-2ab3-4cd1-ac75-c9fc7cfd3e32" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfOperatingSegmentsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsTable_6c290e39-05ec-4262-b649-349ec29d390b" xlink:to="loc_ifrs-full_DisclosureOfOperatingSegmentsLineItems_4aa095d4-2ab3-4cd1-ac75-c9fc7cfd3e32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_SubcontractingCosts_97810b50-b915-4e96-83b1-7d8e8d9b5a5d" xlink:href="inpha-20260630.xsd#inpha_SubcontractingCosts"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsLineItems_4aa095d4-2ab3-4cd1-ac75-c9fc7cfd3e32" xlink:to="loc_inpha_SubcontractingCosts_97810b50-b915-4e96-83b1-7d8e8d9b5a5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RawMaterialsAndConsumablesUsed_8deac205-e88d-4906-a22c-48b14bba9585" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RawMaterialsAndConsumablesUsed"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsLineItems_4aa095d4-2ab3-4cd1-ac75-c9fc7cfd3e32" xlink:to="loc_ifrs-full_RawMaterialsAndConsumablesUsed_8deac205-e88d-4906-a22c-48b14bba9585" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ShorttermEmployeeBenefitsExpense_5c222e90-d980-4a53-bcf2-4002c7e3c31e" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ShorttermEmployeeBenefitsExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsLineItems_4aa095d4-2ab3-4cd1-ac75-c9fc7cfd3e32" xlink:to="loc_ifrs-full_ShorttermEmployeeBenefitsExpense_5c222e90-d980-4a53-bcf2-4002c7e3c31e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees_4cc960c7-67e9-4f9f-b444-7c6a3b47c3b3" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsLineItems_4aa095d4-2ab3-4cd1-ac75-c9fc7cfd3e32" xlink:to="loc_ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees_4cc960c7-67e9-4f9f-b444-7c6a3b47c3b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EmployeeBenefitsExpense_da64b50f-0db1-45e9-9336-90787538e5a9" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_EmployeeBenefitsExpense"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsLineItems_4aa095d4-2ab3-4cd1-ac75-c9fc7cfd3e32" xlink:to="loc_ifrs-full_EmployeeBenefitsExpense_da64b50f-0db1-45e9-9336-90787538e5a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_NonScientificAdvisoryAndConsulting_df904440-a356-4494-b035-5a430aaf4c72" xlink:href="inpha-20260630.xsd#inpha_NonScientificAdvisoryAndConsulting"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsLineItems_4aa095d4-2ab3-4cd1-ac75-c9fc7cfd3e32" xlink:to="loc_inpha_NonScientificAdvisoryAndConsulting_df904440-a356-4494-b035-5a430aaf4c72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_LeasingAndMaintenance_7c670599-97b6-4c2c-a4ec-19321a760ff2" xlink:href="inpha-20260630.xsd#inpha_LeasingAndMaintenance"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsLineItems_4aa095d4-2ab3-4cd1-ac75-c9fc7cfd3e32" xlink:to="loc_inpha_LeasingAndMaintenance_7c670599-97b6-4c2c-a4ec-19321a760ff2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TravelExpense_ada57a7a-8b88-4124-9df4-2fd7c7bf3f46" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TravelExpense"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsLineItems_4aa095d4-2ab3-4cd1-ac75-c9fc7cfd3e32" xlink:to="loc_ifrs-full_TravelExpense_ada57a7a-8b88-4124-9df4-2fd7c7bf3f46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SalesAndMarketingExpense_2f3f53c5-2880-403d-8c07-04131e38e8c6" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_SalesAndMarketingExpense"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsLineItems_4aa095d4-2ab3-4cd1-ac75-c9fc7cfd3e32" xlink:to="loc_ifrs-full_SalesAndMarketingExpense_2f3f53c5-2880-403d-8c07-04131e38e8c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_ScientificAdvisoryAndConsulting_44818f23-23d4-4e9a-937e-31a03caa97e5" xlink:href="inpha-20260630.xsd#inpha_ScientificAdvisoryAndConsulting"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsLineItems_4aa095d4-2ab3-4cd1-ac75-c9fc7cfd3e32" xlink:to="loc_inpha_ScientificAdvisoryAndConsulting_44818f23-23d4-4e9a-937e-31a03caa97e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_OtherPurchasesAndExternalExpenses_8e5c4f1f-6fbc-45ab-a37e-665a14729970" xlink:href="inpha-20260630.xsd#inpha_OtherPurchasesAndExternalExpenses"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsLineItems_4aa095d4-2ab3-4cd1-ac75-c9fc7cfd3e32" xlink:to="loc_inpha_OtherPurchasesAndExternalExpenses_8e5c4f1f-6fbc-45ab-a37e-665a14729970" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DepreciationAndAmortisationExpense_b30b16d8-486e-495e-ab9b-98d55b76e3c8" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DepreciationAndAmortisationExpense"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsLineItems_4aa095d4-2ab3-4cd1-ac75-c9fc7cfd3e32" xlink:to="loc_ifrs-full_DepreciationAndAmortisationExpense_b30b16d8-486e-495e-ab9b-98d55b76e3c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_IntellectualPropertyExpenses_fa3f639f-a5f2-42a6-800a-455e9a2e3ad5" xlink:href="inpha-20260630.xsd#inpha_IntellectualPropertyExpenses"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsLineItems_4aa095d4-2ab3-4cd1-ac75-c9fc7cfd3e32" xlink:to="loc_inpha_IntellectualPropertyExpenses_fa3f639f-a5f2-42a6-800a-455e9a2e3ad5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherOperatingIncomeExpense_2be403d2-a636-42fc-8e46-6f1326137b9d" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherOperatingIncomeExpense"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsLineItems_4aa095d4-2ab3-4cd1-ac75-c9fc7cfd3e32" xlink:to="loc_ifrs-full_OtherOperatingIncomeExpense_2be403d2-a636-42fc-8e46-6f1326137b9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OperatingExpense_f304511a-c52c-4454-9ef0-90cd8ba31603" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OperatingExpense"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsLineItems_4aa095d4-2ab3-4cd1-ac75-c9fc7cfd3e32" xlink:to="loc_ifrs-full_OperatingExpense_f304511a-c52c-4454-9ef0-90cd8ba31603" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.innate-pharma.com/role/OperatingexpensesAdditionalinformationDetails" xlink:type="simple" xlink:href="inpha-20260630.xsd#OperatingexpensesAdditionalinformationDetails"/>
  <link:presentationLink xlink:role="http://www.innate-pharma.com/role/OperatingexpensesAdditionalinformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AnalysisOfIncomeAndExpenseAbstract_87bb6b36-f315-451e-9be5-60a81d863b2c" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AnalysisOfIncomeAndExpenseAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_DisclosureOfOperatingExpensesTable_6cb25671-739c-4152-bb61-8d85ae57eb3a" xlink:href="inpha-20260630.xsd#inpha_DisclosureOfOperatingExpensesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AnalysisOfIncomeAndExpenseAbstract_87bb6b36-f315-451e-9be5-60a81d863b2c" xlink:to="loc_inpha_DisclosureOfOperatingExpensesTable_6cb25671-739c-4152-bb61-8d85ae57eb3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfContractsAxis_8c0cc69d-8670-4695-8cea-18a6d0424bee" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TypesOfContractsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inpha_DisclosureOfOperatingExpensesTable_6cb25671-739c-4152-bb61-8d85ae57eb3a" xlink:to="loc_ifrs-full_TypesOfContractsAxis_8c0cc69d-8670-4695-8cea-18a6d0424bee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfContractsDomain_1b21af8b-210a-42de-958d-5f8d816875f0" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TypesOfContractsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfContractsAxis_8c0cc69d-8670-4695-8cea-18a6d0424bee" xlink:to="loc_ifrs-full_TypesOfContractsDomain_1b21af8b-210a-42de-958d-5f8d816875f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_MonalizumabAgreementMember_3c763013-3421-47e8-8ea2-d01bda30f9f1" xlink:href="inpha-20260630.xsd#inpha_MonalizumabAgreementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfContractsDomain_1b21af8b-210a-42de-958d-5f8d816875f0" xlink:to="loc_inpha_MonalizumabAgreementMember_3c763013-3421-47e8-8ea2-d01bda30f9f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_TypeOfEmployeeAxis_6153545c-abcc-4050-a253-79db0bfbd65d" xlink:href="inpha-20260630.xsd#inpha_TypeOfEmployeeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inpha_DisclosureOfOperatingExpensesTable_6cb25671-739c-4152-bb61-8d85ae57eb3a" xlink:to="loc_inpha_TypeOfEmployeeAxis_6153545c-abcc-4050-a253-79db0bfbd65d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_TypeOfEmployeeDomain_c5720bb5-6341-4649-96dd-1d5ce129e5aa" xlink:href="inpha-20260630.xsd#inpha_TypeOfEmployeeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inpha_TypeOfEmployeeAxis_6153545c-abcc-4050-a253-79db0bfbd65d" xlink:to="loc_inpha_TypeOfEmployeeDomain_c5720bb5-6341-4649-96dd-1d5ce129e5aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_ResearchAndDevelopmentMember_d46064d0-4c62-4a35-a33f-b703112cf3da" xlink:href="inpha-20260630.xsd#inpha_ResearchAndDevelopmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inpha_TypeOfEmployeeDomain_c5720bb5-6341-4649-96dd-1d5ce129e5aa" xlink:to="loc_inpha_ResearchAndDevelopmentMember_d46064d0-4c62-4a35-a33f-b703112cf3da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_AdministrationMember_54928439-ee55-4163-b523-12ae1da96d67" xlink:href="inpha-20260630.xsd#inpha_AdministrationMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inpha_TypeOfEmployeeDomain_c5720bb5-6341-4649-96dd-1d5ce129e5aa" xlink:to="loc_inpha_AdministrationMember_54928439-ee55-4163-b523-12ae1da96d67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_DisclosureOfOperatingExpensesLineItems_8f69b41d-8987-4844-b543-228951d966a6" xlink:href="inpha-20260630.xsd#inpha_DisclosureOfOperatingExpensesLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inpha_DisclosureOfOperatingExpensesTable_6cb25671-739c-4152-bb61-8d85ae57eb3a" xlink:to="loc_inpha_DisclosureOfOperatingExpensesLineItems_8f69b41d-8987-4844-b543-228951d966a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ShorttermEmployeeBenefitsExpense_58d41423-d5d2-4474-8c3a-2b76f76a5a51" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ShorttermEmployeeBenefitsExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inpha_DisclosureOfOperatingExpensesLineItems_8f69b41d-8987-4844-b543-228951d966a6" xlink:to="loc_ifrs-full_ShorttermEmployeeBenefitsExpense_58d41423-d5d2-4474-8c3a-2b76f76a5a51" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NumberOfEmployees_6ab525a8-a2ea-4048-8e96-aec903bb6e2e" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NumberOfEmployees"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inpha_DisclosureOfOperatingExpensesLineItems_8f69b41d-8987-4844-b543-228951d966a6" xlink:to="loc_ifrs-full_NumberOfEmployees_6ab525a8-a2ea-4048-8e96-aec903bb6e2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DepreciationPropertyPlantAndEquipmentIncludingRightofuseAssets_78a802c2-d153-445e-9afb-cd19f9ac640a" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DepreciationPropertyPlantAndEquipmentIncludingRightofuseAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inpha_DisclosureOfOperatingExpensesLineItems_8f69b41d-8987-4844-b543-228951d966a6" xlink:to="loc_ifrs-full_DepreciationPropertyPlantAndEquipmentIncludingRightofuseAssets_78a802c2-d153-445e-9afb-cd19f9ac640a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.innate-pharma.com/role/NetfinancialincomelossDisclosureofnetfinancialincomelossDetails" xlink:type="simple" xlink:href="inpha-20260630.xsd#NetfinancialincomelossDisclosureofnetfinancialincomelossDetails"/>
  <link:presentationLink xlink:role="http://www.innate-pharma.com/role/NetfinancialincomelossDisclosureofnetfinancialincomelossDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AnalysisOfIncomeAndExpenseAbstract_03ced671-8d97-4835-94a7-58f827c3b10c" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AnalysisOfIncomeAndExpenseAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_InterestsAndGainsOnFinancialAssets_edc6d4d0-2b9d-4219-88bd-1fd66159295b" xlink:href="inpha-20260630.xsd#inpha_InterestsAndGainsOnFinancialAssets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AnalysisOfIncomeAndExpenseAbstract_03ced671-8d97-4835-94a7-58f827c3b10c" xlink:to="loc_inpha_InterestsAndGainsOnFinancialAssets_edc6d4d0-2b9d-4219-88bd-1fd66159295b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_ChangeInValuationAllowanceOfFinancialInstruments_194e4f48-edbb-4848-be0b-4d59745e364c" xlink:href="inpha-20260630.xsd#inpha_ChangeInValuationAllowanceOfFinancialInstruments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AnalysisOfIncomeAndExpenseAbstract_03ced671-8d97-4835-94a7-58f827c3b10c" xlink:to="loc_inpha_ChangeInValuationAllowanceOfFinancialInstruments_194e4f48-edbb-4848-be0b-4d59745e364c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ForeignExchangeGain_8d7370b9-b6f4-4fe4-b2b5-cd4cc7ae04ee" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ForeignExchangeGain"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AnalysisOfIncomeAndExpenseAbstract_03ced671-8d97-4835-94a7-58f827c3b10c" xlink:to="loc_ifrs-full_ForeignExchangeGain_8d7370b9-b6f4-4fe4-b2b5-cd4cc7ae04ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FinanceIncome_3679303a-0da1-487c-a274-31e99aacf192" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_FinanceIncome"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AnalysisOfIncomeAndExpenseAbstract_03ced671-8d97-4835-94a7-58f827c3b10c" xlink:to="loc_ifrs-full_FinanceIncome_3679303a-0da1-487c-a274-31e99aacf192" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ForeignExchangeLoss_1527e6c3-407f-4bba-a02b-4f1c9e34164d" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ForeignExchangeLoss"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AnalysisOfIncomeAndExpenseAbstract_03ced671-8d97-4835-94a7-58f827c3b10c" xlink:to="loc_ifrs-full_ForeignExchangeLoss_1527e6c3-407f-4bba-a02b-4f1c9e34164d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_UnrealizedLossesOnFinancialAssets_ebd55b1a-5025-46e6-a687-4fc17142131f" xlink:href="inpha-20260630.xsd#inpha_UnrealizedLossesOnFinancialAssets"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AnalysisOfIncomeAndExpenseAbstract_03ced671-8d97-4835-94a7-58f827c3b10c" xlink:to="loc_inpha_UnrealizedLossesOnFinancialAssets_ebd55b1a-5025-46e6-a687-4fc17142131f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_InterestExpense_877fc2a5-cfba-4a38-816e-e68e8b641b8c" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_InterestExpense"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AnalysisOfIncomeAndExpenseAbstract_03ced671-8d97-4835-94a7-58f827c3b10c" xlink:to="loc_ifrs-full_InterestExpense_877fc2a5-cfba-4a38-816e-e68e8b641b8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FinanceCosts_6862bcb0-0eb9-46de-a0b0-c20462883bc1" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_FinanceCosts"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AnalysisOfIncomeAndExpenseAbstract_03ced671-8d97-4835-94a7-58f827c3b10c" xlink:to="loc_ifrs-full_FinanceCosts_6862bcb0-0eb9-46de-a0b0-c20462883bc1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FinanceIncomeCost_45508cbe-cdc3-4721-adaa-d5f4300ec92b" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_FinanceIncomeCost"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AnalysisOfIncomeAndExpenseAbstract_03ced671-8d97-4835-94a7-58f827c3b10c" xlink:to="loc_ifrs-full_FinanceIncomeCost_45508cbe-cdc3-4721-adaa-d5f4300ec92b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.innate-pharma.com/role/IncometaxexpenseAdditionalinformationDetails" xlink:type="simple" xlink:href="inpha-20260630.xsd#IncometaxexpenseAdditionalinformationDetails"/>
  <link:presentationLink xlink:role="http://www.innate-pharma.com/role/IncometaxexpenseAdditionalinformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_inpha_IncomeTaxAbstract_f3556d85-14d4-4521-96cd-9f2ef264bad8" xlink:href="inpha-20260630.xsd#inpha_IncomeTaxAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable_1bcb1845-2f67-482b-9ff2-2be4cf92c5b4" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inpha_IncomeTaxAbstract_f3556d85-14d4-4521-96cd-9f2ef264bad8" xlink:to="loc_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable_1bcb1845-2f67-482b-9ff2-2be4cf92c5b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_bf99dddc-f43e-45b3-bec6-aba279ba862d" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_StatementScenarioAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable_1bcb1845-2f67-482b-9ff2-2be4cf92c5b4" xlink:to="loc_srt_StatementScenarioAxis_bf99dddc-f43e-45b3-bec6-aba279ba862d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_a5c52442-26e9-4845-9064-2170ec2e8c37" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementScenarioAxis_bf99dddc-f43e-45b3-bec6-aba279ba862d" xlink:to="loc_srt_ScenarioUnspecifiedDomain_a5c52442-26e9-4845-9064-2170ec2e8c37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioForecastMember_35e18922-7f87-4a25-92b8-cbde728f8c8d" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ScenarioForecastMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScenarioUnspecifiedDomain_a5c52442-26e9-4845-9064-2170ec2e8c37" xlink:to="loc_srt_ScenarioForecastMember_35e18922-7f87-4a25-92b8-cbde728f8c8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_DisclosureOfIncomeTaxLineItems_09b45dba-3045-4fa1-89f9-95fd8dfbf808" xlink:href="inpha-20260630.xsd#inpha_DisclosureOfIncomeTaxLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable_1bcb1845-2f67-482b-9ff2-2be4cf92c5b4" xlink:to="loc_inpha_DisclosureOfIncomeTaxLineItems_09b45dba-3045-4fa1-89f9-95fd8dfbf808" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_UnusedTaxLossesWithNoExpirationDate_1656dd72-0b4b-4ea5-9dbb-6292d0d7d007" xlink:href="inpha-20260630.xsd#inpha_UnusedTaxLossesWithNoExpirationDate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inpha_DisclosureOfIncomeTaxLineItems_09b45dba-3045-4fa1-89f9-95fd8dfbf808" xlink:to="loc_inpha_UnusedTaxLossesWithNoExpirationDate_1656dd72-0b4b-4ea5-9dbb-6292d0d7d007" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_UnusedTaxLossesSubjectToExpiration_0d5c293c-d5c1-47c2-bde8-de94af93687e" xlink:href="inpha-20260630.xsd#inpha_UnusedTaxLossesSubjectToExpiration"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inpha_DisclosureOfIncomeTaxLineItems_09b45dba-3045-4fa1-89f9-95fd8dfbf808" xlink:to="loc_inpha_UnusedTaxLossesSubjectToExpiration_0d5c293c-d5c1-47c2-bde8-de94af93687e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CurrentTaxExpenseIncome_f216d5a2-fa9d-4b35-b282-4cefea2ad461" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentTaxExpenseIncome"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inpha_DisclosureOfIncomeTaxLineItems_09b45dba-3045-4fa1-89f9-95fd8dfbf808" xlink:to="loc_ifrs-full_CurrentTaxExpenseIncome_f216d5a2-fa9d-4b35-b282-4cefea2ad461" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ApplicableTaxRate_bfe2bd0c-275f-4628-bdc9-ea6f70921bdc" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ApplicableTaxRate"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inpha_DisclosureOfIncomeTaxLineItems_09b45dba-3045-4fa1-89f9-95fd8dfbf808" xlink:to="loc_ifrs-full_ApplicableTaxRate_bfe2bd0c-275f-4628-bdc9-ea6f70921bdc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.innate-pharma.com/role/IncometaxexpenseDisclosureofDeferredAssetsandLiabilitiesDetails" xlink:type="simple" xlink:href="inpha-20260630.xsd#IncometaxexpenseDisclosureofDeferredAssetsandLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://www.innate-pharma.com/role/IncometaxexpenseDisclosureofDeferredAssetsandLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_inpha_IncomeTaxAbstract_64afae41-8b8e-4858-8e99-dc0572649023" xlink:href="inpha-20260630.xsd#inpha_IncomeTaxAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable_78cc7414-0711-489c-80e6-7433aa143ccc" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inpha_IncomeTaxAbstract_64afae41-8b8e-4858-8e99-dc0572649023" xlink:to="loc_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable_78cc7414-0711-489c-80e6-7433aa143ccc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_8badb142-5df4-41be-9d2b-e2d61b6d6469" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable_78cc7414-0711-489c-80e6-7433aa143ccc" xlink:to="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_8badb142-5df4-41be-9d2b-e2d61b6d6469" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsDomain_7db97a50-9477-4ac5-839b-1c661da4502c" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_8badb142-5df4-41be-9d2b-e2d61b6d6469" xlink:to="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsDomain_7db97a50-9477-4ac5-839b-1c661da4502c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_UnusedTaxLossesMember_b33ecc7a-cfa2-4886-bd78-3e5ec1223e6b" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_UnusedTaxLossesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsDomain_7db97a50-9477-4ac5-839b-1c661da4502c" xlink:to="loc_ifrs-full_UnusedTaxLossesMember_b33ecc7a-cfa2-4886-bd78-3e5ec1223e6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_ProvisionForDefinedBenefitObligationMember_b383c3c5-d280-4ac4-a7b0-72e88ba17d64" xlink:href="inpha-20260630.xsd#inpha_ProvisionForDefinedBenefitObligationMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsDomain_7db97a50-9477-4ac5-839b-1c661da4502c" xlink:to="loc_inpha_ProvisionForDefinedBenefitObligationMember_b383c3c5-d280-4ac4-a7b0-72e88ba17d64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherTemporaryDifferencesMember_3c1e8113-c56f-4c71-9a7f-69e9f0f2bfbd" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherTemporaryDifferencesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsDomain_7db97a50-9477-4ac5-839b-1c661da4502c" xlink:to="loc_ifrs-full_OtherTemporaryDifferencesMember_3c1e8113-c56f-4c71-9a7f-69e9f0f2bfbd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_ContractLiabilitiesMember_bcc33130-cd9b-446d-9e06-aebc6a636174" xlink:href="inpha-20260630.xsd#inpha_ContractLiabilitiesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsDomain_7db97a50-9477-4ac5-839b-1c661da4502c" xlink:to="loc_inpha_ContractLiabilitiesMember_bcc33130-cd9b-446d-9e06-aebc6a636174" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_LeaseContractMember_f6388e7a-8e6b-4ae7-9550-d191f4ac35e7" xlink:href="inpha-20260630.xsd#inpha_LeaseContractMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsDomain_7db97a50-9477-4ac5-839b-1c661da4502c" xlink:to="loc_inpha_LeaseContractMember_f6388e7a-8e6b-4ae7-9550-d191f4ac35e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_TaxAmortizationMember_6f648360-97a8-472f-b638-d6d6da0437fa" xlink:href="inpha-20260630.xsd#inpha_TaxAmortizationMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsDomain_7db97a50-9477-4ac5-839b-1c661da4502c" xlink:to="loc_inpha_TaxAmortizationMember_6f648360-97a8-472f-b638-d6d6da0437fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_480d59f0-be75-45a5-ba85-5a18b20ef909" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable_78cc7414-0711-489c-80e6-7433aa143ccc" xlink:to="loc_srt_StatementGeographicalAxis_480d59f0-be75-45a5-ba85-5a18b20ef909" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_60ccb3a0-b975-4401-8a0c-208f43ac0513" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_480d59f0-be75-45a5-ba85-5a18b20ef909" xlink:to="loc_srt_SegmentGeographicalDomain_60ccb3a0-b975-4401-8a0c-208f43ac0513" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_FR_96dac5fd-c88b-4ba0-b985-9d004f3d95d9" xlink:href="https://xbrl.sec.gov/country/2025/country-2025.xsd#country_FR"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_60ccb3a0-b975-4401-8a0c-208f43ac0513" xlink:to="loc_country_FR_96dac5fd-c88b-4ba0-b985-9d004f3d95d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_5d52d92c-c359-4e8c-b3da-352997cfeabd" xlink:href="https://xbrl.sec.gov/country/2025/country-2025.xsd#country_US"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_60ccb3a0-b975-4401-8a0c-208f43ac0513" xlink:to="loc_country_US_5d52d92c-c359-4e8c-b3da-352997cfeabd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_DisclosureOfIncomeTaxLineItems_7607acd8-3488-42e9-b243-5eb721f761e1" xlink:href="inpha-20260630.xsd#inpha_DisclosureOfIncomeTaxLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable_78cc7414-0711-489c-80e6-7433aa143ccc" xlink:to="loc_inpha_DisclosureOfIncomeTaxLineItems_7607acd8-3488-42e9-b243-5eb721f761e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_DeferredTaxAssetsOffsetAmount_645337c7-2715-4763-8186-e54217e10567" xlink:href="inpha-20260630.xsd#inpha_DeferredTaxAssetsOffsetAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inpha_DisclosureOfIncomeTaxLineItems_7607acd8-3488-42e9-b243-5eb721f761e1" xlink:to="loc_inpha_DeferredTaxAssetsOffsetAmount_645337c7-2715-4763-8186-e54217e10567" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_DeferredTaxLiabilitiesOffsetAmount_09a62f97-45d0-4d78-a07a-38b7fed70bde" xlink:href="inpha-20260630.xsd#inpha_DeferredTaxLiabilitiesOffsetAmount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inpha_DisclosureOfIncomeTaxLineItems_7607acd8-3488-42e9-b243-5eb721f761e1" xlink:to="loc_inpha_DeferredTaxLiabilitiesOffsetAmount_09a62f97-45d0-4d78-a07a-38b7fed70bde" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DeferredTaxAssets_e63d5827-e369-49cd-b48b-5c238c7e24e6" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DeferredTaxAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inpha_DisclosureOfIncomeTaxLineItems_7607acd8-3488-42e9-b243-5eb721f761e1" xlink:to="loc_ifrs-full_DeferredTaxAssets_e63d5827-e369-49cd-b48b-5c238c7e24e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.innate-pharma.com/role/CommitmentsDetails" xlink:type="simple" xlink:href="inpha-20260630.xsd#CommitmentsDetails"/>
  <link:presentationLink xlink:role="http://www.innate-pharma.com/role/CommitmentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_inpha_CommitmentsContingenciesAndLitigationsAbstract_0874165c-48ed-4f5f-901c-f934691af459" xlink:href="inpha-20260630.xsd#inpha_CommitmentsContingenciesAndLitigationsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfContingentLiabilitiesTable_c3705417-7fee-400c-9bf3-b2b3047285f6" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfContingentLiabilitiesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inpha_CommitmentsContingenciesAndLitigationsAbstract_0874165c-48ed-4f5f-901c-f934691af459" xlink:to="loc_ifrs-full_DisclosureOfContingentLiabilitiesTable_c3705417-7fee-400c-9bf3-b2b3047285f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfContractsAxis_64025650-86d6-4ee0-a7fd-7f0fe9b4b691" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TypesOfContractsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesTable_c3705417-7fee-400c-9bf3-b2b3047285f6" xlink:to="loc_ifrs-full_TypesOfContractsAxis_64025650-86d6-4ee0-a7fd-7f0fe9b4b691" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfContractsDomain_694d9034-c010-40db-aa56-b26515fc6b3e" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TypesOfContractsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfContractsAxis_64025650-86d6-4ee0-a7fd-7f0fe9b4b691" xlink:to="loc_ifrs-full_TypesOfContractsDomain_694d9034-c010-40db-aa56-b26515fc6b3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_PreclinicalServicesMember_d01fecb0-80ba-4c1b-af47-20c84ceb26d3" xlink:href="inpha-20260630.xsd#inpha_PreclinicalServicesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfContractsDomain_694d9034-c010-40db-aa56-b26515fc6b3e" xlink:to="loc_inpha_PreclinicalServicesMember_d01fecb0-80ba-4c1b-af47-20c84ceb26d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_ClinicalServicesMember_8451f7bd-2390-46ca-bfb4-cd2aa19a0434" xlink:href="inpha-20260630.xsd#inpha_ClinicalServicesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfContractsDomain_694d9034-c010-40db-aa56-b26515fc6b3e" xlink:to="loc_inpha_ClinicalServicesMember_8451f7bd-2390-46ca-bfb4-cd2aa19a0434" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfFinancialLiabilitiesAxis_62871ba9-7efd-44c3-b818-413b0708ed64" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfFinancialLiabilitiesAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesTable_c3705417-7fee-400c-9bf3-b2b3047285f6" xlink:to="loc_ifrs-full_ClassesOfFinancialLiabilitiesAxis_62871ba9-7efd-44c3-b818-413b0708ed64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_810be74c-c5de-4c4b-b885-932c49637479" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfFinancialLiabilitiesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfFinancialLiabilitiesAxis_62871ba9-7efd-44c3-b818-413b0708ed64" xlink:to="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_810be74c-c5de-4c4b-b885-932c49637479" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_LoanAgreementWithSocitGnraleMember_7040e5d6-786d-418d-87a8-bcfbddc529c6" xlink:href="inpha-20260630.xsd#inpha_LoanAgreementWithSocitGnraleMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_810be74c-c5de-4c4b-b885-932c49637479" xlink:to="loc_inpha_LoanAgreementWithSocitGnraleMember_7040e5d6-786d-418d-87a8-bcfbddc529c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfProvisionsAxis_f7573842-19c9-4b9d-97bd-7e9782a289b9" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfProvisionsAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesTable_c3705417-7fee-400c-9bf3-b2b3047285f6" xlink:to="loc_ifrs-full_ClassesOfProvisionsAxis_f7573842-19c9-4b9d-97bd-7e9782a289b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfOtherProvisionsDomain_3cd2de61-fc41-4fe0-bef8-349d5b425ef4" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfOtherProvisionsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfProvisionsAxis_f7573842-19c9-4b9d-97bd-7e9782a289b9" xlink:to="loc_ifrs-full_ClassesOfOtherProvisionsDomain_3cd2de61-fc41-4fe0-bef8-349d5b425ef4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LegalProceedingsProvisionMember_01a08bb6-28bc-7464-bdd5-a71425e43e36" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_LegalProceedingsProvisionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfOtherProvisionsDomain_3cd2de61-fc41-4fe0-bef8-349d5b425ef4" xlink:to="loc_ifrs-full_LegalProceedingsProvisionMember_01a08bb6-28bc-7464-bdd5-a71425e43e36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfContingentLiabilitiesLineItems_7a3ed04e-3e38-45cc-ac6f-8945de955f6a" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfContingentLiabilitiesLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesTable_c3705417-7fee-400c-9bf3-b2b3047285f6" xlink:to="loc_ifrs-full_DisclosureOfContingentLiabilitiesLineItems_7a3ed04e-3e38-45cc-ac6f-8945de955f6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_NonCancellableOffBalanceSheetPurchasedCommitments_003197d7-1fd8-404e-95f4-17a16e42216f" xlink:href="inpha-20260630.xsd#inpha_NonCancellableOffBalanceSheetPurchasedCommitments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesLineItems_7a3ed04e-3e38-45cc-ac6f-8945de955f6a" xlink:to="loc_inpha_NonCancellableOffBalanceSheetPurchasedCommitments_003197d7-1fd8-404e-95f4-17a16e42216f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_LoanAgreementCollateral_44328937-dc5b-4dcf-b869-c9b0111dee2d" xlink:href="inpha-20260630.xsd#inpha_LoanAgreementCollateral"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesLineItems_7a3ed04e-3e38-45cc-ac6f-8945de955f6a" xlink:to="loc_inpha_LoanAgreementCollateral_44328937-dc5b-4dcf-b869-c9b0111dee2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_SecurityInterestOnPledgeOfFinancialInstrumentsWillBeReleasedIn2024_e66d94ae-50fd-400e-a1fa-400ee08c50ce" xlink:href="inpha-20260630.xsd#inpha_SecurityInterestOnPledgeOfFinancialInstrumentsWillBeReleasedIn2024"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesLineItems_7a3ed04e-3e38-45cc-ac6f-8945de955f6a" xlink:to="loc_inpha_SecurityInterestOnPledgeOfFinancialInstrumentsWillBeReleasedIn2024_e66d94ae-50fd-400e-a1fa-400ee08c50ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_SecurityInterestOnPledgeOfFinancialInstrumentsWillBeReleasedIn2027_75f7b381-79dd-4778-bb3e-0c75fce3e440" xlink:href="inpha-20260630.xsd#inpha_SecurityInterestOnPledgeOfFinancialInstrumentsWillBeReleasedIn2027"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesLineItems_7a3ed04e-3e38-45cc-ac6f-8945de955f6a" xlink:to="loc_inpha_SecurityInterestOnPledgeOfFinancialInstrumentsWillBeReleasedIn2027_75f7b381-79dd-4778-bb3e-0c75fce3e440" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_SecurityInterestOnPledgeOfFinancialInstrumentsWillBeReleasedIn2031_cbf4b253-4df2-4427-ba0a-869046fa9181" xlink:href="inpha-20260630.xsd#inpha_SecurityInterestOnPledgeOfFinancialInstrumentsWillBeReleasedIn2031"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesLineItems_7a3ed04e-3e38-45cc-ac6f-8945de955f6a" xlink:to="loc_inpha_SecurityInterestOnPledgeOfFinancialInstrumentsWillBeReleasedIn2031_cbf4b253-4df2-4427-ba0a-869046fa9181" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_SecurityInterestOnPledgedFinancialInstrumentsReleasedIncludingInterest_921b1a8a-9174-4f0c-8295-9b353e11d60c" xlink:href="inpha-20260630.xsd#inpha_SecurityInterestOnPledgedFinancialInstrumentsReleasedIncludingInterest"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesLineItems_7a3ed04e-3e38-45cc-ac6f-8945de955f6a" xlink:to="loc_inpha_SecurityInterestOnPledgedFinancialInstrumentsReleasedIncludingInterest_921b1a8a-9174-4f0c-8295-9b353e11d60c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_PledgedCollateralMarginPercentage_01a03dc2-4d6c-7178-ad53-d2549f299d44" xlink:href="inpha-20260630.xsd#inpha_PledgedCollateralMarginPercentage"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesLineItems_7a3ed04e-3e38-45cc-ac6f-8945de955f6a" xlink:to="loc_inpha_PledgedCollateralMarginPercentage_01a03dc2-4d6c-7178-ad53-d2549f299d44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FinancialLiabilities_9fd390ae-6a9a-4362-8309-652bbdcd6b16" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_FinancialLiabilities"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesLineItems_7a3ed04e-3e38-45cc-ac6f-8945de955f6a" xlink:to="loc_ifrs-full_FinancialLiabilities_9fd390ae-6a9a-4362-8309-652bbdcd6b16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FinancialAssetsPledgedAsCollateralForLiabilitiesOrContingentLiabilities_01a03dc1-c8a9-7089-926a-9eade7b0147b" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_FinancialAssetsPledgedAsCollateralForLiabilitiesOrContingentLiabilities"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesLineItems_7a3ed04e-3e38-45cc-ac6f-8945de955f6a" xlink:to="loc_ifrs-full_FinancialAssetsPledgedAsCollateralForLiabilitiesOrContingentLiabilities_01a03dc1-c8a9-7089-926a-9eade7b0147b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_Provisions_01a08bb6-28bc-705f-9adc-241931236519" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_Provisions"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesLineItems_7a3ed04e-3e38-45cc-ac6f-8945de955f6a" xlink:to="loc_ifrs-full_Provisions_01a08bb6-28bc-705f-9adc-241931236519" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EstimatedFinancialEffectOfContingentLiabilities_01a08bb6-f2c5-7bf6-b6e7-82fbff65703c" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_EstimatedFinancialEffectOfContingentLiabilities"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesLineItems_7a3ed04e-3e38-45cc-ac6f-8945de955f6a" xlink:to="loc_ifrs-full_EstimatedFinancialEffectOfContingentLiabilities_01a08bb6-f2c5-7bf6-b6e7-82fbff65703c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.innate-pharma.com/role/ProvisionsDetails" xlink:type="simple" xlink:href="inpha-20260630.xsd#ProvisionsDetails"/>
  <link:presentationLink xlink:role="http://www.innate-pharma.com/role/ProvisionsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_inpha_CommitmentsContingenciesAndLitigationsAbstract_01a03dd7-2e1e-7887-b94a-10b922d67f61" xlink:href="inpha-20260630.xsd#inpha_CommitmentsContingenciesAndLitigationsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfContingentLiabilitiesTable_01a03dd8-2321-7537-a82b-dd931ce61318" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfContingentLiabilitiesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inpha_CommitmentsContingenciesAndLitigationsAbstract_01a03dd7-2e1e-7887-b94a-10b922d67f61" xlink:to="loc_ifrs-full_DisclosureOfContingentLiabilitiesTable_01a03dd8-2321-7537-a82b-dd931ce61318" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfProvisionsAxis_01a03dd8-2321-7dc8-bc8d-c1e77d4222cb" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfProvisionsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesTable_01a03dd8-2321-7537-a82b-dd931ce61318" xlink:to="loc_ifrs-full_ClassesOfProvisionsAxis_01a03dd8-2321-7dc8-bc8d-c1e77d4222cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfOtherProvisionsDomain_01a03dd8-2321-7d83-b914-fb4a452d72e0" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfOtherProvisionsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfProvisionsAxis_01a03dd8-2321-7dc8-bc8d-c1e77d4222cb" xlink:to="loc_ifrs-full_ClassesOfOtherProvisionsDomain_01a03dd8-2321-7d83-b914-fb4a452d72e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RestructuringProvisionMember_01a03dd8-adec-7f01-b2b1-2621f871a6ac" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RestructuringProvisionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfOtherProvisionsDomain_01a03dd8-2321-7d83-b914-fb4a452d72e0" xlink:to="loc_ifrs-full_RestructuringProvisionMember_01a03dd8-adec-7f01-b2b1-2621f871a6ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_EmployeeDepartureCompensationMember_01a03de3-62ea-7d8c-b18a-a6a48c4a7531" xlink:href="inpha-20260630.xsd#inpha_EmployeeDepartureCompensationMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfOtherProvisionsDomain_01a03dd8-2321-7d83-b914-fb4a452d72e0" xlink:to="loc_inpha_EmployeeDepartureCompensationMember_01a03de3-62ea-7d8c-b18a-a6a48c4a7531" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_ProvisionsForEmployeeBenefitsMember_01a08baa-ccbc-76dc-8e71-2dc6d36fc839" xlink:href="inpha-20260630.xsd#inpha_ProvisionsForEmployeeBenefitsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfOtherProvisionsDomain_01a03dd8-2321-7d83-b914-fb4a452d72e0" xlink:to="loc_inpha_ProvisionsForEmployeeBenefitsMember_01a08baa-ccbc-76dc-8e71-2dc6d36fc839" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LegalProceedingsProvisionMember_01a03de9-0169-7c45-a80b-5c49aaaeb078" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_LegalProceedingsProvisionMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfOtherProvisionsDomain_01a03dd8-2321-7d83-b914-fb4a452d72e0" xlink:to="loc_ifrs-full_LegalProceedingsProvisionMember_01a03de9-0169-7c45-a80b-5c49aaaeb078" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfContingentLiabilitiesLineItems_01a03dd8-2321-781d-9e61-b36a4648a916" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfContingentLiabilitiesLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesTable_01a03dd8-2321-7537-a82b-dd931ce61318" xlink:to="loc_ifrs-full_DisclosureOfContingentLiabilitiesLineItems_01a03dd8-2321-781d-9e61-b36a4648a916" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_Provisions_01a03dd8-2321-7749-970c-67498ea8939f" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_Provisions"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesLineItems_01a03dd8-2321-781d-9e61-b36a4648a916" xlink:to="loc_ifrs-full_Provisions_01a03dd8-2321-7749-970c-67498ea8939f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ReversalOfProvisionsForCostOfRestructuring_01a03ddf-22d6-75ac-8cf8-80547a747f6b" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ReversalOfProvisionsForCostOfRestructuring"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesLineItems_01a03dd8-2321-781d-9e61-b36a4648a916" xlink:to="loc_ifrs-full_ReversalOfProvisionsForCostOfRestructuring_01a03ddf-22d6-75ac-8cf8-80547a747f6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_EmployerContributionRateOnShareBasedPayments_01a08bb4-5618-78b9-996d-b0020b626c13" xlink:href="inpha-20260630.xsd#inpha_EmployerContributionRateOnShareBasedPayments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesLineItems_01a03dd8-2321-781d-9e61-b36a4648a916" xlink:to="loc_inpha_EmployerContributionRateOnShareBasedPayments_01a08bb4-5618-78b9-996d-b0020b626c13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EstimatedFinancialEffectOfContingentLiabilities_01a08bb2-671c-7f3d-8dea-f448e58543ac" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_EstimatedFinancialEffectOfContingentLiabilities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesLineItems_01a03dd8-2321-781d-9e61-b36a4648a916" xlink:to="loc_ifrs-full_EstimatedFinancialEffectOfContingentLiabilities_01a08bb2-671c-7f3d-8dea-f448e58543ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.innate-pharma.com/role/RelatedpartytransactionsDisclosureofkeymanagementpersonnelcompensationDetails" xlink:type="simple" xlink:href="inpha-20260630.xsd#RelatedpartytransactionsDisclosureofkeymanagementpersonnelcompensationDetails"/>
  <link:presentationLink xlink:role="http://www.innate-pharma.com/role/RelatedpartytransactionsDisclosureofkeymanagementpersonnelcompensationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RelatedPartyTransactionsAbstract_740c5dd4-7b98-47ef-a90b-f898a5e49401" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RelatedPartyTransactionsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits_ae84052a-4a4c-46c4-9ef1-1c5dbd990768" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RelatedPartyTransactionsAbstract_740c5dd4-7b98-47ef-a90b-f898a5e49401" xlink:to="loc_ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits_ae84052a-4a4c-46c4-9ef1-1c5dbd990768" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_KeyManagementPersonnelCompensationExtraPensionBenefits_8315e8f3-bb79-4398-9a66-920ff1e37460" xlink:href="inpha-20260630.xsd#inpha_KeyManagementPersonnelCompensationExtraPensionBenefits"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RelatedPartyTransactionsAbstract_740c5dd4-7b98-47ef-a90b-f898a5e49401" xlink:to="loc_inpha_KeyManagementPersonnelCompensationExtraPensionBenefits_8315e8f3-bb79-4398-9a66-920ff1e37460" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment_7d14490a-b28e-4710-bc86-f75b67d5392c" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RelatedPartyTransactionsAbstract_740c5dd4-7b98-47ef-a90b-f898a5e49401" xlink:to="loc_ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment_7d14490a-b28e-4710-bc86-f75b67d5392c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_KeyManagementPersonnelCompensationAdvisoryFees_d20a32e9-7848-40dc-9099-b4b04cddb28b" xlink:href="inpha-20260630.xsd#inpha_KeyManagementPersonnelCompensationAdvisoryFees"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RelatedPartyTransactionsAbstract_740c5dd4-7b98-47ef-a90b-f898a5e49401" xlink:to="loc_inpha_KeyManagementPersonnelCompensationAdvisoryFees_d20a32e9-7848-40dc-9099-b4b04cddb28b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_KeyManagementPersonnelCompensation_6a9e7540-27c3-4f95-b6ff-c6496240bf6e" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_KeyManagementPersonnelCompensation"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RelatedPartyTransactionsAbstract_740c5dd4-7b98-47ef-a90b-f898a5e49401" xlink:to="loc_ifrs-full_KeyManagementPersonnelCompensation_6a9e7540-27c3-4f95-b6ff-c6496240bf6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.innate-pharma.com/role/RelatedpartytransactionsAdditionalinformationDetails" xlink:type="simple" xlink:href="inpha-20260630.xsd#RelatedpartytransactionsAdditionalinformationDetails"/>
  <link:presentationLink xlink:role="http://www.innate-pharma.com/role/RelatedpartytransactionsAdditionalinformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RelatedPartyTransactionsAbstract_a82a8006-23c4-4223-8278-8998441350c0" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RelatedPartyTransactionsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable_21613dc3-5c29-42d2-a53a-ec3f0239f9d8" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RelatedPartyTransactionsAbstract_a82a8006-23c4-4223-8278-8998441350c0" xlink:to="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable_21613dc3-5c29-42d2-a53a-ec3f0239f9d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_7dc692f6-9b5f-4a93-9988-76aae2d98ba5" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CategoriesOfRelatedPartiesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable_21613dc3-5c29-42d2-a53a-ec3f0239f9d8" xlink:to="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_7dc692f6-9b5f-4a93-9988-76aae2d98ba5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CategoriesOfRelatedPartiesDomain_5f9b3575-4e83-4cf8-8663-2067c01cb471" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CategoriesOfRelatedPartiesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_7dc692f6-9b5f-4a93-9988-76aae2d98ba5" xlink:to="loc_ifrs-full_CategoriesOfRelatedPartiesDomain_5f9b3575-4e83-4cf8-8663-2067c01cb471" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_NovoNordiskASMember_53efc244-1db5-41bc-be8c-a588caadae1b" xlink:href="inpha-20260630.xsd#inpha_NovoNordiskASMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CategoriesOfRelatedPartiesDomain_5f9b3575-4e83-4cf8-8663-2067c01cb471" xlink:to="loc_inpha_NovoNordiskASMember_53efc244-1db5-41bc-be8c-a588caadae1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_SanofiAventisMember_aa2a75ce-1930-4b4d-ab58-f19f6d175408" xlink:href="inpha-20260630.xsd#inpha_SanofiAventisMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CategoriesOfRelatedPartiesDomain_5f9b3575-4e83-4cf8-8663-2067c01cb471" xlink:to="loc_inpha_SanofiAventisMember_aa2a75ce-1930-4b4d-ab58-f19f6d175408" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_c7b583df-3722-4167-9fae-50420508c8c1" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable_21613dc3-5c29-42d2-a53a-ec3f0239f9d8" xlink:to="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_c7b583df-3722-4167-9fae-50420508c8c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_ProvisionForExpensesWithRelatedParties_b5809d0d-6a00-4acd-8f80-a2dcfd86dc84" xlink:href="inpha-20260630.xsd#inpha_ProvisionForExpensesWithRelatedParties"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_c7b583df-3722-4167-9fae-50420508c8c1" xlink:to="loc_inpha_ProvisionForExpensesWithRelatedParties_b5809d0d-6a00-4acd-8f80-a2dcfd86dc84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_ProvisionForAttendanceFees_8dfd3f6f-76d0-463d-9335-e574fb84e817" xlink:href="inpha-20260630.xsd#inpha_ProvisionForAttendanceFees"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_c7b583df-3722-4167-9fae-50420508c8c1" xlink:to="loc_inpha_ProvisionForAttendanceFees_8dfd3f6f-76d0-463d-9335-e574fb84e817" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_NumberOfLicensingAgreementsWithRelatedParties_9ae0d01f-33d1-4986-b87e-936670a2dee1" xlink:href="inpha-20260630.xsd#inpha_NumberOfLicensingAgreementsWithRelatedParties"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_c7b583df-3722-4167-9fae-50420508c8c1" xlink:to="loc_inpha_NumberOfLicensingAgreementsWithRelatedParties_9ae0d01f-33d1-4986-b87e-936670a2dee1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AmountsPayableRelatedPartyTransactions_dda835b4-a40b-4736-a8ea-be7d186df2d6" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AmountsPayableRelatedPartyTransactions"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_c7b583df-3722-4167-9fae-50420508c8c1" xlink:to="loc_ifrs-full_AmountsPayableRelatedPartyTransactions_dda835b4-a40b-4736-a8ea-be7d186df2d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IssueOfEquity_ed69eb85-754e-449c-9cf1-7d6397c34304" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IssueOfEquity"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_c7b583df-3722-4167-9fae-50420508c8c1" xlink:to="loc_ifrs-full_IssueOfEquity_ed69eb85-754e-449c-9cf1-7d6397c34304" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_NumberOfCollaborationContracts_ee8f3777-c020-4231-b516-63b00dd7ed93" xlink:href="inpha-20260630.xsd#inpha_NumberOfCollaborationContracts"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_c7b583df-3722-4167-9fae-50420508c8c1" xlink:to="loc_inpha_NumberOfCollaborationContracts_ee8f3777-c020-4231-b516-63b00dd7ed93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.innate-pharma.com/role/RelatedpartytransactionsDisclosureoftransactionsbetweenrelatedpartiesDetails" xlink:type="simple" xlink:href="inpha-20260630.xsd#RelatedpartytransactionsDisclosureoftransactionsbetweenrelatedpartiesDetails"/>
  <link:presentationLink xlink:role="http://www.innate-pharma.com/role/RelatedpartytransactionsDisclosureoftransactionsbetweenrelatedpartiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RelatedPartyTransactionsAbstract_7480db9c-ccec-40ce-8765-17881d2a7e9c" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RelatedPartyTransactionsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable_5515a65d-995f-4759-8e2b-7e22765303e2" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RelatedPartyTransactionsAbstract_7480db9c-ccec-40ce-8765-17881d2a7e9c" xlink:to="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable_5515a65d-995f-4759-8e2b-7e22765303e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_5cc0c5a5-3a65-4b40-bae4-b5adf434dc95" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CategoriesOfRelatedPartiesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable_5515a65d-995f-4759-8e2b-7e22765303e2" xlink:to="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_5cc0c5a5-3a65-4b40-bae4-b5adf434dc95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CategoriesOfRelatedPartiesDomain_3523a2b2-febf-4638-b75d-078a1413d4cb" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CategoriesOfRelatedPartiesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_5cc0c5a5-3a65-4b40-bae4-b5adf434dc95" xlink:to="loc_ifrs-full_CategoriesOfRelatedPartiesDomain_3523a2b2-febf-4638-b75d-078a1413d4cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_AstraZenecaMember_17d44f6e-a9e3-4a63-97b1-27593a3a8740" xlink:href="inpha-20260630.xsd#inpha_AstraZenecaMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CategoriesOfRelatedPartiesDomain_3523a2b2-febf-4638-b75d-078a1413d4cb" xlink:to="loc_inpha_AstraZenecaMember_17d44f6e-a9e3-4a63-97b1-27593a3a8740" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_SanofiAventisMember_c90afcdb-59fd-4d9b-8e54-94226044ef8c" xlink:href="inpha-20260630.xsd#inpha_SanofiAventisMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CategoriesOfRelatedPartiesDomain_3523a2b2-febf-4638-b75d-078a1413d4cb" xlink:to="loc_inpha_SanofiAventisMember_c90afcdb-59fd-4d9b-8e54-94226044ef8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_e85ef5c2-3f43-4eb9-8734-cadb89f7208f" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable_5515a65d-995f-4759-8e2b-7e22765303e2" xlink:to="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_e85ef5c2-3f43-4eb9-8734-cadb89f7208f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CashAdvancesAndLoansFromRelatedParties_5affcc28-dd03-4da0-80f1-bd383a0ca32f" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CashAdvancesAndLoansFromRelatedParties"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_e85ef5c2-3f43-4eb9-8734-cadb89f7208f" xlink:to="loc_ifrs-full_CashAdvancesAndLoansFromRelatedParties_5affcc28-dd03-4da0-80f1-bd383a0ca32f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AmountsReceivableRelatedPartyTransactions_1bc3e8f8-89a4-4dc4-bbd0-ddf7e7b4c541" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AmountsReceivableRelatedPartyTransactions"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_e85ef5c2-3f43-4eb9-8734-cadb89f7208f" xlink:to="loc_ifrs-full_AmountsReceivableRelatedPartyTransactions_1bc3e8f8-89a4-4dc4-bbd0-ddf7e7b4c541" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CashAdvancesAndLoansMadeToRelatedParties_50964bce-2025-434b-8177-d5f4ffc02f7d" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CashAdvancesAndLoansMadeToRelatedParties"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_e85ef5c2-3f43-4eb9-8734-cadb89f7208f" xlink:to="loc_ifrs-full_CashAdvancesAndLoansMadeToRelatedParties_50964bce-2025-434b-8177-d5f4ffc02f7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AmountsPayableRelatedPartyTransactions_69c4b764-83d4-4da0-ae9f-f34021d0d32b" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AmountsPayableRelatedPartyTransactions"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_e85ef5c2-3f43-4eb9-8734-cadb89f7208f" xlink:to="loc_ifrs-full_AmountsPayableRelatedPartyTransactions_69c4b764-83d4-4da0-ae9f-f34021d0d32b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_NetCashAdvanceReceivedFromMadeToRelatedParties_33cce15b-93ec-4e52-b7ba-5f86abdb6473" xlink:href="inpha-20260630.xsd#inpha_NetCashAdvanceReceivedFromMadeToRelatedParties"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_e85ef5c2-3f43-4eb9-8734-cadb89f7208f" xlink:to="loc_inpha_NetCashAdvanceReceivedFromMadeToRelatedParties_33cce15b-93ec-4e52-b7ba-5f86abdb6473" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_NetAmountsReceivablePayableRelatedPartyTransactions_01a08027-84aa-7b2b-9e8c-ba690927e750" xlink:href="inpha-20260630.xsd#inpha_NetAmountsReceivablePayableRelatedPartyTransactions"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_e85ef5c2-3f43-4eb9-8734-cadb89f7208f" xlink:to="loc_inpha_NetAmountsReceivablePayableRelatedPartyTransactions_01a08027-84aa-7b2b-9e8c-ba690927e750" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.innate-pharma.com/role/IncomelosspershareSummaryofincomelosspershareDetails" xlink:type="simple" xlink:href="inpha-20260630.xsd#IncomelosspershareSummaryofincomelosspershareDetails"/>
  <link:presentationLink xlink:role="http://www.innate-pharma.com/role/IncomelosspershareSummaryofincomelosspershareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_inpha_IncomeLossPerShareAbstract_31d4d685-8c83-4f37-a6f9-f9cef00acec1" xlink:href="inpha-20260630.xsd#inpha_IncomeLossPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProfitLoss_97c73da9-7fcc-4f00-9ac1-3eba0f838a4d" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProfitLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inpha_IncomeLossPerShareAbstract_31d4d685-8c83-4f37-a6f9-f9cef00acec1" xlink:to="loc_ifrs-full_ProfitLoss_97c73da9-7fcc-4f00-9ac1-3eba0f838a4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_WeightedAverageShares_4d938d72-209c-4f31-aa37-f7ddd395fa3b" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_WeightedAverageShares"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inpha_IncomeLossPerShareAbstract_31d4d685-8c83-4f37-a6f9-f9cef00acec1" xlink:to="loc_ifrs-full_WeightedAverageShares_4d938d72-209c-4f31-aa37-f7ddd395fa3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BasicEarningsLossPerShare_83a409fb-ac59-437e-9ce4-ad4e23110d75" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BasicEarningsLossPerShare"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inpha_IncomeLossPerShareAbstract_31d4d685-8c83-4f37-a6f9-f9cef00acec1" xlink:to="loc_ifrs-full_BasicEarningsLossPerShare_83a409fb-ac59-437e-9ce4-ad4e23110d75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DilutiveEffectOfConvertibleInstrumentsOnNumberOfOrdinaryShares_9ce4dd85-1f2d-4a75-a764-15c2884ef454" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DilutiveEffectOfConvertibleInstrumentsOnNumberOfOrdinaryShares"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inpha_IncomeLossPerShareAbstract_31d4d685-8c83-4f37-a6f9-f9cef00acec1" xlink:to="loc_ifrs-full_DilutiveEffectOfConvertibleInstrumentsOnNumberOfOrdinaryShares_9ce4dd85-1f2d-4a75-a764-15c2884ef454" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DilutedEarningsLossPerShare_cc169fe5-5a9b-439d-b9fa-bd4f9f2b3477" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DilutedEarningsLossPerShare"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_inpha_IncomeLossPerShareAbstract_31d4d685-8c83-4f37-a6f9-f9cef00acec1" xlink:to="loc_ifrs-full_DilutedEarningsLossPerShare_cc169fe5-5a9b-439d-b9fa-bd4f9f2b3477" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.innate-pharma.com/role/IncomelosspershareDilutedincomelosspershareDetails" xlink:type="simple" xlink:href="inpha-20260630.xsd#IncomelosspershareDilutedincomelosspershareDetails"/>
  <link:presentationLink xlink:role="http://www.innate-pharma.com/role/IncomelosspershareDilutedincomelosspershareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AnalysisOfIncomeAndExpenseAbstract_01a03def-d864-7eba-ba96-3ead0cdb998a" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AnalysisOfIncomeAndExpenseAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_StatementOfChangesInEquityTable_01a03df2-03ac-72e0-a54c-91e337143e67" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_StatementOfChangesInEquityTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AnalysisOfIncomeAndExpenseAbstract_01a03def-d864-7eba-ba96-3ead0cdb998a" xlink:to="loc_ifrs-full_StatementOfChangesInEquityTable_01a03df2-03ac-72e0-a54c-91e337143e67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ComponentsOfEquityAxis_01a03df2-03ac-7168-a730-8f29e8e307f8" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ComponentsOfEquityAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityTable_01a03df2-03ac-72e0-a54c-91e337143e67" xlink:to="loc_ifrs-full_ComponentsOfEquityAxis_01a03df2-03ac-7168-a730-8f29e8e307f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ComponentsOfEquityDomain_01a03df2-03ac-75a8-967c-f4066d426d0d" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ComponentsOfEquityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ComponentsOfEquityAxis_01a03df2-03ac-7168-a730-8f29e8e307f8" xlink:to="loc_ifrs-full_ComponentsOfEquityDomain_01a03df2-03ac-75a8-967c-f4066d426d0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TreasurySharesMember_01a03df2-03ac-7375-8c76-665ad164e27e" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TreasurySharesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ComponentsOfEquityDomain_01a03df2-03ac-75a8-967c-f4066d426d0d" xlink:to="loc_ifrs-full_TreasurySharesMember_01a03df2-03ac-7375-8c76-665ad164e27e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_StatementOfChangesInEquityLineItems_01a03df2-03ac-7d16-9916-63f0e539390e" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_StatementOfChangesInEquityLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityTable_01a03df2-03ac-72e0-a54c-91e337143e67" xlink:to="loc_ifrs-full_StatementOfChangesInEquityLineItems_01a03df2-03ac-7d16-9916-63f0e539390e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted_01a08bc0-0eee-7ca9-83e5-db7033f204ef" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_01a03df2-03ac-7d16-9916-63f0e539390e" xlink:to="loc_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted_01a08bc0-0eee-7ca9-83e5-db7033f204ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NumberOfSharesOutstanding_01a03df2-03ac-726a-96e8-aabc57f61303" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NumberOfSharesOutstanding"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_01a03df2-03ac-7d16-9916-63f0e539390e" xlink:to="loc_ifrs-full_NumberOfSharesOutstanding_01a03df2-03ac-726a-96e8-aabc57f61303" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.innate-pharma.com/role/EventsafterthereportingdateDetails" xlink:type="simple" xlink:href="inpha-20260630.xsd#EventsafterthereportingdateDetails"/>
  <link:presentationLink xlink:role="http://www.innate-pharma.com/role/EventsafterthereportingdateDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodAbstract_f3d1e913-76ac-428f-8235-2b929ce7d01e" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable_8c1fc50e-2d00-4eba-9a16-d8aab00bb515" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodAbstract_f3d1e913-76ac-428f-8235-2b929ce7d01e" xlink:to="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable_8c1fc50e-2d00-4eba-9a16-d8aab00bb515" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_16a1991a-9fbb-48c1-9525-8e74e6f27d01" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NonadjustingEventsAfterReportingPeriodAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable_8c1fc50e-2d00-4eba-9a16-d8aab00bb515" xlink:to="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_16a1991a-9fbb-48c1-9525-8e74e6f27d01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodDomain_275c4209-25a7-4199-bbd1-ab30c69f77ff" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NonadjustingEventsAfterReportingPeriodDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_16a1991a-9fbb-48c1-9525-8e74e6f27d01" xlink:to="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodDomain_275c4209-25a7-4199-bbd1-ab30c69f77ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_StrategicPartnershipWithSwedishOrphanBiovitrumABMember_01a03e08-9f30-7539-b0af-8f2b18b84457" xlink:href="inpha-20260630.xsd#inpha_StrategicPartnershipWithSwedishOrphanBiovitrumABMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodDomain_275c4209-25a7-4199-bbd1-ab30c69f77ff" xlink:to="loc_inpha_StrategicPartnershipWithSwedishOrphanBiovitrumABMember_01a03e08-9f30-7539-b0af-8f2b18b84457" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_CapitalIncreaseMember_01a03e10-18f2-7fef-8938-70c28a6998dd" xlink:href="inpha-20260630.xsd#inpha_CapitalIncreaseMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodDomain_275c4209-25a7-4199-bbd1-ab30c69f77ff" xlink:to="loc_inpha_CapitalIncreaseMember_01a03e10-18f2-7fef-8938-70c28a6998dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RangeAxis_01a03e05-e46b-7323-9980-c949a2725239" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable_8c1fc50e-2d00-4eba-9a16-d8aab00bb515" xlink:to="loc_ifrs-full_RangeAxis_01a03e05-e46b-7323-9980-c949a2725239" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RangeDomain_01a03e05-e46b-7b51-85a5-5fc7352c6f06" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RangeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RangeAxis_01a03e05-e46b-7323-9980-c949a2725239" xlink:to="loc_ifrs-full_RangeDomain_01a03e05-e46b-7b51-85a5-5fc7352c6f06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_01a03e06-0e74-7447-ac7b-3bb264482e8a" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_MaximumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RangeDomain_01a03e05-e46b-7b51-85a5-5fc7352c6f06" xlink:to="loc_srt_MaximumMember_01a03e06-0e74-7447-ac7b-3bb264482e8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ComponentsOfEquityAxis_01a03e0c-823b-73ff-94b3-ae779d11b089" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ComponentsOfEquityAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable_8c1fc50e-2d00-4eba-9a16-d8aab00bb515" xlink:to="loc_ifrs-full_ComponentsOfEquityAxis_01a03e0c-823b-73ff-94b3-ae779d11b089" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ComponentsOfEquityDomain_01a03e0c-823b-7d20-b447-26bb5f9e522a" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ComponentsOfEquityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ComponentsOfEquityAxis_01a03e0c-823b-73ff-94b3-ae779d11b089" xlink:to="loc_ifrs-full_ComponentsOfEquityDomain_01a03e0c-823b-7d20-b447-26bb5f9e522a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IssuedCapitalMember_01a03e0c-94f6-76b8-b75b-b1dddc5ef75e" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IssuedCapitalMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ComponentsOfEquityDomain_01a03e0c-823b-7d20-b447-26bb5f9e522a" xlink:to="loc_ifrs-full_IssuedCapitalMember_01a03e0c-94f6-76b8-b75b-b1dddc5ef75e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_d07b5900-9c79-44dc-a46d-7808f2649ebf" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable_8c1fc50e-2d00-4eba-9a16-d8aab00bb515" xlink:to="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_d07b5900-9c79-44dc-a46d-7808f2649ebf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_UpfrontPaymentCommitment_01a03e04-00ad-7ce7-9bb9-30944dca43d4" xlink:href="inpha-20260630.xsd#inpha_UpfrontPaymentCommitment"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_d07b5900-9c79-44dc-a46d-7808f2649ebf" xlink:to="loc_inpha_UpfrontPaymentCommitment_01a03e04-00ad-7ce7-9bb9-30944dca43d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_NearTermDevelopmentMilestonePaymentsEligible_01a03e05-0010-7ada-9a84-17b2735d5503" xlink:href="inpha-20260630.xsd#inpha_NearTermDevelopmentMilestonePaymentsEligible"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_d07b5900-9c79-44dc-a46d-7808f2649ebf" xlink:to="loc_inpha_NearTermDevelopmentMilestonePaymentsEligible_01a03e05-0010-7ada-9a84-17b2735d5503" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_inpha_RegulatoryAndCommercialMilestonePaymentsEligible_01a03e07-7dcd-7032-a90b-785a5dd28423" xlink:href="inpha-20260630.xsd#inpha_RegulatoryAndCommercialMilestonePaymentsEligible"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_d07b5900-9c79-44dc-a46d-7808f2649ebf" xlink:to="loc_inpha_RegulatoryAndCommercialMilestonePaymentsEligible_01a03e07-7dcd-7032-a90b-785a5dd28423" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IssueOfEquity_01a03e0c-1cb2-7cda-8f17-c73c52999635" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IssueOfEquity"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_d07b5900-9c79-44dc-a46d-7808f2649ebf" xlink:to="loc_ifrs-full_IssueOfEquity_01a03e0c-1cb2-7cda-8f17-c73c52999635" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NumberOfSharesIssued_01a03e0d-bb90-7d1e-83d7-114cd420e6ad" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NumberOfSharesIssued"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_d07b5900-9c79-44dc-a46d-7808f2649ebf" xlink:to="loc_ifrs-full_NumberOfSharesIssued_01a03e0d-bb90-7d1e-83d7-114cd420e6ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ParValuePerShare_01a03e0e-3a03-79fd-b741-123f69c75240" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ParValuePerShare"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_d07b5900-9c79-44dc-a46d-7808f2649ebf" xlink:to="loc_ifrs-full_ParValuePerShare_01a03e0e-3a03-79fd-b741-123f69c75240" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
